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Abstract 
The present dissertation is focused in neonatal hyperbilirubinemia, a very common 
condition in the neonatal period, characterized by increased concentrations of unconjugated 
bilirubin (UCB). High levels of UCB may lead to bilirubin-induced neurologic dysfunction 
(BIND), particularly in premature infants, which may be a starting point to the appearance of 
long-term neurodevelopment disabilities. In cultures isolated from rat brain, toxicity induced 
by UCB is more pronounced in neuronal cells that in those from glia, and immature cells are 
more prone to this injury. Among the UCB-induced cytotoxic effects, are the extracellular 
accumulation of glutamate and the up-regulation of inflammatory pathways (mainly in glial 
cells), permeabilization of the mitochondrial membrane (in isolated mitochondria), impairment 
of neuritic development (in immature cortical and hippocampal neurons) and oxidative stress 
(in differentiated neurons). Firstly, we intended to better understand the mechanisms of 
neurotoxicity by UCB, mimicking a condition of prematurity, regarding oxidative stress, 
mitochondrial dysfunction associated with bioenergetic alterations and cell death, as well as 
to study the role of known modulators of oxidant species production in the prevention of 
UCB-induced neuronal injury. The obtained results showed that rat immature cortical 
neurons exposed to UCB undergo oxidative stress, mitochondrial dysfunction associated 
with respiration failure and cell death, effects that are prevented in the presence of 
glycoursodeoxycholic acid, a compound with antioxidant and anti-inflammatory properties. In 
addition, since prematurity is often associated with sepsis, these studies evaluated the 
additional effects of inflammation on hyperbilirubinemia. We demonstrated that UCB induced 
nitrosative stress, c-Jun N-terminal kinases 1 and 2 signalling and cell death and that these 
effects are intensified by pro-inflammatory cytokines tumor necrosis factor-α and interleukin-
1β, through the same cascade of mediators. Finally, it was investigated whether there is a 
dissimilar brain regional susceptibility to UCB-induced oxidative damage and neurite 
outgrowth and branching disruption in immature neurons, which might determine the 
preferential UCB deposition and brain damage in specific brain areas characteristic of 
kernicterus, such as cerebellum and hippocampus, and also the mechanisms that are 
involved in the modulation of UCB-induced neurotoxicity. Rat hippocampal neurons were the 
most susceptible to UCB-induced oxidative and nitrosative stress, as well as to UCB-induced 
neuritic impairment and cell death. N-acetylcysteine, a precursor of glutathione synthesis, 
was able to counteract the UCB-induced neurotoxicity. Taken together, these studies will 
substantiate target-driven approaches to the prevention and treatment of BIND, and provide 
fruitful opportunities for future investigations. 
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Resumo 
A presente dissertação é dirigida para o estudo da hiperbilirrubinémia neonatal, uma 
situação clínica frequente durante a primeira semana de vida, resultante da elevação das 
concentrações da bilirrubina não conjugada (BNC). A disfunção neurológica induzida pela 
bilirrubina (DNIB) poderá ser o ponto de partida para algumas doenças do 
neurodesenvolvimento, especialmente nos bebés prematuros. Utilizando modelos de 
culturas celulares obtidas a partir de cérebro de rato, verificou-se que a toxicidade induzida 
pela BNC é mais pronunciada em neurónios do que em astrócitos, sendo as células mais 
jovens particularmente susceptíveis. Do vasto leque de mecanismos moleculares envolvidos 
na toxicidade induzida pela BNC, destacam-se a acumulação de glutamato extracelular e a 
resposta inflamatória (nas células gliais), a diminuição do desenvolvimento neurítico (em 
neurónios do córtex e do hipocampo) e o stresse oxidativo (em neurónios diferenciados). 
Numa primeira fase, este trabalho teve como objectivo compreender os mecanismos 
associados à lesão pela BNC, no que respeita ao stresse oxidativo, disfunção mitocondrial e 
morte celular, assim como avaliar o efeito protector do ácido glico-ursodesoxicólico 
(AGUDC), um composto com propriedades anti-oxidantes, em condições que mimetizam 
uma situação de prematuridade. Para tal foram utilizadas culturas de neurónios corticais 
com 3 dias, obtidos de cérebros de rato. Neste modelo, a exposição à BNC conduziu ao 
stresse oxidativo, disfunção da respiração mitocondrial, e consequente morte celular, efeitos 
que foram prevenidos na presença do AGUDC. De seguida, avaliaram-se os efeitos 
adicionais da incubação concomitante da BNC com as citocinas pro-inflamatórias, 
mimetizando uma reacção inflamatória associada à hiperbilirrubinémia. Utilizando o mesmo 
modelo, observou-se que tanto o stresse nitrosativo, como a morte celular surgem 
aumentados após esta a incubação concomitante da BNC com as citocinas pro-
inflamatórias, estando envolvidos os mesmos mediadores e vias sinalizadoras. Por fim, 
investigou-se de que forma o padrão de deposição específico da BNC encontrado na 
patologia de kernicterus é determinado pela diferente vulnerabilidade regional à lesão 
oxidativa e ao desenvolvimento neurítico pela BNC. Para tal, isolaram-se neurónios não só 
do córtex mas também do hipocampo e do cerebelo de rato. Os neurónios do hipocampo 
mostraram ser mais susceptíveis ao stresse oxidativo e nitrosativo induzidos pela BNC, 
assim como à disfunção do desenvolvimento neurítico e à morte celular. A incubação com o 
precursor da síntese da glutationa N-acetilcisteína preveniu os efeitos tóxicos induzidos pela 
BNC. Em conclusão, estes resultados contribuem para o melhor conhecimento dos 
mecanismos moleculares subjacentes à DNIB no período neonatal, tendo as moléculas com 
capacidade anti-oxidante um efeito notório na prevenção desta disfunção.   
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1. Redox status and cellular bioenergetics in central nervous system: regulation and 
dysfunction 
 
1.1. Free radicals, reactive species and antioxidants 
Oxidative stress is classically defined as an imbalance between the levels of oxidants 
and antioxidants and has been implicated in the cell death pathways of several disorders in 
the central nervous system (CNS). Under normal circumstances, cells can regulate the 
production of oxidants and antioxidants, resulting in redox equilibrium. Oxidative stress 
occurs when cells are subjected to excess levels of reactive oxygen/nitrogen species 
(ROS/RNS), or as a result of depletion in antioxidant defences Figure I.1. ROS result from 
the body’s homeostatic response to the presence of molecular oxygen. Since it contains two 
unpaired electrons, molecular oxygen is considered to be a diradical, accordingly with the 
definition of a free radical - any chemical species containing one or more unpaired electrons 
occupying an atomic or molecular orbital and can generate highly reactive species (Poli et 
al., 2000). 
 
Figure I.1 - Oxidative stress results from imbalance between the levels of reactive oxygen 
and nitrogen species (ROS/RNS) and antioxidants. Under normal circumstances, cells are 
able to balance the production of ROS/RNS and antioxidants, resulting in redox equilibrium. 
Oxidative stress occurs when cells are subjected to excess levels of ROS/RNS, or as a result 
of depletion in antioxidant defences. 
ROS/RNS were originally considered to be exclusively detrimental to the cells but 
nowadays they are recognized as key modulators in cellular functions, such as regulation of 
redox cell signalling, gene modulation, neuromodulation, activation of signalling cascades, 
differentiation, apoptosis and necrosis (Circu and Aw, 2010, Finkel, 2000, Yoneyama et al., 
ROS/RNSAntioxidants
ROS/RNS
Antioxidants
Equilibrium
Oxidative stress
(Depleted Antioxidants)
ROS/RNS
Antioxidants
Oxidative stress
(Excess ROS/RNS)
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2010). Therefore, the classical concept of oxidative stress as “an imbalance between the 
production of oxidants and the occurrence of cell antioxidant defences”, proposed by Sies H. 
(Sies, 1997), is now being redefined as “a disruption of redox signalling and control that 
recognizes the occurrence of compartmentalized cellular redox circuits”, as reviewed by 
Packer and Cadenas (2007).  
Among ROS group, the most common species are: superoxide anion radical (O2.-), 
hydrogen peroxide (H2O2), peroxide anion (O22-) and hydroxyl radical (.OH). Among RNS, the 
most important species are peroxynitrite (ONOO-) and nitric oxide (.NO). Mitochondria are 
the main source of ROS, since generation of O2.- occurs during oxidative phosphorylation. 
O2.- is easily converted into H2O2 by the action of superoxide dismutase (SOD). H2O2 can 
originate .OH in the presence of iron (Fe2+) or copper (Cu+), by Fenton’s reaction. .OH is a 
very potent inducer of lipid peroxidation and, along with peroxidation products, such as 4-
hydroxy-2-nonenal (HNE), is capable of impairing protein and acid nucleic functions, as well 
as destroying cell membranes (Brito et al., 2007).  
.NO is a free radical generated from L-arginine, which is converted to L-citrulline in the 
presence of O2, reduced nicotinamide adenine dinucleotide phosphate (NADPH) and 
tetrahydrobiopterin, by a reaction catalysed by nitric oxide synthase (NOS) (Knowles et al., 
1989). In post-synaptic neurons, .NO is generated subsequently to activation of glutamate 
receptor, mainly of the N-methyl-D-aspartate (NMDA) subtype. After this activation, Ca2+ is 
transiently increased in the cytosol and forms a complex with calmodulin that binds to and 
activates constitutive neuronal NOS (nNOS). Glial cells (astrocytes, microglia and 
oligodendrocytes) synthesize .NO after the transcriptional expression of a Ca2+-independent 
inducible NOS (iNOS). There is a third isoform of NOS, endothelial NOS (eNOS), that is 
Ca2+-dependent (as nNOS) and is able to generate and release .NO from the brain 
microvessels (Knowles and Moncada, 1994, Merrill et al., 1997). Different isoforms of NOS 
are involved in distinct processes: nNOS is mainly involved in neuronal signalling, iNOS is 
generally induced after an inflammatory stimulus and eNOS is involved in vasodilation 
(Moncada and Bolaños, 2006). More recently, it was described a fourth isoform of NOS, 
mitochondrial NOS (mtNOS), in rat liver mitochondria (Ghafourifar and Richter, 1997). The 
mtNOS was identified as the splice variant α of the nNOS with the post-translational 
modifications of myristilation and phosphorylation (Elfering et al., 2002). Although the 
presence of mtNOS have been confirmed in several tissues, organs and cells, the NOS 
isozyme that accounts for the formation of mtNOS is still a matter of debate. However, as 
reviewed by Ghafourifar and Cadenas (2005), there is a growing notion that mtNOS is an 
enzyme associated with the matrix face of the mitochondrial inner membrane, which 
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generates .NO in a Ca2+-dependent manner. It is also believed that .NO produced by mtNOS 
regulates mitochondrial respiration. 
.NO can interact with O2.-, generating ONOO-, which is very unstable and also a potent 
inducer of lipid peroxidation. In addition, ONOO- participates in the nitration of tyrosine and in 
oxidation of glutathione, processes that can impair several cellular functions (Moncada and 
Bolaños, 2006). Besides being essential for neurotransmission, .NO accumulation leads to 
excitotoxicity caused by over-activation of NMDA receptors (Dawson et al., 1991). However, 
it should be taken into account that .NO is an important intercellular neuronal modulator and 
plays a fundamental role not only in neuronal death but also in neuronal survival pathways. 
Being an intercellular messenger, the rate and concentration of .NO are critical for its 
modulatory function in the brain, as reviewed by Laranjinha and Ledo (2007).       
In order to fight against oxidative injury, cells possess mechanisms to destroy or to expel 
reactive species; these are called antioxidant defences, which can be divided enzymatic and 
non-enzymatic systems. The most relevant antioxidant enzymes are SOD, catalase (CAT), 
glutathione peroxidase (GPx) and glutathione S-transferase (GST). SOD, CAT and GPx 
mainly have a preventive action, since they avoid oxidative damage by destroying or 
inactivating ROS. GST acts by a repair mechanism, eliminating ROS-derived molecules, 
such as hydroperoxides. Non-enzymatic systems are constituted by low molecular weight 
compounds that act against peroxyl radicals. Some examples are: (i) α-tocopherol, that 
inhibits lipid peroxidation by scavenging peroxyl radicals at the expense of a poorly reactive 
radical generation, α- tocopheryl; (ii) ascorbic acid, that is able to remove the radical α- 
tocopheryl, generating ascorbyl, a much less reactive radical; (iii) glutathione (γ-glutamyl-L-
cysteinylglycine), a tripeptide  that serves as subtract to GPx and GST and also reacts 
directly with radicals in non-enzymatic reactions, as represented in Figure I.2 (Brito et al., 
2007).  
Glutathione is the most abundant cellular thiol present in mammalian cells. This 
molecule constitutes one of the primary antioxidant defences of the cells, as it reacts directly 
with radicals in nonenzymatic reactions and is also a donor of electrons in the reduction of 
peroxides catalized by GPx (Dringen, 2000). The thiol group (SH) of cysteine serves as a 
proton donor and is responsible for the biological activity of glutathione. Provision of this 
amino acid is the rate-limiting factor in glutathione synthesis by the cells. In addition, 
glutathione is essential for cell proliferation (Cotgreave and Gerdes, 1998) and regulation of 
apoptosis (Ghibelli et al., 1998, Lu, 2009). In vivo, glutathione is synthesized by the action of 
two enzymes: (i) γ-glutamylcysteine synthetase, which uses L-glutamate and cysteine to form 
γ-glutamylcysteine; (ii) glutathione synthetase, which adds glycine to γ-glutamylcysteine, 
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originating the tripeptide glutathione. Both reactions require energy in the form of adenosine 
triphosphate (ATP), being the first one the rate-limiting step in glutathione synthesis (Dringen 
et al., 2000). Glutathione antioxidant action is extremely important in brain injury. In fact, 
glutathione levels are reported to be markedly decreased in case of ischemia-reperfusion 
lesion and inhibition of the enzymes involved in glutathione synthesis results in amplification 
of brain damage (Mizui et al., 1992). In addition, GPx activity is considered determinant in the 
recovery of the immature mouse brain subjected to traumatic brain injury (Tsuru-Aoyagi et 
al., 2009) and several in vitro and in vivo studies support the neuroprotective effect of N-
acetylcysteine (NAC), an important precursor of cellular glutathione (Dringen, 2000, 
Zachwieja et al., 2005) in lipid peroxidation and in antioxidant enzyme activities deficiencies 
of rats’ brain (Nehru and Kanwar, 2004), as well as in hypoxia-induced oxidative stress in rat 
cultured hippocampal neurons (Jayalakshmi et al., 2005). 
      
           
Figure I.2 – Schematic representation of glutathione protective role in oxidative stress. 
Glutathione reacts directly with radicals (R.) in non-enzimatic reactions and is also a donor of 
electrons in the reduction of peroxides (ROOH), a reaction catalyzed by glutathione 
peroxidase (GPx). The resulting oxidized glutathione (GSSG) is recycled through the action 
of glutathione reductase (GR), a reaction dependent of reduced nicotinamide adenine 
dinucleotide phosphate (NADPH). Adapted from Brito et al. (2007).  
 
Another compound that may have some antioxidant properties is bilirubin. The ability of 
low nanomolar concentrations of bilirubin to overcome large amounts of oxidants by 
efficiently scavenge peroxyl radicals was explained by a redox cycling mechanism, whereas 
biliverdin reductase plays a key role. Through this catalytic cycle, and as schematically 
represented in Figure I.3, bilirubin is oxidized to biliverdin by reactive species, neutralizing 
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their toxicity, and then is regenerated by the action of biliverdin reductase, an enzyme 
dependent of NADPH (Barañano et al., 2002, Stocker et al., 1987, Brito et al., 2006).  
 
              
Figure I.3 – Amplification of the antioxidant properties of bilirubin by a redox cycling 
mechanism. Large amounts of oxidant species (R•) can be neutralized (RH) through bilirubin 
oxidation to biliverdin, which is rapidly reduced back to bilirubin by biliverdin reductase, a 
reaction dependent of nicotinamide adenine dinucleotide phosphate (NADPH). Adapted from 
Brito et al. (2006). 
 
1.2. Pathways of glucose utilization 
Maintenance of cellular activity within CNS requires large amounts of energy. Catabolic 
pathways, in which organic nutrient molecules are converted into smaller and simpler end 
products such as lactic acid, carbon dixode (CO2) and ammonia (NH3), release energy, some 
of which is conserved in the formation of ATP and reduced electron carriers [reduced 
nicotinamide adenine dinucleotide (NADH), NADPH, and  reduced flavin adenine 
dinucleotide (FADH2)]; the rest is lost as heat. In spite of fatty acids and aminoacids can be 
bioenergetic precursors, glucose constitutes the main source of energy for most cells, being 
the only one in the brain. Glucose is stored as high molecular weight polymers, such as 
glycogen. However, glycogen stores are very limited in the brain, thus a permanent glucose 
supply via the blood stream is necessary in order to maintain brain function. In the resting 
brain, oxygen is mainly used for the oxidation of glucose. In fact, although brain represents 
only ~2% of the total body weight, it contributes to more that 20% of the total consumption of 
both oxygen and glucose. When energy demands increase, glucose is released from 
glycogen and used to produce ATP either aerobically or anaerobically. In the first step of 
glycolysis, glucose is activated for subsequent reactions by its phosphorylation to yield 
glucose 6-phosphate (G6P), with ATP as the phosphoryl donor, in an irreversible reaction 
catalyzed by hexokinase. G6P is then degraded during the sequential reactions of glycolysis, 
NADPH
NADP2 R
.
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where some of the free energy is conserved in the form of ATP and NADH. This process 
occurs in the cytosol. The end product of glycolysis is pyruvate, which may have three 
distinct metabolic fates, depending on tissue and environmental conditions (Nelson and Cox, 
2005). Under normoxic conditions, pyruvate is converted into acetyl-coenzyme A by pyruvate 
dehydrogenase (PDH) complex, a cluster of enzymes located in the mitochondria of 
eukaryotic cells. The acetyl group is then oxidized to CO2 in the tricarboxylic acid cycle 
(TCA), a process where energy of oxidation is temporarily held in the electron carriers FADH2 
and NADH. The electrons resulting from these oxidations are passed to O2 through a chain 
of carriers in the mitochondria (mitochondrial respiratory chain), in a process called oxidative 
phosphorylation. The energy released by the flow of electrons through the mitochondrial 
respiratory chain complexes is used to pump protons out of the inner mitochondria 
membrane through complexes I (NADH dehydrogenase), II (succinate dehydrogenase), III 
(ubiquinone: cytochrome c oxidoreductase) and IV (cytochrome c oxidase), coupling NADH 
oxidation and passage of protons between mitochondrial matrix and intermembrane space. 
This passage generates an electrochemical gradient across the inner mitochondrial 
membrane, called proton-motive force, which drives protons back into the matrix, providing 
the energy necessary for ATP synthesis, by the phosphorylation of ADP into ATP by F0F1-
ATPase (complex V, ATP synthase), a process denominated chemiosmotic theory. O2 
serves as the ultimate electron acceptor and is reduced to water (Nicholls and Ferguson, 
2002, Bolaños et al., 2010). Pathways of glucose utilization are schematically represented in 
Figure I.4. 
Under conditions of hypoxia or anoxia, or in case of impairment of the components of the 
mitochondrial respiratory chain, NADH cannot be re-oxidized to nicotinamide adenine 
dinucleotide (NAD), in spite of its requirement as an electron acceptor for the further 
oxidation of pyruvate. Under these conditions, glycolytic rate increases and pyruvate is 
reduced to lactate, accepting electrons from NADH and thereby regenerating the NAD 
necessary for glycolysis to continue. Although this process is less efficient from 
bioenergetics’ point of view, it may occur in a necessary level to provide the energetic needs 
of the cells. This alternative is made at the expense of an increase rate in glucose 
consumption (Nicholls and Ferguson, 2002).  
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Figure I.4 - Schematic representation of glucose utilization pathways. Glucose catabolism 
can be divided into three stages: (i) glycolysis, where glucose is metabolized in enzimatic 
sequential reactions. In aerobic conditions, the end product is pyruvate. During glycolysis, a 
small portion of free energy is conserved in the form of adenosine triphosphate (ATP) and 
the electron carrier reduced nicotinamide adenine dinucleotide (NADH); (ii) tricarboxylic acid 
cycle (TCA), a process where energy of oxidation is temporarily held in the electron carriers 
reduced flavin adenine dinucleotide (FADH2) and NADH and also conserved in the form of 
ATP; (iii) oxidative phosphorylation, where the electrons carried by NADH and FADH2 passes 
through a chain of carriers in the mitochondria, that constitute the respiratory chain. This 
passage generates an electrochemical gradient across the mitochondrial inner membrane, 
providing the energy necessary for ATP synthesis. An alternative pathway for glucose 
utilization is the pentose phosphate pathway, necessary for the maintenance of redox 
capacity of the cell, with the formation of reduced nicotinamide adenine dinucleotide 
phosphate (NADPH). Adapted from “Cellular respiration” from Department of Biology, 
University of Miami (2007).  
 
In addition, G6P (the branching point of glucose metabolism) can be metabolized in the 
pentose-phosphate pathway (PPP), an oxidative pathway where G6P is decarboxylated to 
form ribose-5-phosphate, being NADPH the electron carrier that conserves the redox 
potential. More important than participating in a bioenergetic metabolic route, NADPH is the 
cofactor necessary for many reducing reactions, mainly those involved in fatty acids 
biosynthesis and regeneration of reduced glutathione. The rate-limiting step of PPP is the 
conversion of G6P into 6-phosphogluconate, catalyzed by glucose-6-phosphate 
dehydrogenase (G6PD), an enzyme that is activated by oxidized glutathione (Eggleston and 
Krebs, 1974) and in conditions of oxidative stress, in order to provide cytoprotection (Kletzien 
et al., 1994). In addition, G6PD activation exerts its neuroprotective effects against .NO-
mediated apoptosis and glutathione depletion through up-regulation of PPP, which will 
increase NADPH regeneration (García-Nogales et al., 2003, García-Nogales et al., 1999). 
Therefore, NADPH plays a key role for the regeneration of reduced glutathione (GSH) from 
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its oxidized form (GSSG), demonstrating that PPP is tightly connected with the maintenance 
of cellular redox status (Figure I.5).   
 
Figure I.5 - Branching point of glucose utilization. Glucose-6-phosphate (G6P), the 
metabolite resulting from glucose catalyzed by hexokinase, is metabolized either in glycolysis 
[first reaction catalyzed by glucose-6-phosphate isomerase (G6PI)] or in pentose phosphate 
pathway [first reaction catalyzed by glucose-6-phosphate dehydrogenase (G6PD)]. The main 
goal of glycolysis and subsequent metabolic pathways is energy production, whereas the 
main goal of pentose phosphate pathway is the maintenance of redox capacity of the cell, 
mainly due to production of reduced nicotinamide adenine dinucleotide phosphate (NADPH). 
NADPH is an essential cofactor for glutathione reductase activity, which is responsible for 
regeneration of reduced glutathione (GSH) from oxidized form (GSSG).  
 
1.3. Mitochondria: the powerhouse of the cell and the major source of ROS/RNS  
Mitochondria is the site where the oxidative phosphorylation machinery occurs. 
However, during oxidative phosphorylation in mitochondria, electrons can directly react with 
O2, generating ROS. As mentioned in section 1.2, O2 is the ultimate acceptor of electrons 
that flow through mitochondrial respiratory chain complexes. However, electron leak to 
oxygen through complexes I and III can generate O2.- (Figure I.6).  
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Figure I.6 - Respiratory chain is the major source of reactive species. The mitochondrial 
respiratory chain is embedded in the inner mitochondrial membrane (IM) and consists of 
complexes I–IV, coenzyme Q [ubiquinone (Q)] and ATP synthase (also denominated 
complex V). Cytochrome c is also a member of the chain, the only one present in the 
intermembrane space (IMS). These complexes are disposed in an electrochemical hierarchy 
based on their redox potentials. Electrons enter the chain through oxidation of either NADH 
at complex I or FADH2 at complex II and flow down the chain to complex IV to reduce O2 to 
H2O. However some O2 is reduced incompletely to superoxide anion (O2-.) at the level of 
complexes I and III. In addition, mitochondria possess a NOS isoform (mtNOS), which is 
associated with the IM and generates nitric oxide (.NO) in a Ca2+-dependent manner. 
Mitochondrial .NO competes with O2 for binding to complex IV and regulates mitochondrial 
respiration. .NO produced by mtNOS reacts readily with O2-. and produces the powerful 
oxidative species peroxynitrite (ONOO-). ONOO- produced inside mitochondria causes the 
release of cyto c and increases the peroxidation of mitochondrial membrane lipids. Outer 
mitochondrial membrane (OM). Adapted from Ghafourifar and Cadenas (2005).   
 
The rate of O2.- production is affected by mitochondrial metabolic state and increases 
when the electron carriers harbor excess electrons, either from inhibition of oxidative 
phosphorylation or from excessive calorie consumption (Nohl et al., 2005). In addition to O2.- 
production, mitochondria also produces .NO, through the activity of mtNOS (Ghafourifar and 
Cadenas, 2005, Ghafourifar and Richter, 1997). .NO is a physiological regulator of 
mitochondrial respiration. In the arterioles, .NO promotes vasodilatation, increasing blood 
flow and O2 delivery to the tissues (Clementi et al., 1999). However, .NO is capable of rapidly 
and reversibly inhibit the mitochondrial respiratory chain by inhibition of complex IV, which 
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may be implicated in the cytotoxic effects in the CNS (Bolaños et al., 1994, Brown and 
Cooper, 1994, Cleeter et al., 1994). When .NO is present at persistent higher concentrations, 
it acts irreversibly at multiple sites, such as destruction of heme, compromising cellular 
energy metabolism (Sharpe and Cooper, 1998). Additionally, inhibition of the mitochondrial 
transport chain at the level of complex IV can further produce O2.- from O2 due to the 
interruption of electron flow. O2.- can also react with .NO, generating the highly reactive 
ONOO-. Damage to mitochondria by neurotoxins [such as 1-methyl-4-phenylpyridinium ion 
(MPP+) and rotenone] generates more ROS from the electron transport chain and causes 
oxidative damage that modifies proteins and other biomolecules (Szeto, 2006). Other 
conditions can favor ROS production in the mitochondria, such as are high membrane 
potentials, hyperoxia, excessive Ca2+ uptake and anoxia/reoxygenation (Kowaltowski, 2000).  
 
1.4. Dysfunctional mitochondria  
Mitochondria plays a central position in the production of ATP and the decline of basal 
metabolic rate and of physical performance in energy-requiring tasks is characteristic of 
several neurological disorders. One example is mitocondrial dysfunction during the aging 
process (Navarro and Boveris, 2007). An age-dependent impairment of mitochondrial 
function includes: decreased electron transfer rates, increased permeability to H+ of the inner 
membrane, and impairment of the driven ATP synthesis according to chemiosmotic theory. 
As reviewed in Navarro & Boveris (2007), complexes I and IV activities are selectively 
inhibited in isolated mitochondria from rat and mice liver, brain, heart, and kidney upon aging, 
whereas complexes II and III are generally unaffected. Regarding enzyme activities of the 
TCA cycle, only aconitase activity exhibited a significant decrease with age in isolated 
mitochondria from kidneys of old mice and α-ketoglutarate dehydrogenase activity was 
modestly decreased (Yarian et al., 2006). In the same study, the ratio of the 
intramitochondrial redox indicator, NADPH/NADP+, was higher in young animals in 
comparison to old ones, while the NADH/NAD+ ratio remained unchanged. Other metabolic 
enzymes are reported to be selectively inhibited during the aging process, such as acyl 
carnitine transferase, which catalyzes fatty acid transport to the mitochondrial matrix, thus 
being essential for mitochondrial function (Liu et al., 2002). In addition, key glycolytic 
enzymes activities, such as pyruvate kinase, α-enolase and triosephosphate isomerase, also 
showed to be decreased in aging male monkey hearts (Yan et al., 2004).  
Other neurological disorders present features of mitochondrial dysfunction, such as 
hypoxia-ischemia. As reviewed by Vannucci et al. (2004), a cerebral hypoxic–ischemic event 
rapidly depletes tissue energy reserves, promotes acidosis, glutamate excitotoxicity, 
generation of ROS, with consequent inflammation and cell death (Vannucci and Hagberg, 
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2004). In addition, cultured neurons under conditions of hypoxia-ischemia demonstrated 
specific loss of mitochondrial complex I activity, mitochondrial membrane collapse, ATP 
depletion and consequent cell death (Almeida et al., 2002).  
Mitochondrial dysfunction is also verified in sepsis. In fact, several studies have 
implicated pro-inflammatory mediators in the impairment of metabolic function, namely at the 
level of mitochondrial respiratory chain complexes and ATP production (Haden et al., 2007, 
Suliman et al., 2004). Structural alterations of mitochondria were also found in intestinal 
epithelial cells, hepatocytes and cardiomyocytes from septic animals, as reviewed by Wendel 
and Heller (2010). Coupled with this less energetic efficiency, these neurological disorders 
also present an increased production of free radicals, ROS and RNS in the mitochondria, 
(Beckman and Ames, 1998, Sener et al., 2005, Vannucci and Hagberg, 2004, Wendel and 
Heller, 2010). As a result, several mitochondrial proteins become nitrated, such as those 
involved in TCA cycle, complex I, MnSOD, complex V, among others (Kanski et al., 2005), 
which may cause inhibition of enzymatic activity. As a consequence, the mitochondrial 
capacity to produce ATP is seriously compromised in this process.  
 
 
2. Neuronal-glia actions and interplay in the brain  
Brain tissue encloses a complex network of different cells, each one with unique 
structure and function. Neurons are the functioning unit of the CNS, with long processes 
called dendrites and axons. Dendrites are multiple filaments that arise from the cell body, 
often extending for hundreds of microns and branching multiple times, whereas axons are 
single and usually ramified filaments that arise from the cell body. The interconnection of 
these processes enables the reception, integration and transmission of information (Purves 
et al., 2004). In contrast to neurons, glial cells do not fire action potentials, but instead 
surround and enwrap neuronal cell bodies, axons and synapses throughout the CNS (Allen 
and Barres, 2009). Astrocytes comprise about 85% of all glial cells, and contribute to the 
maintenance of vascular, ionic, redox and metabolic homeostasis in the brain by providing 
neurons with energy and substrates for neurotransmission, as well as glutathione precursors 
(Allen and Barres, 2005, Dringen, 2000). Besides different brain cells have their own 
particular functions and specialized machinery, bidirectional communication actually occurs 
between neurons and astrocytes. This communication is essential in the maintenance of 
several cellular processes, such as redox status regulation and metabolic pathways.   
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2.1. Glutathione shuttle 
As mentioned in section 1.1, glutathione is synthesized by the action of two enzymes, at 
the expense of ATP. Intracellular levels of glutathione are controlled by negative feedback of 
γ-glutamylcysteine synthetase, thus, keeping glutathione homeostasis. These metabolic 
steps occur in both neurons and astrocytes, however these two nerve cells use different 
precursors for glutathione synthesis. In astrocytes, glutathione levels are limited by glutamate 
content, and glutamine serves as a glutamate precursor when this aminoacid is not present. 
In these cells, NAC and, most importantly, cystine serve as cysteine donors. However, since 
neurons are not able to use cystine as cysteine donor, astrocytes supply the precursors 
necessary for glutathione biosynthesis in neurons. Glutathione released by astrocytes is 
hydrolyzed originating the dipeptide cysteine-glycine, which will be further hydrolyzed into 
cysteine and glycine, taken up for neuronal usage (Dringen, 2000), as schematically 
represented on Figure I.7.  
Astrocytes also contain higher concentrations of glutathione, as well as greater activities 
of enzymes involved in glutathione metabolism than neurons (Makar et al., 1994), indicating 
that they are more resistant to ROS and that this ROS scavenging mechanism may function 
to support neuronal survival. In fact, neurons co-cultured with astrocytes show increased 
resistance to injury induced by .NO, H2O2 or O2.- than neurons cultured alone (Desagher et 
al., 1996, Haskew-Layton et al., 2010, Lucius and Sievers, 1996) and differences in 
glutathione content of neurons and astrocytes contribute to the increased susceptibility of 
neurons to toxic agents that induce protein oxidation, such as unconjugated bilirubin (Brito et 
al., 2008b).   
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Figure I.7 - Schematic view of interplay between astrocytes and neurons regarding 
glutathione metabolism. Neurons and astrocytes synthesize reduced glutathione (GSH) by 
the action of two enzymes: γ-L-glutamyl-L-cysteinylglycine (γGluCys) synthase, which uses 
glutamate (Glu) and cysteine (Cys) as substrates and GSH synthase, which combines 
γGluCys with Gly. While astrocytes are able to take up cystine through sodium independent 
channel and break it down to yield Cys. In contrast, neurons cannot use cystine as a Cys 
donor, therefore in these cells the rate limiting step of GSH synthesis is the usage of Cys and 
neurons rely on astrocytes for GSH synthesis. Reactive oxygen species (ROS) oxidize GSH 
to oxidized glutathione (GSSG), which is recycled back to GSH by the action of glutathione 
reductase (GR). Glutamine (Gln) and glycine (Gly). Adapted from Brito et al. (2007). 
 
2.2. Glutamate shuttle 
Glutamate toxicity plays an important role in neuronal cell death during brain injury (Yi 
and Hazell, 2006). Therefore, control of extracellular glutamate levels is very important to the 
prevention of neuronal excitotoxicity by excessive activation of glutamate receptors. 
Astrocytes have an essential role in the maintenance of glutamate levels under the toxic 
threshold, since they have Na+-dependent transporters which are responsible for the 
clearance of glutamate from extracellular space, at the expense of ATP (Anderson and 
Swanson, 2000). As schematically represented in Figure I.8, once taken up by astrocytes, 
glutamate can be metabolized in different ways, of which glutamine formation and entry into 
the TCA cycle are the most important. Glutamine formation is catalyzed by glutamine 
synthetase, an enzyme present in astrocytes and in oligodendrocytes, but absent in neurons 
(Suárez et al., 2002). Neuronal glutamate is also formed from α-ketoglutarate, a metabolite 
produced in TCA cycle. Astrocytes take up leucine and transfer its amino group to                
Neurons relie on astrocytes for GSH synthesis (Glu‐Cys‐Gly)
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α-ketoglutarate by the action of branched-chain aminoacid transaminase, originating           
α-ketoisocaproate. α-ketoisocaproate is then transferred to neurons and can originate         
α-ketoglutarate by the reverse reaction (Daikhin and Yudkoff, 2000). Oxidative metabolism of 
α-ketoglutarate produces more than 30 ATP, about 20-fold more than required for glutamate 
uptake. In conditions of oxidative stress there is ATP depletion, which originates cessation of 
glutamate uptake in astrocytes, together with its efflux. Accumulation of glutamate in the 
synaptic cleft results in excitotoxicity phenomenon and neuronal death (Santos et al., 1996). 
Therefore, astrocytes play an important role in the protection against oxidative stress-
induced excitotoxicity (de Arriba et al., 2006). In addition, astrocytes do use glutamate 
released by neurons, for example in the synthesis of glutathione, as mentioned in 2.1, thus 
removing excess of glutamate from the brain, which can be toxic when in elevated levels 
(Dringen and Hamprecht, 1996).   
 
 
 
Figure I.8 – Schematic view of interplay between astrocytes and neurons regarding 
glutamate metabolism. Astrocytes support neuronal glutamate metabolism. Glutamate (Glu) 
is released during neurotransmission and is taken up primarily by neighboring astrocytes 
through excitatory amino acid transporters. A portion of astrocytic Glu is converted to 
glutamine (Gln) by glutamine synthetase, which is abundant in astrocytes and absent in 
neurons. Gln is released from astrocytes and taken up by neurons through specific 
transporters. In neurons, Gln is deaminated into Glu by mitochondrial glutaminase. Neuronal 
Glu is also formed from α-ketoglutarate (α-KG). Astrocytes take up leucine (Leu), and the 
amino group of Leu is transferred to α-KG by branched-chain amino acid (BCAA) 
transaminase. Pyr, pyruvate; Ala, alanine; Pi, inorganic phosphate. Adapted from Chen and 
Swanson (2003). 
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2.3. Lactate shuttle 
The coupling between synaptic activity and glucose utilization (neurometabolic coupling) 
is a central physiological principle of brain function. Neurons and astrocytes are the two 
major contributors for the massive consumption of oxygen and glucose in the brain. While 
glycolysis occurs preferentially in astrocytes, most of the oxygen is consumed by neurons 
(Jolivet et al., 2009). Under resting conditions, astrocytes metabolize ~85% of the glucose 
consumed in lactate. As schematically represented in Figure I.9, glycogen, the main energy 
store in the brain, is localized predominantly in astrocytes. Upon neuronal stimulation with 
glutamate, both glucose uptake and lactate production are observed in surrounding 
astrocytes (Pellerin and Magistretti, 1994). In addition to glucose, lactate (mainly provided by 
astrocytes) can constitute a supplementary fuel for activated neurons. In fact, as reviewed by 
Pellerin et al. (2007), a major glycolytic response in astrocytes upon activation, either by 
direct application of glutamate or stimulation of glutamatergic pathways, represent an 
important lactate source. Lactate accumulated in both extracellular and intracellular space in 
astrocytes constitutes a pool readily available for neurons upon increased energy demands. 
Upon neuronal activation, there is a rapid decrease in mitochondrial NADH in dendrites and 
then an increase in TCA cycle activity, in order to replenish the mitochondrial NADH pool 
(Kasischke et al., 2004). Moreover, there are additional reports that came to the conclusion 
that lactate is the predominant oxidative substrate over glucose in cultured neurons (Itoh et 
al., 2003, Bouzier-Sore et al., 2003).  
In addition to glutamate/glutamine cycling between neurons and astrocytes referred in 
2.2, neurons also rely on astrocytes for the supply of metabolic intermediates, particularly 
oxaloacetate, formed by the condensation of pyruvate with CO2 (Haberg et al., 1998), 
allowing the further synthesis of glutamate or γ-aminobutyric acid. Therefore, a transfer of 
glucose-derived metabolites from glial cells to neurons is necessary for neuronal survival, 
especially during severe hypoglycemia (Forsyth, 1996, Wender et al., 2000).  
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Figure I.9 - Neural activity triggers the release of the neurotransmitter glutamate (Glu) that is 
taken up into the astrocyte, and stimulates the breakdown of glycogen, the uptake of 
glucose, and glycolysis, to produce lactate in astrocytes. Astrocytic released glutamine (Gln) 
favors synaptic process, whereas astrocytic released lactate stimulates neuronal glucose 
uptake. Since neurons use more energy than they are able to produce by themselves, 
interplay with astrocytes constitutes an essential additional source of energy. Adapted from 
Magistretti (2006). 
 
 
2.4. Neuronal susceptibility to oxidative stress  
 
2.4.1. Increased oxidant capacity in the brain 
Mammalian brain cells are particularly susceptible to oxidative damage, since they 
present higher oxidant capacities. The first reason is because large amounts of ATP are 
required to maintain neuronal processes. As a consequence, in neuronal cells, a high O2 and 
glucose consumption occurs, leading to a continuous production of ROS during oxidative 
phosphorylation process. In fact, electrons leak to O2 through complexes I and III of the 
respiratory chain, thus generating O2.-. 
Brain cells are also more susceptible to oxidative stress because of the presence of 
excitatory aminoacids. Oxidative stress damages neurons and induces the release of 
glutamate. This aminoacid will bind to NMDA receptors on adjacent neurons, leading to an 
increase in intracellular Ca2+ within them (Mailly et al., 1999). This increase in intracellular 
Ca2+ concentrations can induce massive production of .NO, by activation of nNOS, a 
Ca2+dependent enzyme, as mentioned in section 1.1. Rise in Ca2+ levels affects 
mitochondrial function, contributing to the generation of O2.-. The excess of O2.- may react 
with .NO, generating ONOO-, which is responsible for inactivation of glutamine synthetase by 
Glycolysis
Glycogen
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tyrosine nitration (Görg et al., 2007). As a consequence of these events, it may occur an 
increase in extracellular levels of glutamate, thus promoting excitotoxicity. 
In addition, several neurotransmitters present in the brain, such as dopamine, serotonin 
and norepinephrine are autoxidizable. By reacting with O2, they can generate O2.-, as well as 
quinones/semiquinones that bind to thiol groups of reduced glutathione, causing its depletion 
(Wrona and Dryhurst, 1998).  
Another fact that accounts for brain increased susceptibility to oxidative stress is the 
elevated concentrations of iron, mostly contained in ferritin in healthy brain (Burdo and 
Connor, 2003). However, in damaged brain, iron accumulation is excessive relative to the 
amount of ferritin and it will catalyze free radical reactions, namely Fenton’s reaction. 
Neuronal membrane lipids are enriched in unsaturated fatty acids, which are thought to 
be target molecules for free radical-induced peroxidation and neural cell damage, thus 
playing a major role in the pathogenesis of many neurological diseases. HNE, one of the 
main products of lipid peroxidation, especially induces neuronal cytotoxicity by increasing 
Ca2+ levels, which will inactivate glutamate transporters and damage neurofilament proteins 
(Mark et al., 1997). HNE also inactivates α-ketoglutarate dehydrogenase, a key enzyme in 
TCA cycle (Sheu and Blass, 1999). 
Brain metabolic pathways are also responsible for huge generation of H2O2, not only by 
the action of SOD, as described in section 1.1, but also by other enzymes, being monoamine 
oxidases A and B and flavoproteins located in the outer mitochondrial membranes of 
neurons and glia particularly important for this process (Gal et al., 2005). Furthermore, 
neuronal NADPH oxidase enzymes (NOX) become activated in response to oxidative stress 
and may promote neuronal apoptosis. This process is extremely important during 
development of the nervous system; however, if trophic support is lost in the developed 
brain, NOX can become overactivated and leading to neuronal apoptosis (Sánchez-Carbente 
et al., 2005, Tammariello et al., 2000).   
Astrocytes and microglial cells can also contribute to oxidant environmental conditions, 
when they become activated by inflammatory features, such as pro-inflammatory cytokines. 
Activated astrocytes and, especially, activated microglia may produce O2.- and H2O2 and, 
.NO, by activation of iNOS. Thus, activated glial cells are major players in oxidative stress 
induced by inflammatory processes in the brain. Commonly, in studies with isolated cultures, 
astrocytes appear less susceptible to ROS and RNS than neurons, since they have higher 
glutathione levels and are more able to promote its synthesis under stress than neurons 
(Halliwell, 2006).   
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2.4.2. Antioxidant capacity in the brain 
Efficiency of antioxidant defences of brain cells is low when compared to that of other 
tissues. In fact, catalase levels are low in most brain regions, specifically located in 
peroxisomes and are hardly able to counteract H2O2 produced in other cellular compartments 
(Angermüller et al., 2009).  
In order to battle against oxidative stress, all parts of the brain contain SODs with active-
site for manganese (MnSOD) in the mitochondrial matrix and for cooper/zinc (CuZnSOD) in 
the mitochondrial intermembrane space and in the rest of the cell. Curiously, neurons 
containing nNOS are reported to be relatively resistant to NMDA and .NO-mediated 
neurotoxicity, by a mechanism involving MnSOD activation (Gonzalez-Zulueta et al., 1998). 
Glutathione/GPx system is also present within all nervous cells. Since neuronal 
concentrations of glutathione are lower than in glia, these cells might assist neurons by 
supplying them with cysteinyl-glycine as a glutathione precursor. In fact, glutathione released 
by astrocytes can be degraded by γ-glutamyl transpeptidase on their cell surface to produce 
cysteinyl-glycine, which neurons then further cleave to release cysteine for uptake and use in 
glutathione synthesis (Dringen et al., 2005). 
In addition to glutathione, brain cells are enriched in low molecular compounds with 
antioxidant activity, mainly ascorbate. In fact, neurons have specific transporters that 
efficiently take up ascorbate and astrocytes take up dehydroascorbate and convert it to 
ascorbate in intracellular space (Rice, 2000). However, in damaged brain, ascorbate can 
stimulate the oxidation of Fe3+ and Cu2+ into Fe2+ and Cu+, respectively, thus potentiating 
Fenton’s reaction and formation of .OH. Another low molecular compound that is present in 
the brain is α-tocopherol, mostly derived from plasma high-density lipoprotein (Hayton and 
Muller, 2004). Furthermore, brain contains elevated levels of histidine-containing dipeptides, 
known for their antioxidant properties, namely, by chelating metal ions and binding cytotoxic 
aldehydes produced during lipid peroxidation (Aruoma et al., 1989, De Marchis et al., 2000, 
Decker et al., 2000).  
Finally, bilirubin has antioxidant properties (Barañano et al., 2002, Stocker et al., 1987). 
Heme oxygenase (HO) is a widespread enzyme in the brain, existing in both inducible     
(HO-1) and constitutive (HO-2) isforms. HO catalyses the degradation of heme, with 
generation of carbon monoxide (CO), which can act as neurotransmitter, and biliverdin that 
will be further converted to bilirubin by biliverdin reductase. Although heme degradation 
causes the release of Fe2+, which can potentiate .OH formation as abovementioned, HO is 
involved in antioxidant mechanisms. HO-2 activation is able to prevent neuronal death in 
cerebral ischemia (Doré et al., 2000, Doré et al., 1999) and HO-1 is rapidly upregulated by 
oxidative and nitrosative stresses in some neurodegenerative diseases, as an attempt to 
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convert the highly damaging heme into the biliverdin and bilirubin (Calabrese et al., 2005). 
However, bilirubin breakdown by ROS originates bilirubin oxidation products, which can 
produce vasoconstricting compounds (Pyne-Geithman et al., 2005) and high levels of 
bilirubin are neurotoxic, as it will be further discussed in section 4, due to its relevance for the 
present thesis.  
 
2.5. Neuronal susceptibility bioenergetic crisis    
Astrocytes and neurons respond differently to .NO-induced inhibition of mitochondrial 
respiration. In fact, whereas neurons suffer a rapid decline in ATP levels, a collapse in 
mitochondrial membrane potential (ΔѰm) and apoptotic cell death, astrocytes utilize 
glycolytically-generated ATP, thus maintaining their ΔѰm (Almeida et al., 2001). This 
differential response in not exclusively to impaired mitochondrial respiration, since it also 
occurs in case of over-activation of neuronal glutamate receptors, an event that inhibits 
mitochondrial ATP synthesis or glucose uptake (Almeida and Bolaños, 2001, Porras et al., 
2004).  
It was reported that one of the main reasons why neurons and astrocytes respond 
differently to .NO-induced inhibition of respiration is the fact that they have very lower activity 
levels of 6-phosphofructo-1-kinase (PFK1), a master regulator of glycolysis, in comparison to 
astrocytes. The content of fructose-2,6-bisphosphate (F2,6P2), the powerful allosteric 
activator of PFK1, is also lower in neurons. In addition, mitochondrial respiration inhibition 
induced F2,6P2 in astrocytes, whereas has no effect on neuronal F2,6P2 (Almeida et al., 
2004). Recently, it was suggested that neurons are unable to increase glycolysis because 
they almost does not possess 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 
(PFKFB), which is the enzyme responsible to F2,6P2 formation (Herrero-Mendez et al., 
2009).  
Glucose metabolism in neurons is directed mainly to the PPP, with the main goal of 
reduced glutathione regeneration. In fact, the antioxidant function of the PPP in neurons was 
demonstrated in response to pro-oxidant compounds exposure (García-Nogales et al., 2003, 
Vaughn and Deshmukh, 2008) or glutamate receptor stimulation, mainly NMDA (Delgado-
Esteban et al., 2000). As described in section 1.1, over-activation of NMDA receptors favors 
.NO formation by activation of nNOS, a process implicated in the pathogenesis of several 
CNS diseases (Suárez et al., 2002).  
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3.  Inflammation and cell death in central nervous system 
 
3.1. Cells involved in inflammation and CNS injury 
The inflammation in the CNS, also designated as neuroinflammation, represents an 
essential response to peripheral inflammation and CNS injury or infection, necessary to the 
maintenance of tissue survival, repair and recovery, and to conserve the energy of the 
organism, by limiting the survival and proliferation of invading pathogens. The produced 
damage may have different causes like infection, traumatism, ischemia, necrosis, 
hemorrhage, among others. However, it is also recognized as a major contributor to acute 
and chronic CNS disorders. As reviewed by Allan and Rothwell (2003), inflammatory 
mediators, such as complement, adhesion molecules, cyclooxygenase enzymes and pro-
inflammatory cytokines, are increased in several neurological diseases, and intervention 
studies in experimental animals suggest that several of these factors contribute directly to 
neuronal injury.  
In the past, studies on CNS injury have focused predominantly on neuronal death and 
survival, since these cells largely determine CNS function and survival and cannot be 
replaced once they are lost. However, the role of other cell types in CNS disease is 
becoming increasingly apparent. Glial cells constitute the majority of the brain volume and 
play an active role in normal physiology and pathology (Raivich et al., 1999). The primary 
glial cells implicated in neuroinflammation are microglia. These are cells of the 
monocyte/macrophage lineage, which are resident in the brain and are activated in response 
to infection, inflammation and injury (Streit, 2002). They are important phagocytic cells and 
release numerous inflammatory molecules, namely cytokines (Hanisch, 2002). Another glial 
cell type important for neuroinflammation is astrocytes, which are the most abundant glial 
cells, and play key physiological roles in supporting neurons, regulating ion and transmitter 
concentrations and in electrical transmission, and are an important source of both 
neuroprotective and inflammatory molecules (Allan and Rothwell, 2003). Oligodendrocytes, 
the third type of glia, are crucial for myelination, but are also a source of specific 
inflammatory molecules (Baumann and Pham-Dinh, 2001, Du and Dreyfus, 2002). Vascular 
endothelial cells are also targets and sources of inflammatory mediators, being particularly 
important in the adhesion of circulating cells of the immune system (Couraud, 1994). 
 
3.2. Inflammatory mediators and signalling pathways 
Cytokines are among the major effectors of neuroinflammation. They can be   involved in 
either neuroprotection or neurodegeneration processes (Konsman et al., 2007). Specific pro-
inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1) β, 
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have pleiotropic effects in the CNS, including their emerging role in neurodevelopment (Marx 
et al., 2001) but are also described as mediators of neuronal apoptosis (Kajta et al., 2006).  
TNF-α exerts its biological activity by binding to type 1 and type 2 receptors (TNFR1 and 
TNFR2) and activating several signalling pathways. TNFR1 contains a common death 
domain whereas TNFR2 does not. Thus, TNFR1 activation is involved in both cell survival 
and cell death signalling, while TNFR2 mediates cell survival signals. However, it is 
suggested that TNFR2 might potentiate death signal mediated by TNFR1 (Gupta, 2002). 
 Like TNF-α, IL-1β is a pro-inflammatory cytokine associated with several CNS 
disorders. Activated microglial cells are the main source of this cytokine in the damaged 
brain (Block and Hong, 2005). Released IL-1β directly affects neurons, astrocytes and 
oligodendrocytes, promoting production of other cytokines and regulation of synaptic function 
on hippocampal neurons (Bellinger et al., 1993). In the opposition of the dual role of TNF-α in 
brain damage, IL-1β is mainly considered by its neurotoxic effects (Panegyres and Hughes, 
1998, Yang et al., 1998). 
The effects of cytokines depend on which cell type they act upon and whether it is a 
direct or indirect effect (Allan and Rothwell, 2003). As reviewed by Allan and Rothwell (2003), 
studies in vitro demonstrated that cytokines directly act on neurons, promoting changes in 
Ca2+ entry, neurotransmitter release and synaptic plasticity, thus contributing to neuronal 
viability in the injured brain. It is speculated that neuronal responses can be modified, 
indirectly or directly, by cytokines. One example of this is in case of seizure activity, which is 
enhanced by IL-1 administration (Vezzani et al., 1999). In addition, pro-inflammatory 
cytokines such as IL-1 and TNF-α are reported to induce blood–brain barrier breakdown 
(Blamire et al., 2000, Cardoso et al., 2010, Quagliarello et al., 1991), as well as to trigger the 
release of toxic substances, such as .NO from the vascular endothelium (Bonmann et al., 
1997), allowing the entrance of leucocytes into the brain parenchyma, which will contribute to 
neuronal injury. 
In addition, several studies demonstrated the association between inflammation and 
generation of ROS/RNS, leading to multiple organ dysfunction (Bian and Murad, 2001, Sener 
et al., 2005). .NO is recognized as a mediator and regulator of inflammatory responses. It 
was first reported that mouse macrophages produce nitrite and nitrate in response to 
bacterial lipopolysaccharide (Stuehr and Marletta, 1985). However, although high levels of 
.NO produced in response to inflammatory stimuli can have deleterious effects, this molecule 
is also important in cellular signalling, having an important role in the amelioration of the 
pathogenesis of inflammation (Korhonen et al., 2005). Furthermore, .NO and induction of 
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NOS are involved in apoptosis induced by inflammatory mediators in neuronal cells (Hemmer 
et al., 2001, Heneka et al., 1998, Thomas et al., 2008). 
The mitogen-activated protein kinases (MAPKs) and the transcription factor nuclear 
factor κB (NF- κB) are among the main effectors that participate in inflammatory signalling 
pathways. MAPKs are divided into three major subfamilies, according to structural 
differences between them: the p38 kinase, the c-Jun N-terminal kinases 1 and 2 (JNK1/2) 
and the extracellular signal-regulated kinases 1 and 2 (ERK1/2), as reviewed by Roux and 
Blenis (2004). In general, p38 and JNK1/2 are more responsive to environmental stress and 
pro-inflammatory cytokines, being designated as stress-activated protein kinases (SAPKs), 
while ERK1/2 are mostly activated in response to mitogens and growth factors (Kyriakis and 
Avruch, 2001). NF- κB is an important transcription factor responsible for modulation of the 
host immune and inflammatory response (O'Neill and Kaltschmidt, 1997). It will be given 
preferential attention to JNK1/2, since their activation is discussed in the present thesis. 
JNK1/2 become activated in response to toxic stimulus, such as ROS (Luo et al., 1998, 
Marques et al., 2003) and pro-inflammatory cytokines TNF-α and IL-1, pointing these SAPKs 
as strong effectors of neuronal apoptosis (Mielke and Herdegen, 2000, Tibbles and 
Woodgett, 1999). The activation of JNK1/2 enzyme is related to toxicity in developing 
neurons, since overexpression of activated c-Jun was shown to produce apoptosis and 
suppression of this protein protected against neuronal death induced by deprivation of nerve 
growth factor in sympathetic and hippocampal neurons (Estus et al., 1994, Ham et al., 1995, 
Schlingensiepen et al., 1993). In addition, .NO-induced JNK phosphorylation is observed in 
models of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s (Katsuki et al., 
2006, Marques et al., 2003).  
 
3.3. Neuronal susceptibility to inflammation    
In spite of being essential to tissue survival, repair and recovery, extensive, prolonged or 
unregulated inflammation is highly detrimental. During the last decades it has been observed 
that not only cells of the immune system participate actively in the inflammation, but also 
cells belonging to the CNS are a fundamental part of this process, especially glial cells, as 
indicated in section 3.1. The neurons have a minor participation in inflammatory processes, 
however they have the ability to express class I molecules, to produce several cytokines like 
IFN-γ and also to induce apoptosis of T cells through the Fas receptor (FasR) interaction 
(Chavarria and Alcocer-Varela, 2004). 
TNF-α is the pro-inflammatory cytokine most characterized in neurologic diseases. This 
cytokine directly affects every neural cell, by inducing the release of other cytokines in glial 
cells (Allan and Rothwell, 2003), several chemokines (Croitoru-Lamoury et al., 2003) and 
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.NO (Madrigal et al., 2002). TNF-α has been demonstrated to induce neuronal apoptosis in 
human brain cell cultures and animal models through TNFR1 signalling (Yang et al., 2002) 
and further production of other inflammatory and/or neurotoxic molecules such as ONOO- by 
induction of iNOS in glial cells (Combs et al., 2001). In addition, post-treatment with TNF-α 
potentiates NMDA-mediated toxicity in organotypic hippocampal slice cultures (Wilde et al., 
2000). TNF-α produced by glial cells was also found to damage neural precursor cells and to 
inhibit neurite elongation and branching during development and regeneration (Sheng et al., 
2005). Furthermore, it is reported that during aging, both TNF-α production and TNF-α-
induced apoptosis are increased (Gupta, 2002).  
Other cytokine that is widely accepted for its role in neuronal injury is IL-1β (as referred 
in section 3.2). In fact, increased expression of this cytokine in CNS is observed after a 
variety of brain insults, and administration of exogenous IL-1β to animals undergoing 
ischemic or excitotoxic challenges leads to a dramatic increase in the resulting cell death 
(Allan and Rothwell, 2003). In addition, administration of the selective IL-1 receptor 
antagonist (IL-1ra) clearly inhibits the extent of cell death induced by ischemic, traumatic or 
excitotoxic injury in the mouse brain (Rothwell and Luheshi, 2000). 
 
3.4. Death signalling pathways 
The principal mechanisms implicated in the death signalling cascades of the CNS cells 
include the alteration of Ca2+ homeostasis, oxidative and nitrosative stress, the accumulation 
of extracellular neurotransmitters, as glutamate and the activation of signalling cascades 
(Neumar, 2000), as schematically represented in Figure I.10.    
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Figure I.10 - Major mechanisms of nerve cell death upon an insult. Overstimulation of         
N-methyl-D-aspartate receptors (NMDAR) by an accumulation of extracellular glutamate 
leads to an accumulation of intracellular Ca2+. Elevated intracellular Ca2+ triggers DNA 
fragmentation, reactive oxygen and nitrogen species (ROS/RNS) formation, calpein 
activation and reduction of mitochondrial membrane potential with cytochrome c (Cyt c) 
release. Released Cyt c, together with protease activating factor 1 (Apaf 1) and pro-caspase 
9 constitute the apoptossome. This association results in activation of caspase-9 that will 
activate effector caspases, such as caspase-3. Engagement of the membrane receptors 
TNF-α receptor 1 (TNFR1) or Fas receptor (FasR), activates specific apoptotic effectors, 
such as caspase-8 or -10. Activated caspase-8 propagates the apoptotic signal by activating 
downstream caspases through proteolytic cleavage, as well as by triggering mitochondrial 
pathway through cleavage and activation of pro-apoptotic Bid into tBid, which in turn 
promotes mitochondria dysfunction with Cyt c release. Like Bid, other proteins of Bcl-2 family 
will modulate mitochondrial apoptotic pathways by enhancing (Bax) or preventing (Bcl-2) the 
formation of mitochondrial permeability transition pore and the release of Cyt c. Dysfunctional 
mitochondria is also a source of ROS/RNS. ROS/RNS may directly promote DNA oxidation.      
 
When ATP depletion occurs, there is a neuronal depolarization, with substantial release 
of glutamate at the synaptic cleft (Santos et al., 1996). ATP depletion also inhibits re-uptake 
of glutamate by glial cells (Di Monte et al., 1999), leading to extracellular accumulation of 
glutamate. Accumulation of glutamate in the synaptic cleft results in excitotoxic phenomenon 
and neuronal death (Santos et al., 1996). Glutamate will bind to NMDA receptors on adjacent 
neurons, leading to an increase in intracellular Ca2+ within them, which may result in 
neurodegeneration (Mailly et al., 1999). This increase in Ca2+ concentrations can induce 
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massive production of .NO, by activation of nNOS. Excessive elevation of intracellular Ca2+ 
also leads to the activation of hydrolytic enzymes and triggers mitochondrial permeability 
transition and activation of many enzymes, including phospholipases and calpains. Calpain 
activation is coupled to execution of caspase-independent apoptosis in cerebellar granule 
neurons (Volbracht et al., 2005). Furthermore, cysteine proteases, including caspases are 
also sensitive to the redox balance of the cell (Blomgren et al., 2007). In addition, 
mitochondrial dysfunction induced by increased production of ROS/RNS is accompanied by 
activation of caspase-3 and DNA fragmentation (Gilland et al., 1998, Puka-Sundvall et al., 
2000). This mitochondrial dysfunction may facilitate the release of proapoptotic factors from 
the intermembrane space of the mitochondria to the cytosol, such as cytochrome c, 
apoptosis-inducing factor 1 (Apaf 1), endonuclease G, SMAC/Diablo and HtrA2/Omi 
(Ravagnan et al., 2002). Release of cytochrome c interacts with Apaf 1 and dATP/ATP to 
form the apoptosome, leading to activation of pro-caspase-9 into the initiator caspase-9 
(Acehan et al., 2002), which in turn cleaves and activates pro-caspase-3, the most abundant 
effector caspase in the brain, and consequent activation of the apoptotic cell death 
(Matapurkar and Lazebnik, 2006). The apoptotic pathway may also be triggered by the 
engagement of the membrane receptors TNFR1 or FasR, often referred as “death 
receptors”, since they are coupled to specific apoptotic effectors, such as caspase-8 or -10 
(Walczak and Krammer, 2000). Activated caspase-8 propagates the apoptotic signal by 
activating downstream caspases through proteolytic cleavage, as well as by triggering 
mitochondrial pathway through cleavage and activation of pro-apoptotic Bid into tBid, which 
in turn promotes mitochondria dysfunction and cytochrome c release (Adams, 2003).  
The role of the inflammatory caspases (mainly caspase-1, also called IL-1 converting 
enzyme) in apoptosis is not clear, however they may contribute to brain injury after ischemia 
through their pro-inflammatory actions (Blomgren et al., 2007).  
 
 
4. Bilirubin induced neurological damage and risk factors involved 
 
4.1. Neonatal hyperbilirubinemia 
In fetal life, bilirubin production begins as early as 12 weeks’ gestation. In this period, 
bilirubin clearance is made through its passage to maternal circulation. At birth, this placental 
protection is suddenly lost and an accumulation of UCB takes place (Brito et al., 2006). 
Neonatal hyperbilirubinemia occurs due to the three main reasons: (i) bilirubin 
overproduction because in neonatal life there is a shortened red blood cell lifespan; (ii) 
decreased bilirubin conjugation in the liver, due to immaturity of newborns’ hepatic 
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machinery; (iii) impaired bilirubin excretion because of the absence of bacterial flora (Porter 
and Dennis, 2002). 
Neonatal hyperbilirubinemia is a very common condition in the neonatal period, with total 
serum bilirubin levels above to 5 mg/dl. This condition occurs in up to 60% of full term 
newborns and 80% of preterms (Dennery et al., 2001). Commonly designated as neonatal 
jaundice, this condition is characterized by accumulation of unconjugated bilirubin (UCB) in 
the skin and mucous membranes, responsible for the yellow-orange coloration observed in 
jaundiced babies (Stevenson et al., 2001).  
Although most of newborn infants have mild to moderate elevated serum UCB levels 
within the first days of life, a condition known as “physiologic jaundice”, higher levels of UCB, 
known as “pathologic jaundice” cause nerve cell damage, a condition called UCB 
encephalopathy, that may lead to adverse neurological outcomes (Hansen, 2002). In fact, 
moderate degrees of hyperbilirubinemia may be a starting point to the appearance of long-
term neurodevelopment disabilities (Dalman and Cullberg, 1999, Soorani-Lunsing et al., 
2001). Neurologic dysfunctions reported to be related with elevated concentrations of UCB in 
neonatal period include risk of otoxoxicity and hearing loss (de Vries et al., 1985), as well as 
visual acuity or mild-to-moderate cerebral palsy (Sampath et al., 2005) in extremely low-birth-
weight infants. Changes in the auditory brainstem response were also found in rhesus 
monkeys during the intravenous infusion of UCB (Ahlfors et al., 1986).  In addition, high 
levels of UCB can constitute the basis for chronic to permanent sequelae, or even death 
(Ostrow et al., 2004, Shapiro, 2005). As reviewed by Hansen (2000), the term kernicterus 
was first used by Schmorl in 1904 to describe the yellow staining of some brain regions, 
notably basal ganglia and medulla oblongata, observed in postmortem analysis of brains of 
term neonates. Statistically, around 70% of infants with kernicterus dye within seven days, 
and the ~30% survivors commonly develop irreversible sequelae such as auditory 
dysfunction, mental retardation and choreoathetoid cerebral palsy (Blanckaert and Fevery, 
1990).     
 
4.2. Prematurity as a risk factor of neonatal hyperbilirubinemia 
The risk of bilirubin-induced neurologic dysfunction is particularly enhanced in premature 
newborns due to the higher rates of UCB production because of the shorter life span of their 
red blood cells. This fact contributes to an increased UCB production, since this molecule 
results from the degradation of heme proteins (Blanckaert and Fevery, 1990). In addition, 
prematures present some metabolic deficiencies at the level of excretion pathways, that will 
account for the decreased UCB clearance from the organism (Stevenson et al., 2001, 
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Watchko, 2006). Moreover, cerebral palsy was found in preterm infants with risk of 
kernicterus, in spite of relatively low total serum bilirubin levels (Gkoltsiou et al., 2008). 
Prematurity is frequently associated with hypoalbuminemia (Cartlidge and Rutter, 1986), 
which will contribute to increased levels of free UCB, since bilirubin is released in circulation 
reversibly bound to albumin, until reaching into the liver in order to be metabolized. If 
concentrations of albumin are lower, a higher rate of free UCB easily crosses the blood brain 
barrier, which is also immature and permeable and presents a reduced content in tight 
junctions and pericytes, together with a more fragile brain vasculature in preterm newborns 
(Ballabh et al., 2004). Furthermore, premature infants present a higher incidence of neonatal 
pathophysiological processes such as hypoxia-ischemia insult and cerebral hemorrhage that 
can contribute for their increased vulnerability to brain damage in comparison to the full term 
infants (Volpe, 1997). Hypoxic-ischemic conditions may lead to development of acidosis 
(O'Shea, 2002), contributing to an environment with lower pH, which favors cellular 
deposition of UCB (Ostrow et al., 1994).  
It should be noticed that in preterms is complicated to establish a threshold at which 
UCB interferes with neurodevelopment outcome, since these infants are commonly clinically 
ill, with other perinatal complications. Thus, UCB-induced neurotoxicity may be more 
pronounced that in full term ones, even at relatively low levels of UCB (Oh et al., 2003). In 
fact, low weight premature infants present decreased albumin concentration and a lower 
affinity and/or capacity for UCB binding (Cashore, 1980, Kaplan and Hammerman, 2005). 
 
4.3. Sepsis-associated neonatal hyperbilirubinemia 
Premature newborns are also more susceptible to some insults that are described as 
risk factors for UCB-induced encephalopathy. In fact, prematurity is frequently associated 
with sepsis, which is responsible for the alteration of blood brain barrier permeability through 
the release of great amounts of pro-inflammatory cytokines, such as TNF-α, IL-1β and IL-6 
(Goldenberg and Andrews, 1996). In addition, a correlation between infection and the 
increased risk of UCB-induced neurotoxicity is reported: (i) in an animal model of sepsis, it 
was shown that serum concentration of both total and free bilirubin was increased, promoting 
a net accumulation of UCB in the brain (Hansen, 1993); (ii) pro-inflammatory cytokines were 
reported to increase blood-brain-barrier permeability, allowing UCB entrance in the brain 
(Petty and Lo, 2002), and to exacerbate UCB-induced cytotoxicity in different cell lines, such 
as in neuroblastoma, glioblastoma, umbilical vein endothelial, liver cell and mouse fibroblasts 
(Ngai and Yeung, 1999), as well as in astrocytes (Fernandes et al., 2004). 
The association between inflammation and generation of ROS/RNS described in section 
3.2 should also be taken into account for the increased susceptibility in sepsis-associated 
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hyperbilirubinemia, since immature brain lacks antioxidant defences, such as catalase and 
GPx, which may help to explain the differential susceptibility of the developing CNS to brain 
injury (Chang et al., 2005). As discussed in section 3, although essential for survival in 
response to tissue injury or infection, inflammatory response also causes neuronal damage, 
through an increased production of pro-inflammatory cytokines, as well as .NO and low-
gestational-age newborns have a prominently increased risk of brain dysfunctions attributed 
to cerebral-cortex damage, including excess of apoptosis and impairment of surviving 
neurons (Leviton and Gressens, 2007). In addition, It has been suggested that infection 
increases the risk for UCB encephalopathy (Dawodu et al., 1984) and presence of 
inflammatory features, namely fever episodes and brain edema, were described during or 
following moderate to severe hyperbilirubinemia (Kaplan and Hammerman, 2005). As 
schematically represented in Figure I.11, inflammatory response of astrocytes and microglia 
causes an increase of apoptotic neurons, which may produce neuropathological sequelae. 
Interestingly, lipopolysaccharide exacerbates the release of TNF-α and IL-1β by cultured 
astrocytes (Falcão et al., 2005). Because of the relevance for the present dissertation, this 
issue will be further dissected into section 4.5.  
              .  
Figure I.11 - Astrocytes and mostly microglia produce an inflammatory response in response 
to a toxic stimulus and may produce neuropathological sequelae. 
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4.4. Differential neuronal vulnerability among brain regions 
Differential susceptibilities may be related with preferential deposition within brain 
regions. In fact, UCB shows a specific deposition pattern when is able to cross the blood 
brain barrier and enters into the brain. Kernicterus condition results from a specific pattern of 
UCB deposition in the brain, mainly in basal ganglia, hippocampus lateral ventricular walls, 
mid brain, pons, cerebellum and inferior cerebellar peduncles, and subthalamic nuclei, 
together with brain edema (Ahdab-Barmada and Moossy, 1984, Perlman et al., 1997). The 
tendency of bilirubin deposits in kernicterus localized in areas vulnerable to hypoxic ischemic 
injury, such as the pyramidal cell layer of the hippocampus, raises the question of whether 
hypoxic-ischemic injury is important to the development of the lesions of kernicterus 
(Perlman et al., 1997). Purkinje cells in the cerebellum have also showed increased 
susceptibility to bilirubin injury in Gunn rats, the well-established animal model for severe 
hyperbilirubinemia (Conlee and Shapiro, 1997, Lin et al., 2005).  
Other studies have referred dissimilar vulnerability to toxic stimuli in different brain 
regions show, such as ischemia and oxidative stress. Many factors have been proposed to 
account for differential vulnerability of brain regions. This includes local differences in 
synaptic input and in neurotransmitter released, differences in expression levels of specific 
neurotransmitter receptors, differences in antioxidant defences, and differences in signaling 
pathways (Xu et al., 2001). In vivo studies demonstrate that brief periods of global ischemia 
cause selective neuronal loss, especially in the CA1 region of hippocampus (Papadopoulos 
et al., 1997, Papadopoulos et al., 1998). Studies with rat primary cultures of neurons and 
astrocytes isolated from cortex, striatum, or hippocampus revealed distinct profiles of 
vulnerability when subjected to injury. While astrocytes from striatum showed increased 
injury by oxygen and glucose deprivation, they were more resistant to H2O2 exposure or 
glucose deprivation, since they presented higher levels of antioxidant defences, such as 
increased glutathione levels and increased activities of GPx and SOD (Xu et al., 2001). In 
addition, it was reported that antioxidant enzymes, such as xantine oxidase and catalase, 
have maximum activity in cortex, followed by cerebellum and hippocampus in developing 
mouse brain exposed to lead (Prasanthi et al., 2010) and glutathione peroxidase activity is 
considered determinant in the recovery of the immature mouse brain subjected to traumatic 
brain injury (Tsuru-Aoyagi et al., 2009). 
In the neonatal brain, the basal ganglia are the most vulnerable region in term infants, 
whereas in preterms the most susceptible one is the periventricular white matter region 
(Barkovich et al., 1995). Neuronal damage after hypoxic-ischemic insult seems to affect 
particularly hippocampal CA1 region, striatum and neocortical layers III, V, and VI in animal 
models of both mature and immature brain (Guzzetta et al., 2000, Jiang et al., 2004). For 
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hypoxia-ischemia-induced regional vulnerability may account preferential distribution of 
immature NMDA receptors, which corresponds to regions that preferentially express nNOS, 
such as layers CA1 and CA3 of the hippocampus, pons and globus pallidus (Black et al., 
1995, Greenamyre et al., 1987, Mitani et al., 1998), regions described for preferential UCB 
deposition (Ahdab-Barmada and Moossy, 1984, Hansen, 2000, Perlman et al., 1997). In 
addition, regional differences in pro-oxidant and antioxidant defences (Candelario-Jalil et al., 
2001, Khan and Black, 2003), the Ca2+-induced mitochondrial permeability transition (Friberg 
et al., 1999) and DNA damage (Cardozo-Pelaez et al., 2000) are observed between 
hippocampus, cortex, and striatum. Among these possible mechanisms, it is suggested that 
insufficient antioxidant defence during oxidative stress is a major contributor to regional 
specificity in the immature brain after ischemia (Jiang et al., 2004).  
 
4.5. Mechanisms underlying bilirubin-induced neurotoxicity  
Encephalopathy by UCB and kernicterus are the main complications of UCB-induced 
neurotoxic effects on the newborn brain. However, accumulating evidence strongly suggests 
that low concentrations of bilirubin have anti-oxidant properties (Stocker et al., 1987), 
providing protection against injury resulting from oxidation (Doré et al., 2000, Doré et al., 
1999), as described in section 2.4.2. However, elevated levels of UCB in neonatal period 
produce neurotoxic effects, as stated in section 4.1.  
Several studies have been made in order to better understand the mechanisms 
underlying UCB neurotoxicity. Experimentally, UCB participates in numerous toxic events 
occurring in different study models. Pioneer studies of Ernster and Zetterstrom (1956) 
showed that UCB inhibits respiration and uncouples oxidative phosphorylation in brain 
homogenates or isolated mitochondria. The energy depletion was later on corroborated by 
the reduced rates of glycolysis and decreased ATP levels observed in Gunn rats and in 
newborn piglets (Hoffman et al., 1996, Park et al., 2001). However, discrepant findings were 
reported in other studies that failed to document significant changes in brain glucose 
metabolism or oxidative phosphorylation (Diamond and Schmid, 1967), whereas others 
demonstrated that hyperbilirubinemia only disturbs brain energy metabolism in the presence 
of additional factors that disrupt the blood brain barrier, such as hypoxia or hyperosmolarity 
(Wennberg et al., 1991). In addition, UCB is reported to induce impairment in neurogenesis, 
neuritogenesis and synaptogenesis of primary cultures from both cortical and hippocampal 
neurons (Falcão et al., 2007b, Fernandes et al., 2009). Among the UCB-induced neurotoxic 
effects are ionic imbalance (Brito et al., 2004), extracellular accumulation of glutamate and 
release of pro-inflammatory cytokines TNF-α, IL-1β and IL-6 by both astrocytes (Falcão et 
al., 2005, Falcão et al., 2006, Fernandes et al., 2004) and microglia (Gordo et al., 2006). 
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Inflammatory signalling pathways triggered by UCB includes the activation of MAPKs and 
NF-κB (Fernandes et al., 2007a, Fernandes et al., 2006, Silva et al., 2010), as well as TNF-α 
and IL-1β receptors signaling pathways (Fernandes et al., 2010). 
Involvement of oxidative stress in the pathways of cellular demise by UCB was already 
demonstrated in neocortical synaptosomes (Brito et al., 2004) and mature cultured neurons 
(Brito et al., 2008a, Brito et al., 2008b). Particular attention has been given to the 
involvement of .NO and induction of nNOS in UCB-induced neurotoxicity (Brito et al., 2010, 
Mancuso et al., 2008), as well as in UCB-induced cytotoxicity in cultured oligodendrocytes, 
pointed to be mediated by activation of iNOS and .NO production (Genc et al., 2003). 
Interestingly, it has been recently reported that synaptic transmission failure observed in 
auditory brainstem of Gunn rats occurs in neurons that are expressing high levels of nNOS, 
whereas antagonism of this enzyme confers protection against hearing loss (Haustein et al., 
2010). These upstream events culminate in nerve cell death by both necrosis and apoptosis. 
Indeed, neurons and astrocytes (Brites et al., 2009, Silva et al., 2002), oligodendrocytes 
(Genc et al., 2003), endothelial cells (Akin et al., 2002) and microglia (Gordo et al., 2006, 
Silva et al., 2010) show a concentration-dependent UCB-induced cell death by both 
oncosis/necrosis and apoptotic processes. Other studies demonstrated that UCB interferes 
with DNA and protein synthesis in Gunn rat model (Greenfield and Majumdar, 1974, Yamada 
et al., 1977), as well as protein phosphorylation (Hansen et al., 1996). It is also established 
that UCB directly interacts with mitochondria, influencing membrane lipid and protein 
properties, redox status, and cytochrome c content (Rodrigues et al., 2002b, Rodrigues et 
al., 2000). In addition, it was demonstrated that UCB induces apoptosis trough mitochondria-
caspase-3 pathway involving cytochrome c release, caspase-3 activation, and subsequent 
poli (ADP-ribose) polymerase (PARP) cleavage in developing rat brain neurons (Rodrigues 
et al., 2002a). 
Comparison of nerve cell susceptibility to UCB showed that neurons and microglia are 
more vulnerable to UCB-induced cell death and microglial cells present the most reactive 
features, such as the highest levels of pro-inflammatory cytokines and glutamate release 
(Brites et al., 2009). In addition, UCB-induced inflammatory response, extracellular 
accumulation of glutamate and cell death were shown to be enhanced in both immature 
neurons and astrocytes when compared to mature ones (Falcão et al., 2005, Falcão et al., 
2006), observations that provide a basis for the increased risk of hyperbilirubinemia in 
premature neonates. Interestingly, the P-glycoprotein (Pgp) and the multidrug resistance 
associated protein 1 (Mrp1), two ATP-dependent plasma membrane efflux pumps, were 
pointed to be responsible for limiting UCB levels inside the nerve cell (Ostrow et al., 2004, 
Watchko et al., 1998). In addition, these proteins are shown to increase along nerve cell 
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maturation (Falcão et al., 2007a, Tsai et al., 2002). Therefore, it seems likely that the limited 
levels of Pgp and Mrp1 in the initial maturation cellular stages may have a role in the 
increased vulnerability of immature nerve cells to UCB. 
Finally, neonatal hyperbilirubinemia is considered a vulnerability factor for the 
development of mental disorders (Dalman and Cullberg, 1999), such as schizophrenia 
(Hayashida et al., 2009) and it is reported that structural abnormalities at cytoskeleton level 
are produced by ROS generated by prolonged treatment with haloperidol, commonly used in 
the treatment of schizophrenia (Benitez-King et al., 2010). 
 
5. Promising molecules for modulation in hyperbilirubinemia 
Understanding the various molecular players involved in neurotoxicity induced by 
hyperbilirubinemia or hyperbilirubinemia with associated inflammation will contribute to 
identify adequate therapeutic targets. For the present thesis we focused on a better 
understanding on the role of molecules involved in response to oxidative stress and whether 
they represent important strategies to prevent neuronal injury in hyperbilirubinemia.  
 
5.1. Glycoursodeoxycholic acid (GUDCA) 
Ursodeoxycholic acid (UDCA), the 7β-hydroxy epimer of chenodeoxycholic acid, is an 
endogenous bile acid that has been widely used for the treatment of hepatobiliary disorders 
(Lazaridis et al., 2001) and is also considered an anti-apoptotic agent (Rodrigues and Steer, 
2001). After oral administration, UDCA is conjugated with taurine and glycine in the liver, 
originating tauroursodeoxycholic acid (TUDCA) and, mostly, glycoursodeoxycholic acid 
(GUDCA), respectively (Lazaridis et al., 2001). Thus, GUDCA is the conjugate form of UDCA 
with highest clinical relevance.  
UDCA is able to suppress the production of pro-inflammatory cytokines by inactivation of 
the NF-κB pathway in different cell types (Joo et al., 2004, Schoemaker et al., 2004, Shah et 
al., 2006, Solá et al., 2003). In other studies UDCA or its conjugates were able to act as a 
cytoprotective agent, by promoting the stabilization of the plasma and mitochondrial 
membranes and preventing cellular apoptosis (Güldütuna et al., 1993, Solá et al., 2002). 
Regarding neurotoxic effects of UCB, both UDCA and TUDCA are able to prevent form UCB-
induced neuronal apoptosis by inhibiting the Bax translocation to mitochondria, the 
consequent mitochondrial depolarization, cytochrome c release, caspase-3 activation and 
PARP cleavage (Rodrigues et al., 2000, Solá et al., 2002).  
More recently, it was demonstrated that GUDCA prevents from cell death, as well as 
from release of pro-inflammatory cytokines in astrocytes exposed to UCB. This 
immunomodulatory effect is made at post-translational level, since it affects mainly the 
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activity of TNF-α- and IL-1β-converting enzymes (TACE and ICE, respectively), thus 
preventing the maturation of this cytokines and their consequent release (Fernandes et al., 
2007b). Furthermore, GUDCA counteracts UCB-induced neuronal cell death and oxidative 
stress, by inhibiting UCB-induced protein oxidation, lipid peroxidation and glutathione loss in 
mature neurons (Brito et al., 2008a), as well as to induces a rapid and sustained decrease in 
plasma UCB concentrations in Gunn rat model (Cuperus et al., 2009). 
 
5.2. N-ω-nitro-L-arginine methyl ester hydrochloride (L-NAME) 
L-NAME is an analog of L-arginine that inhibits NOS and subsequent .NO production in a 
enantiomerically specific manner. L-NAME is structurally related to N-ω-monomethyl-L-
arginine (L-NMMA), which was previously used in studies of the cytotoxicity of activated 
macrophages, before the discovery that .NO is involved in this process. L-NAME, unlike L-
NMMA, shows progressive and irreversible or only slowly reversible inhibition of brain NOS 
following the initial binding as reviewed by Knowles and Moncada (1994). Analogues of       
L-arginine are also muscarinic acetylcholine receptor antagonists (Buxton et al., 1993). As 
mentioned in section 3.2, .NO and induction of NOS are involved in apoptotic pathways 
induced by inflammatory mediators in neuronal cells. Therefore, .NO inhibitors represent 
important strategies in the comprehension of cellular injury associated with inflammatory 
processes. In fact, local elimination of nNOS in P7 rats resulted in a significant attenuation of 
the damage after hypoxic-ischemic insult (Ferriero et al., 1995) and nNOS deficiency through 
genetic targeting was also neuroprotective in neonatal mice (Ferriero et al., 1996). Other 
experimental models of hypoxia-ischemia demonstrated that NOS inhibition reduced 
apoptosis at the level of caspase-3 activation (Zhu et al., 2004) and conferred tissue 
protection (Peeters-Scholte et al., 2002). The role of .NO in UCB-induced cytotoxicity was 
demonstrated in primary cultures of oligodendrocytes (Genc et al., 2003) and, more recently, 
in primary cultures of mature neurons concomitantly treated with UCB and L-NAME (Brito et 
al., 2008a, Brito et al., 2010).  
 
5.3. N-acetylcysteine (NAC) 
As mentioned in section 1.1, NAC is a thiol compound that is converted to cysteine, an 
important precursor of cellular glutathione (Dringen, 2000, Zachwieja et al., 2005). 
Antioxidant effects of NAC embrace its action as a source of sulfydryl groups, promoting 
glutathione biosynthesis and its supply for GPx. In addition, NAC reacts with ROS (Ocal et 
al., 2004). There are several in vitro and in vivo studies supporting antioxidant effect of NAC. 
Treatment with NAC was shown to confer neuroprotection in lead-induced lipid peroxidation 
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and inhibition of antioxidant enzyme activities in rats’ brain (Nehru and Kanwar, 2004). In 
addition, supplementation of cultured hippocampal neurons subjected to hypoxia with NAC 
resulted in a significant cytoprotection, decline in ROS generation, and higher antioxidant 
levels similar to that of control cells (Jayalakshmi et al., 2005). NAC was also able to inhibit 
DNA strand breaks induced by hypoxia. Moreover, NAC attenuated long-term depletion of 
dopamine and lipid peroxidation in rat striatum subjected to hypothermia induced by 
amphetamine (Wan et al., 2006). 
Regarding NAC effects on hyperbilirubinemia models, treatment with NAC was able to 
decrease lipid peroxidation in cerebral cortex, midbrain and cerebellum observed in 
jaundiced rats (Karageorgos et al., 2006), as well as to protect against UCB-induced protein 
oxidation, oxidative disruption and cell death in rat cultured mature cortical neurons (Brito et 
al., 2008b).   
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6. Global aims of the thesis 
The main goal of the present work is to further dissect the cellular mechanisms of 
neonatal neurotoxicity by hyperbilirubinemia. Oxidative stress, mitochondrial dysfunction and 
consequent cell death will be the major features studied. Since prematurity and sepsis are 
risk factors for hyperbilirubinemia, it will be used an experimental model that intends to mimic 
conditions of a moderate to severe neonatal jaundice in prematures, alone or with 
associatied inflammation. Regarding that bilirubin presents a specific deposition pattern in 
the brain, regional susceptibility will also be evaluated in different areas. In addition, it will be 
discussed the role of antioxidants or known modulators of oxidant species production in 
prevention of neuronal injury in neonatal hyperbilirubinemia. 
The major questions addressed in the present thesis are: 
1. Does UCB interfere with mitochondrial function and energy metabolic pathways 
through increased oxidative status in immature neurons? Can GUDCA counteract 
such effects?  
2. Does sepsis have an aggravating role in UCB-induced dysfunction in immature 
neurons? Can .NO/NOS and JNK1/2 activation be considered signalling 
determinants in this neuronal dysfunction?   
3. Does UCB deposition specific pattern in the brain determine the differential 
regional susceptibility to UCB-induced oxidative damage? Can DJ-1 protein 
expression and glutathione content be considered potential modulators of this 
neurotoxicity? 
The studies developed to address these questions are described and discussed in the 
three subsequent chapters.  
In summary, they bring new insights into UCB effects on metabolic pathways, cellular 
redox status and cell death in conditions mimicking a moderate to severe hyperbilirubinemia 
in the early neonatal period. In addition, these results provide a basis for the commonly 
indicated higher risk of UCB brain damage in a condition of inflammation. Furthermore, these 
data provide specific features that may explain the differential susceptibility to UCB observed 
in different brain areas. These advances may substantiate target-driven approaches to the 
prevention and treatment of UCB-induced neurological damage, and provide fruitful 
opportunities for future investigations. 
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Abstract 
High levels of unconjugated bilirubin (UCB) may initiate encephalopathy in neonatal life, 
mainly in premature infants. The molecular mechanisms of this bilirubin-induced neurologic 
dysfunction (BIND) are not yet clarified and no neuroprotective strategy is currently 
worldwide accepted. Here, we show that UCB, at conditions mimicking those of 
hyperbilirubinemic newborns (50 µM UCB in the presence of 100 µM human serum albumin), 
rapidly (within 1 h) inhibited cytochrome c oxidase activity and ascorbate-driven oxygen 
consumption in 3 days in vitro rat cortical neurons. This was accompanied by a bioenergetic 
and oxidative crisis, and apoptotic cell death, as judged by the collapse of the inner 
mitochondrial membrane potential, increased glycolytic activity, superoxide anion radical 
production and ATP release, as well as disruption of glutathione redox status. Furthermore, 
the antioxidant compound glycoursodeoxycholic acid, fully abrogated UCB-induced 
cytochrome c oxidase inhibition and significantly prevented oxidative stress, metabolic 
alterations and cell demise. These results suggest that the neurotoxicity associated with 
neonatal bilirubin-induced encephalopathy occur through a deregulation of energy 
metabolism, and supports the notion that glycoursodeoxycholic acid may be useful in the 
treatment of BIND. 
 
Keywords: bilirubin neurotoxicity, glycolysis, glycoursodeoxycholic acid, mitochondrial 
dysfunction, oxidative stress, respiratory chain. 
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1. Introduction 
As a consequence of the short half-life of fetal erythrocytes, and of the limited ability of 
the neonate to conjugate and excrete bilirubin, newborn infants often show increased levels 
of serum unconjugated bilirubin (UCB). This condition, known as the physiologic jaundice, is 
usually resolved by the end of the first week of life without treatment (Ostrow et al., 2003, 
Reiser, 2004). However, severe hyperbilirubinemia in neonates with prematurity and/or 
systemic illnesses such as hemolytic disease, acidosis, and hypoxemia enhances their risk 
for bilirubin-induced neurologic dysfunction (BIND) (McDonald et al., 1998, Ostrow et al., 
2004, Shapiro, 2005). In fact, in vitro experiments revealed that immature neurons have an 
increased susceptibility to UCB (Falcão et al., 2006). Although the molecular mechanisms of 
BIND remain to be fully clarified, it was shown to involve immunostimulation, accumulation of 
extracellular glutamate, oxidative stress, apoptosis and loss of cell viability (Brites et al., 
2009, Brito et al., 2008b). This excitotoxic-like situation prompted us to hypothesize whether 
UCB would exert the death of immature nerve cells through an impairment of energy 
metabolism.  
Many previous studies have examined the effects of UCB on cerebral energy status but 
the results have been equivocal. In fact, initial reports of an inhibition of respiration and 
uncoupling of oxidative phosphorylation, observed in brain homogenates or isolated 
mitochondria, pointed to mitochondrial dysfunction as an important element of UCB toxicity 
(Mustafa et al., 1969, Ernster and Zetterström, 1956, Day, 1954). The energy depletion was 
later on corroborated by the reduced rates of glycolysis and decreased ATP levels observed 
in Gunn rats and in newborn piglets (Katoh-Semba, 1976, McCandless and Abel, 1980, 
Hoffman et al., 1996, Park et al., 2001). However, discrepant findings were reported in other 
studies that failed to document significant changes in brain glucose metabolism or oxidative 
phosphorylation (Diamond and Schmid, 1967, Brann et al., 1987), whereas others 
demonstrated that hyperbilirubinemia only disturbs brain energy metabolism in the presence 
of additional factors that disrupt the blood brain barrier, such as hypoxia or hyperosmolarity 
(Ives et al., 1988, Ives et al., 1989, Wennberg et al., 1991). Thus, further studies are needed 
to clarify the effects of UCB on brain energy and glucose metabolism in nerve cells, 
particularly in poor differentiated neurons. This would provide a valuable contribute to the 
current understanding of the neuropathological effects of UCB, as neuronal energy 
metabolism is determinant for processes as neurotransmitter release, neurite outgrowth and 
cell survival (Mattson and Liu, 2002), which are impaired by UCB. Moreover, energy 
hypometabolism is one of the most consistent and earliest abnormalities seen in mild 
cognitive impairment (Atamna and Frey, 2007), which is particularly relevant in premature 
jaundiced infants. 
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Recent data indicate that ursodeoxycholic acid and its glycine-conjugated species are 
able to prevent UCB-induced apoptosis and loss of cell viability, oxidative stress and 
immunostimulation (Brito et al., 2008a, Fernandes et al., 2007) and induces a rapid and 
sustained decrease in plasma UCB concentrations in Gunn rats, the well-established animal 
model for severe hyperbilirubinemia (Cuperus et al., 2009). Thus, we decided to test the 
neuroprotective effects of glycoursodeoxycholic acid (GUDCA) in our model of immature 
neurons. 
In this study we show that UCB at a UCB to HSA molar ratio that can be found in the 
plasma of moderately jaundiced neonates (Brito et al., 2006), rapidly and selectively inhibits 
the activity of cytochrome c oxidase, the terminal component of the mitochondrial respiratory 
chain, in immature neurons; this led to an impairment in oxygen consumption, inner-
mitochondrial membrane potential (ΔѰm) collapse and apoptosis. These phenomena were 
associated with an increase in cellular oxidized glutathione, production of superoxide anion 
radical (O2.-) and a decrease in NADPH. Pretreatment of neurons with GUDCA prior to 
exposure to UCB prevented inhibition of cytrochrome c oxidase activity together with 
preservation of glutathione and NADPH status. These data indicate that cytochrome c 
oxidase inhibition may be involved in the neurotoxicity associated with BIND and strongly 
indicates the possible therapeutic potential of GUDCA in the treatment of this disorder. 
 
 
2. Materials and Methods 
 
2.1. Chemicals 
Neurobasal medium, B-27 supplement, Hanks’ balanced salt solution (HBSS-1), Hanks’ 
balanced salt solution without Ca2+ and Mg2+ (HBSS-2), gentamicin (50 mg/mL), 
tetramethylrhodamine (TMRE), MitoSOX Red and trypsin (0.025%) were acquired from 
Invitrogen (Carlsbad, CA). Human serum albumin (HSA) (fraction V, fatty acid free), carbonyl 
cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), ubiquinone-5 (coenzyme Q1, CoQ1), 
2,2,4-trimethyl-1,3-pentanediol (TMPD), sulfosalicyclic acid and 2-vinylpyridine were 
purchased from Sigma Chemical Co (St Louis, MO). UCB was also from Sigma and purified 
as previously described (McDonagh, 1979). Cytochrome c was obtained from Roche 
Diagnostics (Heidelberg, Germany), and it was reduced with sodium ascorbate (Sigma) just 
before use and passed through Sephadex G-25 M (PD-10 columns, Amersham Pharmacia 
Biotech, Uppsala, Sweden) to remove excess ascorbate. GUDCA, as well as Caspases 3 
and 9 substrates, Ac-DEVD-pNA and Ac-LEHD-pNA, respectively, were purchased from 
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Calbiochem (Darmstadt, Germany). Other substrates, inhibitors, enzymes, and coenzymes 
were purchased from Sigma, Roche Diagnostics or Merck (Darmstadt, Germany). 
 
2.2. Neurons in primary culture 
Animal care followed the European Legislation on Protection of Animals Used for 
Experimental and Scientific Purposes (EU directive L0065, 22/07/2003). Neurons were 
isolated from fetuses of 16-17-day pregnant Wistar rats, as described previously (Silva et al., 
2002). The fetuses were collected in HBSS-1, the brain cortex was mechanically fragmented, 
and the fragments transferred to a 0.025% (w/v) trypsin in HBSS-2 solution and incubated for 
15 min at 37ºC. After trypsinization, cells were washed twice in HBSS-2 containing 10% (v/v) 
FBS, and resuspended in Neurobasal medium supplemented with 0.5 mM L-glutamine, 25 
μM L-glutamic acid, 2% B-27 supplement, and 0.12 mg/mL gentamicin. Finally, cells were 
seeded on poly-D-lysine coated tissue culture plates at a density of 2.5 x 105 cells/cm2 and 
maintained at 37ºC in a humidified atmosphere of 5% CO2. In this work we used neurons at 3 
days in vitro (DIV). 
 
2.3. Treatment of neurons 
Neurons were incubated in Neurobasal medium without (control) or with 50 μM UCB 
(from a 10 mM stock solution) in the presence of 100 μM HSA (UCB/HSA molar ratio of 0.5) 
for 1 h at 37ºC. Stock UCB solutions were extemporarily prepared in 0.1 M NaOH under the 
dark and the pH adjusted to 7.4 using 0.1 M HCl. When appropriate, neurons were pre-
incubated with GUDCA (50 µM) 1 h prior to UCB addition. 
 
2.4. Determination of the mitochondrial respiratory chain complex activities and citrate 
synthase 
Neurons plated on 60 cm2 Petri dishes were washed with ice-cold PBS and surviving 
cells were collected by trypsinization, centrifuged and resuspended in 300 μL of 0.1 M 
potassium phosphate buffer (pH 7.0). Cell suspensions (containing about 7-8 mg of 
protein/mL) were frozen and thawed three times to ensure cell lysis. Enzyme activities were 
determined in the cell lysates using an Uvikon XL spectrophotometer (Secomam, Domont, 
France). NADH-CoQ1 reductase (complex I; EC 1.6.99.3) activity was measured as 
described by Ragan et al. (1987). The activity of succinate-cytochrome c reductase (complex 
II-III; EC 1.8.3.1) was determined following the method of King (1967). Cytochome c oxidase 
(complex IV, EC 1.9.3.1) activity was assessed as described by Wharton and Tzagoloff 
(1967). Citrate synthase (EC 4.1.3.7) activity was assessed as referred by Shepherd and 
Garland (1969). Protein concentrations were determined by the method of Lowry et al. 
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(1951). All enzyme activities were expressed as nanomoles per minute per milligram of 
protein, except for cytochrome c oxidase, which was expressed as the first-order rate 
constant (k) per minute per milligram of protein (Almeida and Bolaños, 2001). 
 
2.5. Detection of superoxide anion radical (O2.-) 
After incubation in 9.6 cm2 wells, neurons were incubated in PBS containing MitoSox-
Red (2 μM) for 30 min, washed with PBS and fluorescence assessed by flow cytometry, 
using MitoSox-Red method (Invitrogen), as previously described (Mukhopadhyay et al., 
2007). For the determination of mitochondrial superoxide by flow cytometry, the 
measurements were carried out using FACScalibur flow cytometer (15 mW argon ion laser 
tuned at 488 nm; CellQuest software, Becton Dickinson Biosciences) and the data collected 
at 585/42 nm (FL2) and 670LP (FL3) channel. In this study, the data were presented in the 
FL2 channel. Antimycin A at 20 µM was used for 15 minutes as a mitochondrial superoxide 
generator.  
 
2.6. Determination of oxygen consumption 
Oxygen consumption was determined with a Clark-type electrode (Rank Brothers, 
Cambridge, UK). Briefly, after the incubation period, neurons plated on 60 cm2 Petri dishes 
were collected by trypsinization, centrifuged, rinsed once with buffered Hank’s solution and 
resuspended in 500 μL of Hank’s solution (without glucose). Cell suspensions were kept on 
ice until used for oxygen consumption (within 1 h). The rates of oxygen consumption were 
calculated from the slopes (monitored for at least 15 min per trace), and expressed as 
nanomoles of oxygen consumed per minute per 106 cells (Almeida et al., 1998). TMPD was 
used together with ascorbate to assure the reduced form of cytochrome c. 
 
2.7. ∆Ѱm measurements 
For fluorescence measurements, neurons incubated in 9.6 cm2 wells were stained as 
previously described (Almeida et al., 1999) with minor modifications. Briefly, neurons were 
incubated in Hanks’ solution containing 1 μg/mL of tetramethylrhodamine (TMRE) for 30 min 
at 37ºC. Excess dye was removed by washing cells twice with buffered Hanks’ solution and 
covered with 1 mL of Hanks’solution. For each Petri dish, four fluorescence 
microphotographs were taken with an inverted microscope with a fluorescein filter (excitation 
filter 480-490 nm; emission filter 510-530 nm) and the intensity of fluorescence was 
quantified using an image analyser system (NIH Image Program). The representative 
selected area was always the same for all experimental conditions studied. The fluorescence 
intensity corresponding to control cells was arbitrarily assigned a value of 100% 
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fluorescence. The 0% ΔѰm value was obtained when cells were loaded with TMRE in the 
presence 10 μM of carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) as 
previously referred (Almeida and Bolaños, 2001). The monotonic decrease of fluorescence 
with FCCP assures that we are measuring mitochondrial membrane potential and not the 
plasma membrane potential where a different pattern of fluorescence would be observed 
(Farkas et al., 1989).  
 
2.8. Metabolite determinations 
Neurons (about 3x107) cultured in 60 cm2 Petri dishes and treated as abovementioned 
were rapidly washed with ice-cold PBS, scrapped off with 0.3 M HClO4 and neutralized with 2 
M KHCO3 to pH 6.5. The perchlorate precipitate was removed by centrifugation, and 
fructose-6-phosphate (F6P) and fructose-1,6-bisphosphate (F1,6P2) concentrations were 
measured in the supernatants as previously described (Almeida et al. 2004); intracellular 
lactate concentrations were determined in the same neutralized extracts as previously 
mentioned (Gutmann and Wahlefeld, 1974). 
For the assessment of fructose-2,6-bisphosphate (F2,6P2), cell extracts were lysed in 
0.1 M sodium hydroxide and centrifuged (20,000g for 20 min) as previously described 
(Almeida et al., 2004). Briefly, an aliquot of the homogenate was used for protein 
determination and the remaining sample was heated at 80°C (5 min), centrifuged (20,000g 
for 20 min) and the resulting supernatant used for the determination of F2,6P2 concentrations 
(Kawaguchi et al., 2001, Van Schaftingen et al., 1982). 
For intracellular ATP evaluation, neurons were cultured in 2 cm2 wells and treated as 
above. At the end of the incubation period, cells were rapidly washed with ice-cold PBS, 
scrapped off with 2 x 0.5 mL of 0.3 M HClO4, and neutralized with 0.5 mL of 2 M KHCO3 at 
pH 6.5. The perchlorate precipitate was removed by centrifugation, and ATP was determined 
in the supernatants by chemiluminescence using a commercially available kit following the 
manufacturer’s instructions. The released ATP was considered to be that found in the culture 
medium and the quantification was an adaptation of the method previously described by 
Silva et al. (1997). Briefly, after incubation period, supernatants were collected, placed on ice 
and exposed to 2 M HClO4. A solution of 2 M KHCO3 was used to restore pH at 6.5. The 
perchlorate precipitate was removed by centrifugation, and ATP levels were measured 
fluorimetrically in the protein-free supernatants.  
For glutathione measurement, neurons incubated in 9.6 cm2 wells were washed with ice-
cold PBS and immediately collected by scrapping off with 0.5 mL of 1% (w/v) sulfosalicyclic 
acid. Cell lysates were centrifuged at 13,000 g for 5 min at 4ºC, and the supernatants used 
for glutathione determinations on the same day. Total glutathione content (GSx, i.e. the 
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amount of GSH plus two times the amount of GSSG) and oxidized glutathione (GSSG) were 
measured and calculated as previously described (Dringen and Hamprecht, 1996, García-
Nogales et al., 1999). GSX and GSSG concentrations were expressed as nanomoles per 
milligram of protein.  
NADPH concentrations were measured accordingly with García-Nogales et al. (1999). In 
brief, neurons incubated in 2 cm2 wells were washed with ice-cold PBS, and collected in 200 
μL of 0.5 M KOH in 50% (v/v) ethanol. Cell lysates were neutralized (pH 7.8) with 200 μL of 
0.5 M triethanolamine/0.5 M potassium phosphate and centrifuged at 13,000 g for 2 min at 
4ºC. A 50-μL aliquot of the supernatant was immediately used for NADPH determination 
(Wulff, 1985), with the exception that NADH was oxidized by incubation of the samples with 
0.5 mU/μL lactate dehydrogenase and 1 mM pyruvate (Klingerberg, 1985). 
 
2.9. Assessment of apoptotic cell death by flow citometry 
Allophycocyanin (APC)-conjugated annexin-V and 7-amino-actinomycin D (7-AAD) 
(Apoptosis Assay Kit; Becton Dickinson Biosciences, San Jose, CA, USA) were used to 
quantitatively determine the percentage of apoptotic cells by flow cytometry. After incubation 
in 2 cm2 wells, neurons were stained with annexin-V-APC and 7-AAD, following the 
manufacturer’s instructions, and they were analysed on a FACScalibur flow cytometer (15 
mW argon ion laser tuned at 488 nm; CellQuest software, Becton Dickinson Biosciences). 
The annexin V-APC-stained cells that were 7-AAD negative were considered apoptotic 
(Almeida et al., 2004). 
 
2.10. Analysis of apoptotic cell death by 4'-6-diamidino-2-phenylindole (DAPI) nuclear 
staining 
Neurons were fixed with 4% (v/v, in PBS) paraformaldehyde for 30 min at room 
temperature, rinsed with PBS and incubated with DAPI (30 µM, Sigma). After 10 min, cells 
were washed three times with PBS and their nuclei examined under a fluorescence 
microscope by an author blinded to the test. A total of ~200 cells per condition in three 
different cultures were quantified, and the results were expressed as the percentage of 
condensed or fragmented nuclei. 
 
2.11. Caspase-3 and -9 activity assays 
Activities of caspase-3 and -9 were measured by a colorimetric method (Calbiochem, 
Darmstadt, Germany). Cells were harvested, washed with ice-cold PBS and lysed for 30 
minutes on ice in the lysis buffer [50 mM HEPES (pH 7.4); 100 mM NaCl; 0.1% (w/v) 
CHAPS; 1 mM DTT; 0.1 mM EDTA]. The lysate was centrifuged at 10,000 g for 10 min at 
Chapter II 
__________________________________________________________________________ 
 
 
68 
 
4ºC and the supernatants were collected and stored at -80ºC. Protein concentrations were 
determined as aforementioned. The activity of caspases 3 and 9 was determined in cell 
lysates by enzymatic cleavage of chromophore p-nitroanilide (pNA) from the substrate Ac-
YVAD-pNA, according to manufacturer’s instructions. The proteolytic reaction was carried 
out in protease assay buffer buffer [50 mM HEPES (pH 7.4); 100 mM NaCl; 0.1% (w/v) 
CHAPS; 10 mM DTT; 0.1 mM EDTA; 10% (v/v) glicerol], containing 2 mM substrate Ac-
DEVD-pNA for caspase-3 and Ac-LEHD-pNA for caspase-9. Following incubation of the 
reaction mixtures for 2 h at 37ºC, the formation of pNA was measured at λ= 405 nm with a 
reference filter of 620 nm. 
 
2.12. Statistical analysis 
Measurements from individual cultures were performed in triplicate. The results are 
expressed as the mean ± SEM values for the number of culture preparations indicated in the 
legends. Statistical analysis of the results was performed by one-way analysis of variance 
followed by the least significant difference multiple range test, and p<0.05 was accepted as 
statistically significant in all cases. 
 
 
3. Results  
 
3.1. UCB selectively impairs cytochrome c oxidase activity in immature neurons, 
which is prevented by GUDCA 
To investigate the possible role of UCB on mitochondrial function in immature nerve 
cells, 3 DIV cortical neurons were incubated with UCB at conditions mimicking neonatal 
jaundice (50 µM UCB + 100 µM HSA) that had previously shown to induce oxidative injury 
and cell death in mature neurons (Brites et al., 2009, Brito et al., 2008b). Cells were collected 
1 h after treatment for the analysis of the activities of the mitochondrial respiratory chain 
complexes. Activity of NADH-CoQ1 (Fig. II.1A) was unaffected and that of succinate-
cytochrome c reductase (Fig. II.1B), although slightly reduced, did not significantly change 
after neuronal exposure to UCB. In contrast, cytochrome c oxidase activity (Fig. II.1C) was 
inhibited by UCB in approximately 50% (p<0.01). Finally, since the activity of citrate synthase 
(Fig. II.1D) was also unchanged, this indicates that no differences in mitochondrial 
enrichment in our study model account for the decreased complex activity. Since GUDCA 
has shown to have neuroprotective effects through the prevention of mitochondrial swelling 
we have tested the beneficial effects of this bile acid on the UCB-induced alterations on the 
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mitochondrial respiratory chain. GUDCA revealed to be able to completely reverse the 
inhibition of the cytochrome c oxidase activity (Fig. II.1C).  
 
 
Figure II.1 - Unconjugated bilirubin (UCB) selectively impairs cytochrome c oxidase 
activity in immature neurons and glycoursodeoxycholic acid (GUDCA) exerts a 
preventive effect. Neurons at 3 days in vitro were incubated for 1 h with UCB (50 µM) plus 
human serum albumin (100 µM). When indicated, neurons were pre-treated with GUDCA (50 
µM) for 1 h. After incubation, neurons were used for enzyme activity determinations, as 
indicated in Methods. UCB did not alter NADH-CoQ1 reductase - Complex I (A) as well as 
succinate-cytochrome c reductase - Complex II-III (B), but inhibited cytochrome c oxidase 
activity that was prevented by GUDCA (C). Additionally, no changes were noticed in citrate 
synthase activity (D). **p<0.01 vs. control; ##p<0.01 vs. UCB. 
 
 
3.2. UCB produces oxidative stress in immature neurons, which is prevented by 
GUDCA 
Next we explored the oxidative status of immature neurons exposed to UCB. We 
observed that UCB markedly induced the production of reactive oxygen species (ROS), 
namely O2.- (Fig. II.2A)  and oxidized glutathione (Fig. II.2B),  as well as decreased NADPH 
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concentrations (Fig. II.2C). Moreover, pre-incubation of neurons with GUDCA efficiently 
prevented all these oxidative events caused by UCB. 
 
Figure II.2 - Unconjugated bilirubin (UCB) produces oxidative stress in immature 
neurons and glycoursodeoxycholic acid (GUDCA) exerts a preventive effect. Neurons 
at 3 days in vitro were treated as in Figure II.1. After incubation, neurons were used for 
metabolite assessments as indicated in Methods. UCB-induced oxidative stress through the 
increase in superoxide anion radical production, as indicated by a higher MitoSox 
fluoresence intensity (A), oxidized glutathione (B), as revealed by the increase in GSSG/GSx 
ratio, and the decrease in NADPH concentrations (C) that were prevented by GUDCA. 
**p<0.01 and *p<0.05 vs. control; #p<0.05 vs. UCB. 
 
3.3. UCB impairs cellular oxygen consumption and collapses ΔѰm in immature 
neurons and GUDCA exerts a preventive effect 
In view that the mitochondrial respiratory chain thresholds for oxygen consumption 
(Davey et al., 1998), it could be speculated that the level of cytochrome c oxidase inhibition 
caused by UCB might not be enough to impair the mitochondrial function. To elucidate this, 
we first determined the rate of oxygen consumption in the dissociated neurons previously 
incubated with UCB. As shown in Figure II.3A, UCB significantly reduced the rates of oxygen 
consumption using glucose, succinate or ascorbate as substrates, effects that were 
significantly prevented by GUDCA. The effects on O2 consumption are related to 
mitochondria, since both succinate and ascorbate reproduced the same results as with 
glucose. In addition, in all cases antimycin or potassium cyanide abolished O2 consumption 
driven by succinate or ascorbate, respectively (data not shown). The inhibition of oxygen 
consumption from ascorbate indicates that UCB-inhibition of cytochrome c oxidase, affects 
cell respiration. To further test this possibility, we assessed the ΔѰm as an index of the 
mitochondrial inner membrane integrity; as depicted in Figure II.3B, UCB caused the 
collapse of ΔѰm, and GUDCA showed ability to restore mitochondrial integrity.  
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Figure II.3 - Unconjugated bilirubin (UCB) impairs cellular oxygen consumption and 
collapses ΔѰm in immature neurons and glycoursodeoxycholic acid (GUDCA) exerts a 
preventive effect. Neurons at 3 days in vitro were treated as in Figure II.1. After incubation, 
neurons were either subjected to ΔѰm assessment in the plates or collected for oxygen 
consumption determinations as indicated in Methods. UCB inhibited the rate of glucose-, 
succinate- and ascorbate-driven oxygen consumption (A) that was prevented by GUDCA. 
UCB decreased ΔѰm (B), as assessed by TMRE staining (left panels) and fluorescence 
quantification (right panel), effects that were prevented by GUDCA **p<0.01 and *p<0.05; 
#p<0.05 and ##p<0.01 vs. UCB (scale bar 50 µm).  
 
3.4. UCB increases extracellular ATP content, glycolysis and F2,6P2 levels in immature 
neurons, which are counteracted by GUDCA  
Curiously, although UCB-induced impairment of mitochondrial respiratory chain function 
was not accompanied by a reduction of the intracellular ATP levels (data not shown), an 
increase in the concentrations of extracellular ATP (Fig. II.4A) was obtained. In addition, it 
was also observed an increase in the concentration of intracellular lactate (Fig. II.4B), as well 
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as in F1,6P2/F6P ratio (Fig. II.4C), suggesting an activation of glycolysis, which was further 
supported by the concomitant elevated levels of F2,6P2 (Fig. II.4D). Noticeably, all these 
effects were abolished by GUDCA. 
 
Figure II.4 - Unconjugated bilirubin (UCB) increases extracellular ATP content, 
glycolysis and fructose-2,6-bisphosphate (F2,6P2) levels in immature neurons, and 
glycoursodeoxycholic acid (GUDCA) exerts a preventive effect. Neurons at 3 days in 
vitro were treated as in Figure II.1. After incubation, extracellular ATP was evaluated, and 
neurons were lysed for intracellular lactate, fructose-1,6-bisphosphate (F1,6P2), fructose-6-
phosphate (F6P) and F2,6P2 measurements, as indicated in Methods. UCB triggered an 
increase in ATP release (A), intracellular lactate concentration (B), F1,6P2/F6P (C) and 
F2,6P2 concentration (D), which were prevented by GUDCA. **p<0.01 and *p<0.05 vs. 
control; ##p<0.01 and  #p<0.05 vs. UCB. 
 
3.5. UCB triggers apoptotic cell death in immature neurons, which is prevented by 
GUDCA  
Finally, we sought to investigate whether the mitochondrial impairment triggered by UCB 
was associated with neurotoxicity. As shown in Figure II.5A, UCB enhanced the proportion of 
annexin V+/7-AAD- neurons, as assessed by flow cytometry; it also triggered an increase in 
the proportion of condensed or fragmented nuclei, as visualized with DAPI by fluorescence 
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microscopy (Fig. II.5B). Cell death by apoptosis was further corroborated by the increase in 
the activation of caspase-3 (Fig. II.5C). Similar increase in the activation of caspase-9 
indicates the involvement of mitochondria in this process. Such effects were again 
completely counteracted by GUDCA. We can then speculate that the increased glycolytic 
rate (Fig. II4) is a failed attempt to compensate the mitochondrial impairment. These results 
support the notion that UCB causes nerve cell death by apoptosis, mainly in immature 
neurons, and confirms that GUDCA efficiently protects cells against this type of neurotoxicity. 
 
 
4. Discussion 
Here we show, for the first time, that brief exposure (1 h) of primary cortical immature 
neurons to UCB in conditions that have relevance to the clinical manifestations of BIND (50 
µM UCB + 100 µM HSA) inhibits mitochondrial respiratory chain, at the level of cytochrome c 
oxidase complex. Mitochondrial dysfunction by UCB appears to involve .NO, accordingly with 
previous studies (Brito et al., 2008a, Mancuso et al., 2008) reporting that neuronal oxidative 
dysruption by UCB is abrogated by inhibition of neuronal NO synthase (nNOS). .NO is 
capable of rapidly and reversibly inhibit the mitochondrial respiratory chain and may be 
implicated in the cytotoxic effects in the CNS (Bolaños et al., 1994, Brown and Cooper, 1994, 
Cleeter et al., 1994). Additionally, inhibition of the mitochondrial transport chain at the level of 
complex IV can further produce O2.-  from O2, a finding also observed in this study (Fig. 
II.2A). Thus, inhibition of mitochondrial cytochrome c oxidase by .NO can lead to the 
formation of both .NO and O2.-  and thereby lead to the formation of ONOO- (Sharpe and 
Cooper, 1998). Interestingly, we previously demonstrated that UCB induces protein oxidation 
and lipid peroxidation, while diminishes the thiol antioxidant defences, events that were 
correlated with the extent of cell death, and that GUDCA primarily acts as an antioxidant at 
protecting neurons against UCB-induced oxidative stress (Brito et al., 2008a). The present 
study extended our previous ones by showing that UCB decreases NADPH concentrations 
(Fig. II.2C) in immature neurons, in adition to glutathione oxidation (Fig. II.2B) and O2.- 
production, confirming oxidative stress by UCB. 
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Figure II.5 – Unconjugated bilirubin (UCB) triggers apoptotic death in immature 
neurons and glycoursodeoxycholic acid (GUDCA) exerts a preventive effect. Neurons 
at 3 days in vitro were treated as in Figure II.1. After incubation, neurons were subjected to 
assessment of apoptotic death by flow cytometry (annexin V+/7-AAD-), nuclear condensation 
or fragmentation in DAPI-stained cells, and caspase-3 and -9 activities, as indicated in 
Methods. UCB increased neuronal apoptosis as measured by the percentage of annexin 
V+/7-AAD- cells (A) (left panel shows a typical diagram; right panel represents the 
quantification) or fragmented or condensed nuclei (B) (left panel show a typical 
microphotograph of the DAPI-stained cells; right panel represents the quantification), which 
was prevented by GUDCA. Data was corroborated by the increase in the activation of 
caspase-3 and caspase-9 (C) pointing to the involvement of mitochondria. GUDCA was able 
to markedly prevent this effect. **p<0.01 and *p<0.05 vs. control; ##p<0.01 vs. UCB (scale 
bar 20 µm). 
0.0
0.5
1.0
1.5
2.0
2.5
3.0
C
as
pa
se
 9
 a
ct
iv
ity
 (f
ol
d 
vs
.c
on
tro
l)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
C
as
pa
se
 3
 a
ct
iv
ity
 (f
ol
d 
vs
.c
on
tro
l)
0
5
10
15
20
C
on
de
ns
ed
 o
r 
fra
gm
en
te
d 
nu
cl
ei
(%
)
0
5
10
15
20
25
30
A
po
pt
ot
ic
 n
eu
ro
ns
(%
 A
nn
ex
in
+ /
7A
A
D
- )
A
B
*
##
C
**
##
##
**
##
**
Control
UCB
UCB, mitochondrial dysfunction and GUDCA 
__________________________________________________________________________ 
 
 
75 
 
Moreover, pre-incubation of neurons with GUDCA efficiently prevented these oxidative 
events, thus highlighting the antioxidant properties of the bile acid in this paradigm. In 
addition, GUDCA abolished the inhibition of cytochrome c oxidase caused by UCB (Fig. 
II.1C), indicating that the mitochondrial respiratory chain damage caused by UCB would be a 
free radical-mediated process. To the best of our knowledge, this is the first evidence 
reporting the ability of GUDCA to completely restore the activity of cytochrome c oxidase 
when impaired. 
Once a defective respiratory function also includes decreased oxygen consumption, we 
explored the effects of UCB at such level, since contradictory results were previously found 
by several authors using neither relevant physiological concentrations nor purified UCB 
(Diamond and Schmid, 1967, Ernster and Zetterström, 1956, Mustafa et al., 1969). Since 
glucose provides NAD-linked electrons through NADH-CoQ1 reductase, and succinate FAD-
linked ones through succinate dehydrogenase, the inhibition of cell respiration from these 
substrates by UCB is compatible with, but does not demonstrate, inhibition at the terminal 
complex, cytochrome c oxidase. However, the inhibition of oxygen consumption from 
ascorbate, which directly supplies electrons to cytochrome c oxidase, confirms that the 
inhibition at the level of this complex by UCB affects cell respiration. This was reinforced by 
the collapse of ΔѰm produced by UCB indicating decreased mitochondrial membrane 
potential and mitochondrial dysfunction, which was again prevented when neurons were pre-
treated with GUDCA before the exposure to UCB. Permeabilization of the mitochondrial 
membrane by UCB and increased efflux of cytochrome c were previously observed in 
isolated mitochondria from the brain and liver of adult male Wistar rats (Rodrigues et al., 
2002, Rodrigues et al., 2000). Such mitochondrial impairment by UCB was in the present 
study accompanied by an increase in intracellular lactate concentrations and F1,6P2/F6P 
ratio, suggesting an activation of glycolysis by stimulation of 6-phosphofructo-1-kinase 
(Pfk1), i.e. a master regulator of this pathway (Uyeda, 1979); this notion was further 
supported by the observed increased levels of F2,6P2, i.e. the positive effector of Pfk1 (Van 
Schaftingen et al., 1982). Moreover, intracellular ATP content was unchanged, whereas 
extracellular levels were increased. Altogether, these results suggest that UCB disrupts the 
mitochondrial function in immature neurons leading to up-regulation of glycolysis, which 
reflects the natural metabolic response of cells to cytochrome c oxidase deficiency (Almeida 
et al., 2004, Bolaños et al., 1994) and may determine the unchanged intracellular ATP levels. 
In fact, it is conceivable that the up-regulation of glycolysis in these still immature neuronal 
cells may provide sufficient ATP as a self-protective attempt to support the bioenergetic 
crisis, as previously demonstrated for astrocytes exposed to injurious stimuli (Bolaños et al., 
2004). In parallel, the release of ATP by neurons has been suggested to be determined by 
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the production of .NO and oxidative stress and to be associated with neuronal cell death by 
apoptosis, in that ATP is critical to inducing several apoptotic events (Figueroa et al., 2006, 
López et al., 2006). Noticeably, all these effects were prevented by GUDCA. 
Another new finding on the mechanisms of UCB-induced oxidative stress is the 
decrease of NADPH levels which may contribute to the altered glutathione redox status 
(Dringen, 2000) observed in the presence of UCB. This result is consistent with the recently 
reported notion that, in neurons, the activation of glycolysis leads to inhibition of the pentose-
phosphate pathway (PPP), causing glutathione oxidation (Herrero-Mendez et al., 2009). 
Interestingly, through PPP, neurons maintain cytochrome c in a reduced status in order to 
prevent its release and apoptotic death (Vaughn and Deshmukh, 2008). In good agreement 
with this, GUDCA restored reduced glutathione levels in immature neurons, as it did with 
differentiated cells (Brito et al., 2008a) and also re-established NADPH values reinforcing its 
antioxidant capacity. An up-regulation of gamma-glutamyl cysteine synthetase, together with 
the efficient scavenging of free radicals previously reported for the non conjugated form of 
the bile acid  (Lapenna et al., 2002, Rodriguez-Ortigosa et al., 2002, Serviddio et al., 2004) 
shall contribute to the protective actions herewith found.  
UCB induced mitochondrial dysfunction in 3 DIV neurons by selective inhibition of 
cytochrome c oxidase activity, and decreased mitochondrial membrane potential, but 
maintained intracellular ATP levels, ultimately leading to apoptotic cell death. The activation 
of caspase-3, but mostly of caspase-9, points to the activation of the mitochondrial apoptotic 
pathway in immature neurons after a short exposure to UCB in conditions mimicking an 
acute neonatal jaundice. To the prevention of this neurotoxicity by GUDCA may account its 
ability to re-establish the energy metabolism and redox status of the injured cell. 
In conclusion, in this study we report evidence of UCB induced inhibition of cytochrome c 
oxidase activity in immature rat neurons resulting in respiratory chain dysfunction, a 
decrease in antioxidant defences and apoptosis, as schematically represented in Figure II.6. 
The ability of GUDCA to ameliorate UCB induced mitochondrial respiratory chain dysfunction 
and restore cellular antioxidant potential supports the efficacy of this compound as a 
potential treatment for BIND. 
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Figure II.6 - Schematic representation of some important steps in neuronal injury by 
unconjugated bilirubin (UCB) and potential targets of glycoursodeoxycholic acid 
(GUDCA). UCB interaction with immature neurons causes the selective inhibition of complex 
IV (CIV) activity, impairs oxygen (O2) consumption, leads to a loss of mitochondrial 
membrane potential (ΔѰm) and superoxide anion radical production (O2.-) production. UCB 
also induces the up-regulation of glycolysis and increased amounts of extracellular ATP, 
together with an inhibition of the pentose-phosphate pathway (PPP), as inferred by the 
decreased NADPH and increased oxidized glutathione (GSSG) levels. All these events shall 
contribute to the activation of caspases 9 and 3 and apoptotic cell death. GUDCA fully 
abrogated UCB-induced mitochondrial dysfunction, alterations in energy metabolism and 
disruption of the redox status, therefore counteraction immature nerve cell demise resulting 
from UCB exposure. 
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Abstract 
Hyperbilirubinemia may lead to encephalopathy in neonatal life, particularly in premature 
infants. Although the mechanisms were never established, clinicians commonly consider 
sepsis as a risk factor for bilirubin-induced neurological dysfunction (BIND). Our previous 
studies showed that elevated levels of unconjugated bilirubin (UCB) have immunostimulant 
effects, which are potentiated by LPS, and that immature neural cells are more vulnerable to 
UCB. The present study was undertaken to explore the role of nitric oxide (.NO)/NO synthase 
(NOS), c-Jun N-terminal kinase (JNK) 1/2 and caspase activation in BIND, as well as the 
additional effects of inflammation, in immature neurons incubated from 1 h to 24 h, at 37ºC. 
UCB, at conditions mimicking those of jaundiced newborns (UCB/serum albumin = 0.5), 
induced .NO production, nNOS expression and JNK1/2 activation in 3 days in vitro neuron 
cultures. As a consequence of these events, mitochondrial and extrinsic pathways of 
apoptosis were initiated, ultimately leading to neuronal dysfunction. Co-incubation with TNF-
α+IL-1β intensified the activation of .NO/NOS, JNK1/2, caspase-8, caspase-9 and caspase-3 
by UCB. Cleavage of Bid and truncated Bid (tBid) up-regulation, as well as increased 
cytotoxic potential, was also observed. Interestingly, both L-NAME (NOS inhibitor) and 
SP600125 (JNK1/2 inhibitor) reversed the effects produced by UCB either alone, or in 
association to pro-inflammatory cytokines. Taken together, our data reveal not only that 
activation of .NO/NOS, JNK1/2 and caspase cascades are important determinants of BIND 
but also that the association of TNF-α+IL-1β have cumulative effects. These events provide a 
reason for the risk of sepsis in BIND and point to potential targets for therapeutic 
intervention. 
 
Keywords: neuronal .NO/NOS system; JNK1/2 signalling pathway; Caspase activation; TNF-
α+IL-1β; Bilirubin-induced neurological dysfunction (BIND) 
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1. Introduction 
Elevated levels of unconjugated bilirubin (UCB) are responsible for the clinical 
manifestation of jaundice, a common condition in the neonatal period. Although normal (or 
slightly increased) levels of UCB provide protection against injury resulting from oxidation 
(Doré et al., 2000), elevated UCB concentrations cause nerve cell damage, leading to 
adverse neurological outcomes (Hansen, 2002), ranging from minimal damage to chronic 
and permanent sequelae, or even death (Ostrow et al., 2004, Shapiro, 2005). The risk of 
bilirubin-induced neurologic dysfunction (BIND) is particularly enhanced in premature 
newborns due to the higher rates of UCB production and the immaturity of the excretion 
pathways (Stevenson et al., 2001, Watchko, 2006).  
Although the determinants of vulnerability to BIND are only partially understood, it is well 
known that UCB triggers the accumulation of extracellular glutamate (Falcão et al., 2006), 
oxidative stress (Brito et al., 2008a, Brito et al., 2010, Brito et al., 2008b), as well as the 
release of the pro-inflammatory cytokines tumor necrosis factor-α (TNF-α), interleukin-1β  
(IL-1β) and IL-6 by both astrocytes (Fernandes et al., 2004) and microglia (Fernandes et al., 
2006). Inflammatory signalling pathway involves the activation of mitogen-activated protein 
kinases (MAPKs) and nuclear factor (NF)-kB (Fernandes et al., 2006, Silva et al., 2010). 
These upstream events culminate in nerve cell death by both necrosis and apoptosis (Silva 
et al., 2002). UCB directly interacts with mitochondria influencing membrane lipid and protein 
properties, redox status, and cytochrome c content (Rodrigues et al., 2002b). In addition, we 
also demonstrated that UCB induces apoptosis trough mitochondria-caspase-3 pathway 
involving cytochrome c release, caspase-3 activation, and subsequent PARP cleavage in 
developing rat brain neurons (Rodrigues et al., 2002a). Recent findings evidenced that UCB 
inhibits cytochrome c oxidase activity, and induces both ATP release and disruption of 
glutathione redox status in immature neurons (Vaz et al., 2010).  
Interestingly, immature nerve cells are more susceptible than differentiated ones to 
UCB-induced toxicity and release higher levels of glutamate and TNF-α providing a basis for 
the increased susceptibility of premature newborns to UCB deleterious effects (Falcão et al., 
2006). In addition, LPS showed to exacerbate the release of TNF-α and IL-1β by immature 
astrocytes (Falcão et al., 2005).  
It has been suggested that infection increases the risk for UCB encephalopathy 
(Dawodu et al., 1984) and presence of inflammatory features, namely fever episodes and 
brain edema, were described during or following moderate to severe hyperbilirubinemia 
(Kaplan and Hammerman, 2005). The inflammatory reaction is essential for survival in 
response to tissue injury or infection, but it can also cause neuronal damage, since cytokines 
are not only involved in neuroprotection but also in neurodegeneration processes (Konsman 
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et al., 2007). Pro-inflammatory cytokines, such as TNF-α and IL-1β, besides having 
pleiotropic effects in the central nervous system, including their emerging role in 
neurodevelopment (Marx et al., 2001) have also been described as mediators of neuronal 
apoptosis (Kajta et al., 2006, Takahashi et al., 2008). Several studies have shown that 
inflammation is associated with the enhanced generation of reactive oxygen species (ROS), 
and/or reactive nitrogen species (Bian and Murad, 2001, Sener et al., 2005, Brito et al., 
2007). One of the oxidant species, nitric oxide (.NO), although important in cellular signalling, 
has an important role in the pathogenesis of inflammation (Korhonen et al., 2005). In fact, 
.NO and induction of nitric oxide synthase (NOS) are involved in apoptosis induced by 
inflammatory mediators in neuronal cells (Hemmer et al., 2001, Heneka et al., 1998, Thomas 
et al., 2008). To add that exposure to UCB leads to increased expression of neuronal NOS 
(nNOS) and production of .NO, cyclic guanosine 3',5'-monophosphate (cGMP) and ROS, 
along with protein oxidation and depletion of glutathione (Brito et al., 2008b, Fernandes et al., 
2010). Therefore, .NO inhibitors represent important strategies to prevent cellular injury 
associated with jaundice and inflammatory processes. Among the upstream signals leading 
to neuronal degeneration, one may include the stress-activated protein kinases (SAPKs). In 
fact, c-Jun N-terminal kinases 1/2 (JNK1/2) become activated in response to toxic stimulus, 
such as the reactive nitrogen species (Luo et al., 1998, Marques et al., 2003) and the pro-
inflammatory cytokines TNF-α and IL-1, pointing these SAPKs as strong effectors of 
neuronal apoptosis (Tibbles and Woodgett, 1999, Mielke and Herdegen, 2000). JNK 1/2 
directly mediates the UCB-stimulation of TNF-α by astrocytes as we showed by the use of 
SP600125, a JNK1/2 inhibitor (Fernandes et al., 2007). This feature may be relevant if we 
consider that astrocytic activation has also been reported in several neurodegenerative 
disorders and that this transition may be accompanied by dysfunction of astrocytes leading to 
incorrect glia-to-neuron cross-talk (Rossi and Volterra, 2009).  
In this study, we investigated if .NO/NOS and JNK 1/2 activation were signalling 
determinants for caspase-8 activation and mitochondrial death pathway in UCB-induced 
dysfunction of immature neurons. Most of all, we explored if the combination of the pro-
inflammatory cytokines TNF-α and IL-1β aggravate the functional de-regulation of immature 
neurons produced by UCB and whether use the same cascade of mediators. 
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2. Materials and Methods 
 
2.1. Chemicals 
Neurobasal medium, B-27 supplement (50X), Hanks’ balanced salt solution (HBSS-1), 
Hanks’ balanced salt solution without Ca2+ and Mg2+ (HBSS-2), gentamicin (50 mg/mL), and 
trypsin (0.025%) were acquired from Invitrogen (Carlsbad, CA). Recombinant rat IL-1β and 
TNF-α were form R&D Systems Inc. (Minneapolis, MN, USA). Human serum albumin (HSA) 
(fraction V, fatty acid free), N-ω-nitro-L-arginine methyl ester hydrochloride (L-NAME), 
primary monoclonal antibody mouse anti-β-actin, N-1-naphthylethylenediamine, 
sulfanilamide, sodium nitrite and MTT [3-(4,5-dimethylthiazol, 2-yl)-2,5-diphenyltetrazolium 
bromide] were purchased from Sigma Chemical Co (St Louis, MO). UCB was also from 
Sigma and purified as previously described (McDonagh, 1979). Nitrocellulose membrane, 
Hyperfilm ECL and horseradish peroxidase-labelled sheep anti-mouse IgG were from 
Amersham Biosciences (Piscataway, NJ, USA). Cell lysis buffer and LumiGLO® were 
acquired from Cell Signalling (Beverly, MA, USA). Antibodies directed to phosphorylated 
JNK1/2 (P-JNK1/2) and Bid were from Santa Cruz Biotechnology (Santa Cruz, CA, USA) 
while antibody against neuronal NOS (nNOS) was from Becton Dickinson Biosciences (San 
José, CA, USA). Caspases 3, 8 and 9 substrates, Ac-DEVD-pNA, Ac-IETD-pNA and Ac-
LEHD-pNA, respectively, were purchased from Calbiochem (Darmstadt, Germany). A 
concentrated solution (10 mM) of the JNK1/2 inhibitor SP600125 (Calbiochem) was prepared 
in dimethylsulfoxide. 
 
2.2. Neurons in primary culture 
Animal care followed the recommendations of European Convention for the Protection of 
Vertebrate Animals Used for Experimental and other Scientific Purposes (Council Directive 
86/609/EEC) and National Law 1005/92 (rules for protection of experimental animals). 
Neurons were isolated from fetuses of 16-17-day pregnant Wistar rats, as previously 
described (Silva et al., 2002). The fetuses were collected in Hanks’ balanced salt solution 
(HBSS), the brain cortices were mechanically fragmented, and the fragments transferred to a 
0.5 g/L trypsin in Ca2+ and Mg2+ free HBSS medium and incubated for 15 min at 37ºC. After 
trypsinization, cells were washed twice in Ca2+ and Mg2+ free HBSS medium containing 10% 
fetal bovine serum, and resuspended in Neurobasal medium supplemented with 0.5 mM L-
glutamine, 25 μM L-glutamic acid, 2% B-27 supplement, and 0.12 mg/mL gentamicin. Finally, 
cells were seeded on poly-D-lysine coated tissue culture plates at a density of 2 x 105 
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cells/cm2 and maintained at 37ºC in a humidified atmosphere of 5% CO2. In this work we 
used neurons at 3 days in vitro (DIV).  
2.3. Treatment of neurons 
Immature neurons were incubated in Neurobasal medium without (control) or with 50 μM 
UCB (Sigma Chemical Co, St Louis, MO, USA) in the presence of 100 μM HSA from 1 h to 
24 h, at 37ºC. For co-incubation studies, neurons were co-incubated with recombinant 50 
ng/mL TNF-α plus 50 ng/mL IL-1β (R&D Systems Inc., Minneapolis, MN, USA). Stock UCB 
solutions were extemporarily prepared in 0.1 M NaOH under the dark and the pH adjusted to 
7.4 using 0.1 M HCl.  In parallel studies, cells were co-incubated with 100 µM N-ω-nitro-L-
arginine methyl ester hydrochloride (L-NAME) (Sigma Chemcial Co), a non-selective NOS 
inhibitor or treated with 0.2 µM SP600125 (Calbiochem, Darmstadt, Germany), an inhibitor of 
JNK1/2, 1 h prior to UCB addition, alone or in combination with TNF-α+IL-1β. 
 
2.4. Quantification of nitrite levels 
Nitric oxide levels were estimated by measuring the concentrations of nitrites (NO2-), 
which are the resulting .NO metabolites. Briefly, supernatants free from cellular debris were 
mixed with Griess reagent [1 part 1% (w/v) sulfanilamide in 5% H3PO4, 1 part 0.1% (w/v) N-1-
naphthylethylenediamine (v/v)] in 96-well tissue culture plates for 10 min at room 
temperature in the dark. The absorbance at 540 nm was determined using a microplate 
reader (Bio-Rad Laboratories, Hercules, CA, USA). 
 
2.5. Western blot assay 
The intracellular forms of nNOS, Bid and phosphorylated P-JNK1/2 were determined by 
Western blot analysis as usual in our laboratory (Fernandes et al., 2006). Briefly, cells were 
washed in ice-cold PBS and lysed in a buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM 
NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% (v/v) Triton X-100, 2.5 mM sodium pyrophosphate, 
1 mM β-glycerophosphate, 1 mM Na3VO4, 1 μg/mL leupeptine, 1 mM PMSF. The lysate was 
sonicated for 20 s, centrifuged at 14.000 g for 10 min at 4ºC and the supernatants were 
collected and stored at -80ºC. Protein concentrations were determined according to the 
Bradford method (Bradford, 1976) using Bio-Rad’s Protein Assay reagent (Bio-Rad, CA, 
USA). Equal amounts of protein were subjected to sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis and transferred to a nitrocellulose membrane. After blocking with 5% milk 
solution, membranes were incubated with the primary antibody overnight at 4ºC [mouse anti-
nNOS (BD Biosciences, San José, CA, USA) diluted at 1:2.500, rabbit anti-Bid (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) diluted at 1:500, mouse anti-P-JNK1/2 (Santa Cruz 
Biotechnology) diluted at 1:200 or anti-β-actin (Sigma Chemical Co) diluted at 1:10.000], and 
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finally with horseradish peroxidase-labelled secondary antibody. Protein bands were 
detected by LumiGLO® and visualized by autoradiography with Hyperfilm ECL.  
2.6. Caspase activity determination 
Activities of caspase-3, -8 and -9 were measured by a colorimetric method (Calbiochem, 
Darmstadt, Germany) as usual in our laboratory (Vaz et al., 2010). Cells were harvested, 
washed with ice-cold PBS and lysed for 30 minutes on ice in the lysis buffer [50 mM HEPES 
(pH 7.4), 100 mM NaCl, 0.1% (w/v) cholamidopropyldimethylammonio-1-propanesulfonate 
(CHAPS), 1 mM DTT, 0.1 mM EDTA]. The lysate was centrifuged at 10,000 g for 10 min at 
4ºC and the supernatants were collected and stored at -80ºC. Protein concentrations were 
determined as aforementioned. The activity of caspases 3, 8 and 9 was determined in cell 
lysates by enzymatic cleavage of chromophore p-nitroaniline (pNA) from the substrate Ac-
YVAD-pNA, according to manufacturer’s instructions. The proteolytic reaction was carried 
out in protease assay buffer [50 mM HEPES (pH 7.4), 100 mM NaCl, 0.1% (w/v) CHAPS, 10 
mM DTT, 0.1 mM EDTA, 10% (v/v) glicerol], containing 2 mM substrate Ac-DEVD-pNA for 
caspase-3, Ac-IETD-pNA for caspase-8 and Ac-LEHD-pNA for caspase-9. Following 
incubation of the reaction mixtures for 2 h at 37ºC, the formation of pNA was measured at 
405 nm with a reference filter of 620 nm.  
 
2.7. MTT reduction 
Cellular reduction of [3-(4,5-dimethylthiazol, 2-yl)-2,5-diphenyltetrazolium bromide] 
(MTT) was measured in nerve cells as previously described by us (Silva et al., 2002). Briefly, 
a stock solution of MTT at 5 mg/mL was freshly prepared and after the incubation periods, 
supernatants were removed and cells were incubated for 1 h, at 37°C, with 0.5 mL of MTT at 
0.5 mg/mL. After incubation, medium was discarded and MTT formazan crystals were 
dissolved by addition of 1 mL isopropanol/HCl 0.04 M and gentle shaking for 15 min, at room 
temperature. After centrifugation, absorbance values at 570 nm were determined in a 
Unicam UV2 spectrophotometer (Unicam Limited, UV2, Cambridge, UK). Results were 
expressed as percentage of control, which was considered as 100%. 
 
2.8. Densitometry and statistical analysis 
The relative intensities of protein and nucleic acid bands were analysed using the 
Quantity One (version 4.6) program (Bio-Rad, CA, USA). Results of, at least, three different 
experiments were expressed as mean ± S.E.M. Significant differences between two groups 
were determined by the two-tailed t-test performed on the basis of equal and unequal 
variance as appropriate. Comparison of more than two groups was done by ANOVA using 
Instat 3.05 (GraphPad Software, San Diego, CA, USA) followed by multiple comparisons 
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Bonferroni post-hoc correction. Mean values were considered statistically significant when P 
values were lower than 0.05. 
3. Results 
3.1. UCB, alone or in combination with TNF-α+IL-1β, induces nNOS expression and 
.NO production in immature neurons, which are counteracted by L-NAME 
To investigate the possible role of UCB -induced neuronal damage in immature nerve 
cells, 3 DIV cortical neurons were incubated with UCB at conditions mimicking moderate to 
severe neonatal jaundice (UCB to HSA molar ratio of 0.5) that had previously shown to 
promote oxidative injury and cell death in 8 DIVs neurons (Brito et al., 2008a). Cells were 
collected after treatment during 1 h to 12 h for the analysis of nNOS expression and 
production of nitrites. We also investigated the aggravating effects of pro-inflammatory 
cytokines TNF-α and IL-1β on UCB-induced oxidative stress. In order to evaluate the 
importance of .NO signalling in oxidative damage resulting from UCB or UCB+TNF-α+IL-1β, 
we used L-NAME to inhibit nNOS activity. We observed that UCB induced nNOS expression, 
together with a raise in nitrite production in immature neurons. Co-incubation with           
TNF-α+IL-1β, in concentrations that have been described to induce neuronal loss (Patel and 
Brewer, 2008, Zhang et al., 2008), aggravated UCB-induced nNOS expression and nitrite 
production in these cells (Fig. III.1A and III.1C). In parallel studies, co-incubation with 100 µM 
L-NAME led to at least ~70% and ~60% inhibition in nNOS expression and nitrite production 
(p<0.05), respectively (Fig. III.1B and III.1D).  
 
3.2. Inhibition of nNOS by L-NAME prevents the cascade of apoptosis induced by UCB 
or UCB+TNF-α+ IL-1β in immature neurons 
To deepen characterize the mechanisms of neuronal apoptosis upon exposure of 
immature neurons to UCB and pro-inflammatory cytokines, we evaluated the activity of 
initiator caspases from mitochondrial (intrinsic) and death receptor (extrinsic) pathways, 
caspases-9 and -8, respectively, as well as of the effector caspase-3. As shown in Figures 
III.2A and III.2C UCB led to the activation of caspases-3 and -9, indicating the stimulation of 
the intrinsic pathway of apoptosis. Interestingly, co-incubation with TNF-α+IL-1β significantly 
enhanced this activation.  
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Figure III.1 - Unconjugated bilirubin (UCB) induces neuronal nitric oxide synthase 
(nNOS) expression and nitrite production in immature neurons, which are intensified 
by co-treatment with TNF-α+IL-1β and prevented by nNOS inhibition (L-NAME). Rat 
neurons cultured for 3 days in vitro were incubated with UCB (50 µM), alone or plus        
TNF-α+IL-1β (50 ng/mL each), in the presence of human serum albumin (100 μM), from 1 to 
12 h at 37ºC. In sister experiments, cells were treated with L-NAME (100 μM). Expression 
levels of nNOS (A,B) were assessed by Western blot analysis and nitrite levels (C,D) were 
measured by the Griess reagent, as indicated in Methods. Results are mean (± SEM) from at 
least three independent experiments performed in duplicate. *p<0.05, **p<0.01 vs. control; 
#p<0.05, ##p<0.01 vs. UCB alone; §p<0.05, §§p<0.01 vs. respective condition without L-NAME. 
 
To investigate whether .NO plays a role in neurotoxicity induced by UCB or UCB+TNF-
α+IL-1β, we evaluated caspase activation in cells co-incubated with L-NAME. Our results 
demonstrated that inhibition of nNOS prevents activation of the effector caspase (Fig. III.2B), 
as well as of the caspase from the intrinsic pathway (Fig. III.2D). In addition, UCB induced 
the extrinsic pathway of apoptosis, as indicated by the activation of caspase-8, which was 
further increased when cells were concomitantly exposed to TNF-α+IL-1β (Fig. III.3A). Once 
more, capase-8 activity was significantly reduced in cells co-incubated with L-NAME (Fig. 
III.3B). We also analyzed the cleavage of Bid, a Bcl-2 family member that is a specific 
substrate of caspase-8 and plays a role in caspase 8-mediated mitochondrial damage and 
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cell death (Li et al., 1998). As shown in Figure III.3C, the cleavage profile of Bid (22-kDa) into 
truncated Bid (tBid, a 15-kDa fragment) occurred after the activation of caspase-8, as we 
observed the activation of caspase-8 after 1 h treatment with UCB or UCB+TNF-α+IL-1β and 
tBid significantly increased only after 4 h treatment (p<0.01 vs. 1 and 12 h of treatment). In 
addition, co-incubation with L-NAME prevented tBid generation in cells treated with UCB or 
UCB+TNF-α+IL-1β UCB (Fig. III.3D, p<0.05). 
 
 
Figure III.2 - Unconjugated bilirubin (UCB) triggers the activation of caspases-3 and -9 
in immature neurons, which is intensified by co-treatment with TNF-α+IL-1β and 
prevented by nNOS inhibition (L-NAME). Rat neurons cultured for 3 days in vitro were 
treated as in Figure III.1. Activation of caspases-3 (A,B) and -9 (C,D) was determined by 
using colorimetric substrate cleavage assays, as indicated in Methods. Results are mean    
(± SEM) from at least three independent experiments performed in duplicate. **p<0.01 vs. 
control; #p<0.05, ##p<0.01 vs. UCB alone; §p<0.05, §§p<0.01 vs. respective condition without 
L-NAME. 
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Figure III.3 - Unconjugated bilirubin (UCB) triggers the activation of caspase-8 and Bid 
in immature neurons, which is intensified by co-treatment with TNF-α+IL-1β and 
prevented by nNOS inhibition (L-NAME). Rat neurons cultured for 3 days in vitro were 
treated as in Figure III.1. Activation of caspase-8 (A,B) was determined by using colorimetric 
substrate cleavage assay and expression levels of truncated form of Bid, tBid (C,D), was 
assessed by Western blot analysis, as indicated in Methods. Results are mean (± SEM) from 
at least three independent experiments performed in duplicate. **p<0.01 vs. control; #p<0.05, 
##p<0.01 vs. UCB alone; §p<0.01 vs. respective condition without L-NAME. 
 
3.3. Inhibition of nNOS by L-NAME decreases P-JNK1/2 in immature neurons treated 
with UCB or UCB+TNF-α+IL-1β 
In order to verify if oxidative stress occurs in parallel with JNK1/2 activation in our model, we 
determined P-JNK1/2 expression, in the absence or presence of L-NAME. Our results 
demonstrated that neuronal exposure to UCB increases P-JNK1/2 levels only after 4 h 
treatment (p<0.01 and p<0.05 vs. 1 and 12 h of treatment, respectively), effect that was 
increased by co-incubation with TNF-α+IL-1β (Fig. III.4A). Furthermore, inhibition of nNOS by 
L-NAME decreased P-JNK1/2 expression (Fig. III.4B), indicating that JNK1/2 activation is 
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mediated by production of .NO. To better understand whether JNK1/2 activation takes part in 
neuronal dysfunction, we tested the effects of SP600125, a specific inhibitor of JNK1/2, on 
cells treated with UCB or UCB+TNF-α+IL-1β. Immature neurons were pre-treated with 0.2  
µM of the inhibitor for 1 h, followed by 4 h stimulation with UCB alone or in combination with 
TNF-α+IL-1β. As shown in Figures III.4C and III.4D, SP600125 efficiently prevented the 
appearance of P-JNK1/2 induced by UCB or UCB+TNF-α+IL-1β (~90%, p<0.05). 
 
 
Figure III.4 - Unconjugated bilirubin (UCB) leads to activation of c-Jun N-terminal 
kinases 1/2 (JNK1/2) in immature neurons, which is intensified by co-treatment 
with TNF-α+IL-1β and prevented by inhibition of nNOS (L-NAME) or JNK1/2 
(SP600125). Rat neurons cultured for 3 days in vitro were treated as in Figure 1 (A,B). In 
another set of experiments, cells were treated for 1 h with 0.2 μM SP600125 (C,D), prior 
to UCB (50 µM) exposure, alone or in combination with TNF-α+IL-1β (50 ng/mL each), in 
the presence of human serum albumin (100 μM), for 4 h at 37ºC. Activation of JNK1/2 
was determined by measuring the expression levels of phosphorylated forms of this 
enzyme (P-JNK1/2) by Western blot analysis, as indicated in Methods. Results are mean 
(± SEM) from at least three independent experiments performed in duplicate. **p<0.01 
vs. control; ##p<0.01 vs. UCB alone; §§p<0.01, §p<0.05 vs. respective condition without L-
NAME; &&p<0.01 vs. respective condition without SP600125. 
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3.4. Inhibition of P-JNK1/2 by SP600125 prevents the cascade of apoptosis induced by 
UCB or UCB+TNF-α+IL-1β in immature neurons 
Having established that the appearance of P-JNK1/2 induced by UCB or UCB+TNF-
α+IL-1β is mediated, at least in part, by .NO production, we attempted to examine whether 
JNK1/2 activation is also linked to the apoptotic events described previously. As shown in 
Figure III.5, pre-treatment with SP600125 significantly reduced the activation of caspases-3, 
-8 and -9, as well as activation of Bid into tBid in cells treated with UCB or UCB+TNF-α+IL-1β 
(p<0.05), suggesting that, in our model, both intrinsic and extrinsic apoptotic pathways are 
being initiated during JNK1/2 activation by bilirubin and cytokines.  
 
3.5. Loss of neuronal functionality in immature cells exposed to UCB is increased by 
UCB+TNF-α+IL-1β and prevented by inhibition of nNOS and JNK1/2 activation 
To investigate whether induction of nNOS and JNK1/2 is implicated in neuronal 
dysfunction, we assessed the effects of UCB, alone or in combination with TNF-α+IL-1β, on 
the immature cell function in neurons treated with or without L-NAME or SP600125. Our 
results demonstrated that the loss of functionality in immature neurons exposed to UCB for 
24 h is increased by the pro-inflammatory cytokines TNF-α+IL-1β (Fig. III.6). In addition, this 
neuronal dysfunction was prevented by co-incubation with L-NAME, as well as with 
pretreatment with SP600125, suggesting both .NO and JNK1/2 as key elements in neuronal 
dysfunction during hyperbilirubinemia with associated inflammation.  
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Figure III.5 - Inhibition of c-Jun N-terminal kinases 1/2 (JNK1/2) with SP600125 
prevents the cascade of apoptosis induced either by unconjugated bilirubin (UCB) 
alone or by UCB co-treatment with TNF-α+IL-1β. Rat neurons cultured for 3 days in vitro 
were treated as in Figure III.4. Activation of caspases-3, -9 and -8 (A-C) was determined by 
using colorimetric substrate cleavage assays and expression levels of truncated form of Bid, 
tBid (D,E), was assessed by Western blot analysis, as indicated in Methods. Results are 
mean (± SEM) from at least three independent experiments performed in duplicate. **p<0.01 
vs. control; ##p<0.01, #p<0.05 vs. UCB alone; 0.05, &&p<0.01 vs. respective condition without 
SP600125. 
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Figure III.6 - Loss of cell functionality in immature neurons exposed to unconjugated 
bilirubin (UCB) is intensified by co-treatment with TNF-α+IL-1β and prevented by 
inhibition of nNOS (L-NAME) or JNK1/2 (SP600125). Rat neurons cultured for 3 days in 
vitro were incubated with UCB (50 µM), alone or in combination with TNF-α+IL-1β (50 ng/mL 
each), in the presence of human serum albumin (100 μM), for 24 h at 37ºC. In one set of 
experiments, cells were treated with L-NAME (100 μM); in the other set, cells were pre-
treated for 1 h with 0.2 μM SP600125. Cell functionality was evaluated by measuring 3-(4,5-
dimethylthiazol, 2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction, as indicated in 
Methods. Results are mean (± SEM) from at least three independent experiments performed 
in duplicate. **p<0.01 vs. control; ##p<0.01 vs. UCB alone; §p<0.05, §§p<0.01 vs. respective 
condition without L-NAME; &&p<0.01, &p<0.05  vs. respective condition without SP600125. 
 
 
4. Discussion 
Previously, we demonstrated that UCB induces neurotoxicity, which differ from neural 
cell type and maturation state, being neurons and immature cells the most susceptible ones 
(Falcão et al., 2006, Brito et al., 2008b). Moreover, co-incubation with LPS showed to 
enhance the demise of astrocytes (Fernandes et al., 2004), namely in immature cells (Falcão 
et al., 2005). Based on these data, we investigated whether pro-inflammatory cytokines are 
able to strengthen the oxidative stress exerted by UCB in immature neurons, and if the effect 
is reproduced on the extrinsic and intrinsic signalling apoptotic pathways, as well as at the 
level of neuronal dysfunction. 
 In this paper, we demonstrate that UCB induces oxidative damage in immature rat 
neurons, as indicated by the cell function impairment and apoptosis associated with .NO 
production. Interestingly, we previously reported an inhibition of mitochondrial cytochrome c 
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oxidase by UCB in the same in vitro model (Vaz et al., 2010), which can explain the 
formation of .NO. In addition, we also observed that UCB decreases NADPH concentration 
and increases glutathione oxidation and superoxide anion radical production, thus confirming 
neuronal oxidative stress by UCB. Furthermore, UCB was shown to induce protein oxidation 
and lipid peroxidation, and to diminish the antioxidant defences in mature neurons (8 DIV), 
events that occur in parallel with necrotic cell death and could be due to low glutathione 
stores (Brito et al., 2008a). 
Here, we present evidence that mitochondrial-dependent and -independent apoptotic 
pathways are induced in immature rat cultured neurons after UCB treatment. To the best of 
our knowledge, this is the first evidence reporting UCB to induce neuronal extrinsic pathway 
of apoptosis, in addition to that of mitochondria-mediated apoptosis observed in differentiated 
neurons for UCB/HSA molar ratio of 3 (Rodrigues et al., 2002a). However, this molar ratio is 
supposed to never occur in jaundiced babies, even during the worst pathological situations 
and, therefore, we have repeated the experiments for the most suitable molar ratio of 0.5. 
Interestingly, the same effect was significantly produced in immature neurons, after a short 
exposure (1 h incubation) to UCB (Vaz et al., 2010).  It is widely accepted that activated 
caspase-8 propagates the apoptotic signal by activating downstream caspases through 
proteolytic cleavage, as well as by triggering mitochondrial pathway through cleavage and 
activation of pro-apoptotic Bid into tBid (Adams, 2003). In fact, in our model, activation of 
caspase-8 begins early in time (at 1 h incubation), followed by tBid generation (at 4 h 
incubation). This raises interesting possibilities as both caspase-8 and -9-initiated apoptotic 
pathways converge independently to activate the execution phase of caspase-3 (Hengartner, 
2000). In addition, we are tempted to propose that caspase-8/tBid-related route may play an 
important role in UCB-induced neuronal cell death. The results herein obtained in immature 
neurons are in line with our own previous observations showing that UCB induces intrinsic 
signalling pathways by requiring Bax translocation to the mitochondria, mitochondrial 
depolarization, release of cytochrome c and caspase-3 activation in isolated mitochondria 
from the brain and liver of adult male Wistar rats (Rodrigues et al., 2002a, Rodrigues et al., 
2000). They also agree with other findings indicating activation of TNFR1 upon exposure of 
astrocytes, to UCB reflecting the activation of the death receptor pathway (Fernandes et al., 
2006), and therefore the extrinsic cascade. 
The present study also shows for the first time that pro-inflammatory cytokines TNF-α 
and IL-1β intensify UCB-induced oxidative stress and apoptotic cell death by both 
mitochondrial-dependent and –independent apoptotic pathways in immature neurons. These 
observations are particularly important, since low-gestational-age newborns have a 
prominently increased risk of brain dysfunction attributed to cerebral-cortex damage, 
Chapter III 
__________________________________________________________________________ 
 
 
100 
 
including excess of apoptosis and impairment of surviving neurons (Leviton and Gressens, 
2007). With our data, we associate inflammation with the increased risk of UCB-induced 
neurotoxicity. In fact, there are some reports in agreement with our finding: (i) in an animal 
model of sepsis, it was shown that serum concentration of total and free bilirubin was 
increased, promoting a net accumulation of UCB in the brain (Hansen et al., 1993); (ii) pro-
inflammatory cytokines were reported to increase blood-brain-barrier permeability (Petty and 
Lo, 2002), allowing UCB entrance into the brain, and to exacerbate UCB-induced cytotoxicity 
in different cell lines, such as in neuroblastoma (ATCC, HTB-10, SK-N-MC), glioblastoma 
(ATCC, CRL 1690, T98G), umbilical vein endothelial (ATCC, CRL 1730, HUV-EC), liver cell 
(ATCC, CCL 13) and mouse fibroblasts (L-929) (Ngai and Yeung, 1999, Yeung and Ngai, 
2001). Thus, with our model, that mimics pro-inflammatory cytokine release from glial cells, 
as we have previously reported for astrocytes and microglia exposed to UCB (Fernandes et 
al., 2004, Fernandes et al., 2006), we can establish a relation between UCB-induced toxicity 
and associated inflammation in immature neurons. 
In this study we demonstrate that .NO production mediates, at least in part, neurotoxicity 
in immature neurons exposed to UCB, alone or in combination with TNF-α+IL-1β. This 
corroborates our recent observation in that oxidative stress and necrotic cell death induced 
by UCB in mature neurons decreases by concomitant treatment with the NOS inhibitor, l-
NAME (Fernandes et al., 2010). Additionally, in P7 rats, local elimination of nNOS resulted in 
a significant attenuation of the damage after hypoxic-ischemic insult (Ferriero et al., 1995) 
and nNOS deficiency through genetic targeting was also neuroprotective in neonatal mice 
(Ferriero et al., 1996). In other studies with hypoxia-ischemia models, NOS inhibition reduced 
caspase-3 activation (Zhu et al., 2004) and conferred tissue protection (Peeters-Scholte et 
al., 2002), further indicating that .NO production exerts cytotoxicity in the developing brain.  
A very remarkable finding of our study is the JNK1/2 MAPK activation observed when 
immature neurons are exposed to UCB, alone or in combination with TNF-α+IL-1β. The 
activation of JNK1/2 is related to toxicity in developing neurons, since overexpression of 
activated JNK1/2 was shown to produce apoptosis, as suppression of this protein protected 
against neuronal death induced by deprivation of nerve growth factor in sympathetic and 
hippocampal neurons (Estus et al., 1994, Ham et al., 1995, Schlingensiepen et al., 1993). 
Interestingly, in our study, inhibition of .NO production led to a significant reduction in JKN1/2 
activation. This observation is in good agreement with some reports on models of 
neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, where inhibition of .NO-
induced JNK 1/2 phosphorylation conferred protection against neuronal cell death (Katsuki et 
al., 2006, Marques et al., 2003).  
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Here, we observed a reduction of either the intrinsic and extrinsic caspase cascades by 
using the selective JNK1/2 inhibitor, SP600125. Due to the fact that members of the 
antiapoptotic Bcl-2 family proteins are inactivated through JNK1/2 phosphorylation (Inoshita 
et al., 2002, Maundrell et al., 1997), we may conclude that in our model JNK1/2 activation is 
altering mitochondrial function. In agreement with our thoughts, there are several reports on 
dopaminergic neuron models, where a correlation between SAPKs activation and 
neurotoxicity was established: (i) phosphorylation of p38 by oxidative stress was linked to 
activation of both caspases-8- and -9 (Choi et al., 2004); and (ii) repression of JNK1/2 
activation by transfection of a dominant negative mutant SEK1(Lys 3 Arg) blocked dopamine-
induced apoptosis (Luo et al., 1998). In this last study, antioxidants, such as N-acetylcysteine 
(NAC) and catalase, blocked dopamine-induced JNK1/2 activation and subsequent 
apoptosis, confirming that dopamine-induced oxidative stress is involved in JNK1/2 pathway. 
More recently, apoptotic cascade mediated by caspase-3 activation has been demonstrated 
to be JNK1/2 dependent in different neuronal cell models (Cerezo-Guisado et al., 2007, 
Sahara et al., 2008). Therefore, inhibition of SAPKs signalling might represent a therapeutic 
target in acute brain insults, such as neonatal hyperbilirubinemia and associated 
inflammation.  
In summary, the data obtained in the present study contributes to a better understanding 
of the mechanisms underlying neurotoxicity in conditions mimicking a moderate to severe 
hyperbilirubinemia in the early neonatal period. Actually, and as schematically represented in 
Figure III.7, they demonstrate that UCB-induced neuronal dysfunction in 3 DIV neurons 
results from activation of both the intrinsic and extrinsic pathways of apoptosis, that injury is 
linked to oxidative stress, and that .NO signalling and JNK1/2 activation are key players. The 
association of pro-inflammatory cytokines, TNF-α+IL-1β, to the condition of 
hyperbilirubinemia significantly increased the cytotoxic potential of UCB through the same 
cascade of mediators. Most important, the results provide supportive evidence for the 
commonly indicated higher risk of UCB brain damage in a condition of infection, thus 
justifying that treatment should be carried out in these conditions at lower levels of UCB than 
those for well-appearing jaundiced neonates. These advances may substantiate target-
driven approaches to the prevention and treatment of UCB-induced neurological damage, 
and provide fruitful opportunities for future investigations. 
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Figure III.7 - Schematic 
representation of the cellular targets 
involved in unconjugated bilirubin 
(UCB) injury to immature cortical 
neurons, all of them further 
stimulated by the combination of 
UCB with pro-inflammatory cytokines 
(TNF-α and IL-1β), and modulating 
effects by specific inhibitors. Lighter 
grey and small arrows indicate the 
effects of UCB, while darkness grey and 
large arrows point to the combined 
effects of UCB plus TNF-α+IL-1β; lines 
with blocked ends indicate steps that are 
being modulated. UCB interaction with 
neurons leads to neuronal nitric oxide 
synthase (nNOS) increased expression, 
nitric oxide (.NO) production and 
activation of c-Jun N-terminal kinase 
(JNK1/2). As a consequence of these 
events, mitochondrial and extrinsic 
pathways of apoptosis are initiated, with 
activation of caspases-9 and -8, 
respectively. Activation of caspase-9 
further activates the effector capase-3, 
leading to neuronal apoptosis. Activation 
of caspase-8 triggers the cleavage of 
the pro-apoptotic Bid into the truncated 
form (tBid) that is translocated to 
mitochondria, thus propagating the 
apoptotic signal by activation of 
caspase-3. Ultimately, these events lead 
to neuronal dysfunction, as assessed by 
3-(4,5-dimethylthiazol, 2-yl)-2,5-diphenyltetrazolium bromide (MTT) test. Co-incubation of 
UCB with TNF-α+IL-1β intensifies all the events activated by UCB alone. Inhibition of JNK1/2 
activation by SP600125 conferred neuroprotection to immature neurons exposed either to 
UCB alone or UCB plus TNF-α+IL-1β, corroborating the involvement of this signaling 
pathway in the neuronal demise observed. Upstream inhibition of nNOS by N-ω-nitro-L-
arginine methyl ester (L-NAME) prevents downstream events from occurring, thus pointing to 
.NO as a key mediator in UCB-induced neuronal dysfunction of immature neurons. 
 
  
nNOS activation
JNK1/2 activation
NO production
Caspase-9Caspase-3
L- NAME
SP600125
Caspase-8
Bid
UCB
TNF-α
IL-1β
UCB
tBid
BIND is increased by inflammation 
__________________________________________________________________________ 
 
 
103 
 
5. References 
Adams, J. M. (2003) Ways of dying: multiple pathways to apoptosis. Genes Dev, 17, 2481-
2495. 
Bian, K. and Murad, F. (2001) Diversity of endotoxin-induced nitrotyrosine formation in 
macrophage-endothelium-rich organs. Free Radic Biol Med, 31, 421-429. 
Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72, 248-
254. 
Brito, M. A., Vaz, A. R., Silva, S. L., Falcão, A. S., Fernandes, A., Silva, R. F. M. and Brites, 
D. (2010) N-methyl-D-aspartate receptor and neuronal nitric oxide synthase activation 
mediate bilirubin-induced neurotoxicity. Mol Med, 16, 372-380. 
Brito, M. A., Lima, S., Fernandes, A., Falcão, A. S., Silva, R. F. M., Butterfield, D. A. and 
Brites, D. (2008a) Bilirubin injury to neurons: contribution of oxidative stress and rescue by 
glycoursodeoxycholic acid. Neurotoxicology, 29, 259-269. 
Brito, M. A., Rosa, A. I., Falcão, A. S., Fernandes, A., Silva, R. F. M., Butterfield, D. A. and 
Brites, D. (2008b) Unconjugated bilirubin differentially affects the redox status of neuronal 
and astroglial cells. Neurobiol Dis, 29, 30-40. 
Brito, M. A., Rosa, A. I., Silva, R. F. M., Falcão, A. S., Fernandes, A. and Brites, D. (2007) 
Oxidative stress and disruption of the nervous cell. In: Focus in Brain Research, pp. 1-33. 
Nova Science Publishers, Inc., New York. 
Cerezo-Guisado, M. I., Alvarez-Barrientos, A., Argent, R., Garcia-Marin, L. J., Bragado, M. J. 
and Lorenzo, M. J. (2007) c-Jun N-terminal protein kinase signalling pathway mediates 
lovastatin-induced rat brain neuroblast apoptosis. Biochim Biophys Acta, 1771, 164-176. 
Choi, W. S., Eom, D. S., Han, B. S. et al. (2004) Phosphorylation of p38 MAPK induced by 
oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic 
pathways in dopaminergic neurons. J Biol Chem, 279, 20451-20460. 
Dawodu, A. H., Owa, J. A. and Familusi, J. B. (1984) A prospective study of the role of 
bacterial infection and G6PD deficiency in severe neonatal jaundice in Nigeria. Trop 
Geogr Med, 36, 127-132. 
Doré, S., Goto, S., Sampei, K. et al. (2000) Heme oxygenase-2 acts to prevent neuronal 
death in brain cultures and following transient cerebral ischemia. Neuroscience, 99, 587-
592. 
Estus, S., Zaks, W. J., Freeman, R. S., Gruda, M., Bravo, R. and Johnson, E. M., Jr. (1994) 
Altered gene expression in neurons during programmed cell death: identification of c-jun 
as necessary for neuronal apoptosis. J Cell Biol, 127, 1717-1727. 
Chapter III 
__________________________________________________________________________ 
 
 
104 
 
Falcão, A. S., Fernandes, A., Brito, M. A., Silva, R. F. M. and Brites, D. (2005) Bilirubin-
induced inflammatory response, glutamate release, and cell death in rat cortical 
astrocytes are enhanced in younger cells. Neurobiol Dis, 20, 199-206. 
Falcão, A. S., Fernandes, A., Brito, M. A., Silva, R. F. M. and Brites, D. (2006) Bilirubin-
induced immunostimulant effects and toxicity vary with neural cell type and maturation 
state. Acta Neuropathol, 112, 95-105. 
Fernandes, A., Barateiro, A., Falcão, A. S., Silva, S. L., Vaz, A. R., Brito, M. A., Silva, R. F. 
M. and Brites, D. (2010) Astrocyte reactivity to unconjugated bilirubin requires TNF-a and 
IL-1b receptor signalling pathways. Glia, in press. 
Fernandes, A., Falcão, A. S., Silva, R. F. M., Brito, M. A. and Brites, D. (2007) MAPKs are 
key players in mediating cytokine release and cell death induced by unconjugated bilirubin 
in cultured rat cortical astrocytes. Eur J Neurosci, 25, 1058-1068. 
Fernandes, A., Falcão, A. S., Silva, R. F. M., Gordo, A. C., Gama, M. J., Brito, M. A. and 
Brites, D. (2006) Inflammatory signalling pathways involved in astroglial activation by 
unconjugated bilirubin. J Neurochem, 96, 1667-1679. 
Fernandes, A., Silva, R. F. M., Falcão, A. S., Brito, M. A. and Brites, D. (2004) Cytokine 
production, glutamate release and cell death in rat cultured astrocytes treated with 
unconjugated bilirubin and LPS. J Neuroimmunol, 153, 64-75. 
Ferriero, D. M., Holtzman, D. M., Black, S. M. and Sheldon, R. A. (1996) Neonatal mice 
lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. 
Neurobiol Dis, 3, 64-71. 
Ferriero, D. M., Sheldon, R. A., Black, S. M. and Chuai, J. (1995) Selective destruction of 
nitric oxide synthase neurons with quisqualate reduces damage after hypoxia-ischemia in 
the neonatal rat. Pediatr Res, 38, 912-918. 
Ham, J., Babij, C., Whitfield, J., Pfarr, C. M., Lallemand, D., Yaniv, M. and Rubin, L. L. (1995) 
A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell 
death. Neuron, 14, 927-939. 
Hansen, T. W. R. (2002) Mechanisms of bilirubin toxicity: clinical implications. Clin Perinatol, 
29, 765-778, viii. 
Hansen, T. W. R., Maynard, E. C., Cashore, W. J. and Oh, W. (1993) Endotoxemia and brain 
bilirubin in the rat. Biol Neonate, 63, 171-176. 
Hemmer, K., Fransen, L., Vanderstichele, H., Vanmechelen, E. and Heuschling, P. (2001) An 
in vitro model for the study of microglia-induced neurodegeneration: involvement of nitric 
oxide and tumor necrosis factor-alpha. Neurochem Int, 38, 557-565. 
Heneka, M. T., Loschmann, P. A., Gleichmann, M., Weller, M., Schulz, J. B., Wullner, U. and 
Klockgether, T. (1998) Induction of nitric oxide synthase and nitric oxide-mediated 
BIND is increased by inflammation 
__________________________________________________________________________ 
 
 
105 
 
apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-
alpha/lipopolysaccharide. J Neurochem, 71, 88-94. 
Hengartner, M. O. (2000) The biochemistry of apoptosis. Nature, 407, 770-776. 
Inoshita, S., Takeda, K., Hatai, T., Terada, Y., Sano, M., Hata, J., Umezawa, A. and Ichijo, H. 
(2002) Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to 
oxidative stress. J Biol Chem, 277, 43730-43734. 
Kajta, M., Trotter, A., Lason, W. and Beyer, C. (2006) Impact of 17beta-estradiol on cytokine-
mediated apoptotic effects in primary hippocampal and neocortical cell cultures. Brain 
Res, 1116, 64-74. 
Kaplan, M. and Hammerman, C. (2005) Understanding severe hyperbilirubinemia and 
preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin. Clin Chim 
Acta, 356, 9-21. 
Katsuki, H., Okawara, M., Shibata, H., Kume, T. and Akaike, A. (2006) Nitric oxide-producing 
microglia mediate thrombin-induced degeneration of dopaminergic neurons in rat midbrain 
slice culture. J Neurochem, 97, 1232-1242. 
Konsman, J. P., Drukarch, B. and Van Dam, A. M. (2007) (Peri)vascular production and 
action of pro-inflammatory cytokines in brain pathology. Clin Sci (Lond), 112, 1-25. 
Korhonen, R., Lahti, A., Kankaanranta, H. and Moilanen, E. (2005) Nitric oxide production 
and signaling in inflammation. Curr Drug Targets Inflamm Allergy, 4, 471-479. 
Leviton, A. and Gressens, P. (2007) Neuronal damage accompanies perinatal white-matter 
damage. Trends Neurosci, 30, 473-478. 
Li, H., Zhu, H., Xu, C. J. and Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the 
mitochondrial damage in the Fas pathway of apoptosis. Cell, 94, 491-501. 
Luo, Y., Umegaki, H., Wang, X., Abe, R. and Roth, G. S. (1998) Dopamine induces 
apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem, 273, 
3756-3764. 
Marques, C. A., Keil, U., Bonert, A., Steiner, B., Haass, C., Muller, W. E. and Eckert, A. 
(2003) Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish 
amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J 
Biol Chem, 278, 28294-28302. 
Marx, C. E., Jarskog, L. F., Lauder, J. M., Lieberman, J. A. and Gilmore, J. H. (2001) 
Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for 
schizophrenia. Biol Psychiatry, 50, 743-749. 
Maundrell, K., Antonsson, B., Magnenat, E. et al. (1997) Bcl-2 undergoes phosphorylation by 
c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the 
constitutively active GTP-binding protein Rac1. J Biol Chem, 272, 25238-25242. 
Chapter III 
__________________________________________________________________________ 
 
 
106 
 
McDonagh, A. F. (1979) Bile pigments: Bilatrienes and 5,15-biladienes. In: The Porfirins, pp. 
293-491. Academic Press, San Diego. 
Mielke, K. and Herdegen, T. (2000) JNK and p38 stresskinases--degenerative effectors of 
signal-transduction-cascades in the nervous system. Prog Neurobiol, 61, 45-60. 
Ngai, K. C. and Yeung, C. Y. (1999) Additive effect of tumor necrosis factor-alpha and 
endotoxin on bilirubin cytotoxicity. Pediatr Res, 45, 526-530. 
Ostrow, J. D., Pascolo, L., Brites, D. and Tiribelli, C. (2004) Molecular basis of bilirubin-
induced neurotoxicity. Trends Mol Med, 10, 65-70. 
Patel, J. R. and Brewer, G. J. (2008) Age-related changes to tumor necrosis factor receptors 
affect neuron survival in the presence of beta-amyloid. J Neurosci Res, 86, 2303-2313. 
Peeters-Scholte, C., Koster, J., Veldhuis, W. et al. (2002) Neuroprotection by selective nitric 
oxide synthase inhibition at 24 hours after perinatal hypoxia-ischemia. Stroke, 33, 2304-
2310. 
Petty, M. A. and Lo, E. H. (2002) Junctional complexes of the blood-brain barrier: 
permeability changes in neuroinflammation. Prog Neurobiol, 68, 311-323. 
Rodrigues, C. M. P., Solá, S. and Brites, D. (2002a) Bilirubin induces apoptosis via the 
mitochondrial pathway in developing rat brain neurons. Hepatology, 35, 1186-1195. 
Rodrigues, C. M. P., Solá, S., Brito, M. A., Brites, D. and Moura, J. J. (2002b) Bilirubin 
directly disrupts membrane lipid polarity and fluidity, protein order, and redox status in rat 
mitochondria. J Hepatol, 36, 335-341. 
Rodrigues, C. M. P., Solá, S., Silva, R. F. M. and Brites, D. (2000) Bilirubin and amyloid-β 
peptide induce cytochrome c release through mitochondrial membrane permeabilization. 
Mol Med, 6, 936-946. 
Rossi, D. and Volterra, A. (2009) Astrocytic dysfunction: insights on the role in 
neurodegeneration. Brain Res Bull, 80, 224-232. 
Sahara, N., Murayama, M., Lee, B., Park, J. M., Lagalwar, S., Binder, L. I. and Takashima, A. 
(2008) Active c-jun N-terminal kinase induces caspase cleavage of tau and additional 
phosphorylation by GSK-3beta is required for tau aggregation. Eur J Neurosci, 27, 2897-
2906. 
Schlingensiepen, K. H., Schlingensiepen, R., Kunst, M., Klinger, I., Gerdes, W., Seifert, W. 
and Brysch, W. (1993) Opposite functions of jun-B and c-jun in growth regulation and 
neuronal differentiation. Dev Genet, 14, 305-312. 
Sener, G., Toklu, H., Kapucu, C., Ercan, F., Erkanli, G., Kacmaz, A., Tilki, M. and Yegen, B. 
C. (2005) Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg 
Today, 35, 52-59. 
BIND is increased by inflammation 
__________________________________________________________________________ 
 
 
107 
 
Shapiro, S. M. (2005) Definition of the clinical spectrum of kernicterus and bilirubin-induced 
neurologic dysfunction (BIND). J Perinatol, 25, 54-59. 
Silva, R. F. M., Rodrigues, C. M. P. and Brites, D. (2002) Rat cultured neuronal and glial cells 
respond differently to toxicity of unconjugated bilirubin. Pediatr Res, 51, 535-541. 
Silva, S. L., Vaz, A. R., Barateiro, A., Falcão, A. S., Fernandes, A., Brito, M. A., Silva, R. F. 
M. and Brites, D. (2010) Features of bilirubin-induced reactive microglia: From 
phagocytosis to inflammation. Neurobiol Dis. 
Stevenson, D. K., Dennery, P. A. and Hintz, S. R. (2001) Understanding newborn jaundice. J 
Perinatol, 21 Suppl 1, S21-24; discussion S35-29. 
Takahashi, K., Funata, N., Ikuta, F. and Sato, S. (2008) Neuronal apoptosis and 
inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-
2. J Neuroinflammation, 5, 11. 
Thomas, T., Timmer, M., Cesnulevicius, K., Hitti, E., Kotlyarov, A. and Gaestel, M. (2008) 
MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing 
neuroinflammation--relevance in a mouse model of Parkinson's disease. J Neurochem, 
105, 2039-2052. 
Tibbles, L. A. and Woodgett, J. R. (1999) The stress-activated protein kinase pathways. Cell 
Mol Life Sci, 55, 1230-1254. 
Vaz, A. R., Delgado-Esteban, M., Brito, M. A., Bolaños, J. P., Brites, D. and Almeida, A. 
(2010) Bilirubin selectively inhibits cytochrome c oxidase activity and induces apoptosis in 
immature cortical neurons: assessment of the protective effects of glycoursodeoxycholic 
acid. J Neurochem, 112, 56-65. 
Watchko, J. F. (2006) Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clin 
Perinatol, 33, 839-852; abstract ix. 
Yeung, C. Y. and Ngai, K. C. (2001) Cytokine- and endotoxin-enhanced bilirubin cytotoxicity. 
J Perinatol, 21 Suppl 1, S56-58; discussion S59-62. 
Zhang, R., Yamada, J., Hayashi, Y., Wu, Z., Koyama, S. and Nakanishi, H. (2008) Inhibition 
of NMDA-induced outward currents by interleukin-1beta in hippocampal neurons. 
Biochem Biophys Res Commun, 372, 816-820. 
Zhu, C., Wang, X., Qiu, L., Peeters-Scholte, C., Hagberg, H. and Blomgren, K. (2004) 
Nitrosylation precedes caspase-3 activation and translocation of apoptosis-inducing factor 
in neonatal rat cerebral hypoxia-ischaemia. J Neurochem, 90, 462-471. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Chapter IV   
IV. Selective vulnerability of rat brain regions to unconjugated 
bilirubin  
 
 
Ana Rita Vaz, Sandra Leitão Silva, Andreia Barateiro, Ana Sofia Falcão, Adelaide 
Fernandes, Maria A Brito, Dora Brites 
 
Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculdade 
de Farmácia, University of Lisbon,  Av. Professor Gama Pinto, Lisbon 1649-003, 
Portugal. 
 
Molecular  and Cellular Neuroscience (submitted). 
  
 
 
 
 
 
 
Acknowledgements 
 
This work was supported by grants PTDC/SAU-NEU/64385/2006 (to D.B.) and 
BD/30292/2006 (to A.R.V.) from Fundação para a Ciência e a Tecnologia, Lisbon, 
Portugal. 
 
Hallmarks in hippocampal susceptibility to UCB 
__________________________________________________________________________ 
 
 
 
111 
 
 
Abstract 
Hippocampus is one of the brain regions most vulnerable to unconjugated bilirubin 
(UCB) encephalopathy, although cerebellum also shows selective yellow staining in 
kernicterus. We demonstrated that UCB induces oxidative stress in cortical neurons, 
disruption of neuronal network dynamics, either in developing cortical or hippocampal 
neurons, and that immature cortical neurons are more prone to UCB-induced injury. 
Here, we studied features of oxidative stress and cell dysfunction induced by UCB in 
immature rat neurons isolated from cortex, cerebellum and hippocampus. We also 
explored whether oxidative damage and its regulation contribute to neuronal dysfunction 
induced by hyperbilirubinemia, in terms of neurite extension and ramification, and cell 
death. Our results show that UCB induces neuronal nitric oxide synthase expression, as 
well as production of nitrites and cyclic guanosine monophosphate in immature neurons, 
mainly in those from hippocampus. After exposure to UCB, hippocampal neurons 
presented the highest content of reactive oxygen species, disruption of glutathione redox 
status and cell death, when compared to those from cortex or cerebellum. In particular, 
the results indicated that cells exposed to UCB undertake an adaptive response that 
involves DJ-1, a multifunctional neuroprotective protein involved in cellular oxidation 
status maintenance. However, longer neuronal exposure to UCB down-regulated DJ-1 
expression, especially in hippocampal neurons.  In addition, UCB induced impairment in 
neurite outgrowth and branching, mainly in immature neurons from hippocampus. 
Interestingly, pre-incubation with N-acetylcysteine, a precursor of glutathione synthesis, 
conferred neuroprotection to UCB-induced oxidative stress and necrotic cell death, as 
well as prevented DJ-1 down-regulation and neuritic impairment. Taken together, these 
data point oxidative injury and disruption of neuritic network as hallmarks in hippocampal 
susceptibility to UCB. Furthermore, it is suggested that local differences in glutathione 
content may account to the different susceptibility found between brain regions exposed 
to UCB. 
 
Keywords: Cortex; cerebellum; DJ-1; hippocampus; immature neurons; oxidative and 
nitrosative stress; neurite outgrowth and branching; unconjugated bilirubin. 
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1. Introduction 
Hyperbilirubinemia, a very common condition in the neonatal period, characterized by 
increased serum levels of unconjugated bilirubin (UCB) (Stevenson et al., 2001, Dennery et 
al., 2001), is responsible for the clinical manifestation of jaundice. Although normal (or 
slightly increased) levels of UCB provides protection against injury resulting from oxidation 
(Doré et al., 2000), elevated UCB concentrations cause nerve cell damage, leading to 
adverse neurological outcomes (Hansen, 2002), ranging from minor neurologic dysfunction 
(Soorani-Lunsing et al., 2001) to chronic and permanent sequelae, or even death (Ostrow et 
al., 2004, Shapiro, 2005). In addition, high levels of UCB are related with an augmented risk 
for the appearance of long-term neurodevelopment disabilities (Dalman and Cullberg, 1999). 
The risk of bilirubin-induced neurologic dysfunction is particularly enhanced in premature 
newborns due to the higher rates of UCB production and the immaturity of the excretion 
pathways (Stevenson et al., 2001, Watchko, 2006). Moreover, cerebral palsy is a common 
condition in preterm infants at risk of kernicterus, in spite of the relatively low total serum 
bilirubin levels (Gkoltsiou et al., 2008). However, little is known about mechanisms underlying 
the increased vulnerability of selected regional neuronal populations in UCB-induced 
neuronal damage. Hippocampus is one of the brain regions with preferential UCB 
accumulation in severely jaundiced neonates who died with kernicterus, although cerebellum 
and corpus striatum also showed selective yellow deposits (Ahdab-Barmada and Moossy, 
1984, Hansen, 2000). This preferential deposition seems to be related with increased 
vulnerability to hypoxic-ischemic injury (Perlman et al., 1997), as well as with the enhanced 
vascularization and up-regulation of vascular endothelial growth factor (VEGF) that we have 
recently observed in the hippocampus, cerebellum and striatum of a preterm infant with 
sepsis who died with the diagnosis of kernicterus (personal communication Alexandra Brito, 
2010).  
In the last years, we demonstrated the involvement of oxidative stress in the 
mechanisms underlying neuronal cell demise by clinically relevant concentrations of UCB 
(Brito et al., 2004, Brito et al., 2008a, Brito et al., 2010).  The UCB-induced dysfunction may 
culminate in neuronal cell death (Silva et al., 2002, Falcão et al., 2006), which appears to be 
mediated, at least in part, by perturbation of mitochondria (Rodrigues et al., 2002, Rodrigues 
et al., 2000, Vaz et al., 2010). In addition, immature nerve cells were shown to be more 
susceptible than more differentiated ones to UCB-induced toxicity (Falcão et al., 2006). 
These findings provided a valuable contribute to the current understanding of the 
neuropathological effects of UCB, as dysfunction and degeneration of neurons in several 
neurological disorders are usually associated with reactive oxygen species (ROS) and/or 
reactive nitrogen species (RNS) production  (Mattson and Liu, 2002, Brito et al., 2007). 
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Recently, one of these oxidant species, nitric oxide (.NO), although important in cellular 
signalling, showed to have a key role in the mechanisms of neurotoxicity by UCB, both in 
mature (Brito et al., 2008a, Brito et al., 2010) and in immature neurons (personal 
communication Ana Rita Vaz, 2010). RNS are also implicated in synapse injury (Sunico et 
al., 2010) and early exposure to UCB provoked deleterious effects in neurogenesis, 
neuritogenesis and synaptogenesis (Falcão et al., 2007, Fernandes et al., 2009), possibly 
contributing to the development of mental illness in later life. Therefore, a better 
understanding of the role of antioxidants and molecules involved in response to oxidative 
stress represent important strategies to prevent neuronal injury by hyperbilirubinemia.  
N-acetylcysteine (NAC) is a thiol compound that is converted to cysteine, an important 
precursor of cellular glutathione (Zachwieja et al., 2005, Dringen, 2000). NAC is described by 
its antioxidant effects in two ways:  firstly, as a source of the cysteine aminoacid, it promotes 
the biosynthesis of the tripeptide γ-l-glutamyl-l-cysteinylglycine, known as glutathione (GSH), 
thus increasing GSH supply for glutathione peroxidise; secondly, as a source of sulfydryl 
groups it promotes the reduction of ROS (Ocal et al., 2004). Several in vitro and in vivo 
studies support the antioxidant effect of NAC. Treatment with NAC conferred neuroprotection 
in lead-induced lipid peroxidation and in antioxidant enzyme activities deficiencies of rats’ 
brain (Nehru and Kanwar, 2004), as well as in hypoxia-induced oxidative stress in rat 
cultured hippocampal neurons (Jayalakshmi et al., 2005). In addition, treatment with NAC 
decreased lipid peroxidation in cerebral cortex, midbrain and cerebellum observed in 
jaundiced rats (Karageorgos et al., 2006), and results from our group demonstrated that NAC 
protects against UCB-induced protein oxidation in rat cultured cortical neurons (Brito et al., 
2008b).   
DJ-1, also known as PARK7 [Parkinson disease (autosomal recessive, early onset) 7] is 
a member of the peptidase C56 family of proteins, but is not known to exhibit proteolytic 
activity. It functions as a redox-sensitive chaperone, like a sensor for oxidative stress, 
protecting neurons against oxidative stress and cell death (Jin et al., 2005, Bonifati et al., 
2003). Recently, it was proposed that UCB-treated cells may undertake an adaptative 
response that involves DJ-1 (Deganuto et al., 2010). 
In this study, we investigated whether there is a dissimilar brain regional susceptibility to 
UCB-induced oxidative damage and disruption of neurite outgrowth and branching in 
immature neurons able to determine the selective pattern of UCB deposition and brain 
damage in specific brain areas characteristic of kernicterus, such as cerebellum and 
hippocampus. We also looked for potential mechanisms involved in UCB-induced 
neurotoxicity modulation, namely DJ-1 protein expression and glutathione content.  
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2. Materials and Methods 
 
2.1. Chemicals 
Neurobasal medium, B-27 supplement (50X), Hanks’ balanced salt solution (HBSS), 
Hanks’ balanced salt solution without Ca2+ and Mg2+ (Ca2+ and Mg2+ free HBSS), gentamicin 
(50 mg/mL), and trypsin (2.5 g/L) were acquired from Invitrogen (Carlsbad, CA). Human 
serum albumin (HSA) (fraction V, fatty acid free), NAC, dihydrorhodamine 123 (DHR 123), 
3,8-diamino-5-(3-(diethyl-methylamino)propyl)-6-phenyl phenanthridinium diiodide, 
sulfosalicyclic acid, and 2-vinylpyridine, Hoechst 33258 dye, 1-isobutyl-3-methylxanthine 
(IBMX), primary monoclonal antibody mouse anti-β-actin, N-1-naphthylethylenediamine, 
sulfanilamide and sodium nitrite were purchased from Sigma Chemical Co (St Louis, MO). 
UCB was also from Sigma and purified as previously described (McDonagh 1979). 
Nitrocellulose membrane, Hyperfilm ECL and horseradish peroxidase-labelled sheep anti-
mouse IgG were from Amersham Biosciences (Piscataway, NJ, USA). Cell lysis buffer, 
LumiGLO® and antibody directed to caspase-3 were acquired from Cell Signalling (Beverly, 
MA, USA).Cyclic guanosine monophosphate (cGMP) determination kit was from Enzo Life 
Sciences (Plymouth Meeting, PA, USA). Antibodies directed to DJ-1 and microtubule 
associated protein (MAP)-2 were from Chemicon (Temecula, CA, USA) while antibody 
against neuronal nitric oxide synthase (nNOS) was from Becton Dickinson Biosciences (San 
José, CA, USA).  
 
2.2. Neurons in primary culture 
Animal care followed the recommendations of European Convention for the Protection of 
Vertebrate Animals Used for Experimental and other Scientific Purposes (Council Directive 
86/609/EEC) and National Law 1005/92 (rules for protection of experimental animals). 
Cortical, hippocampal and cerebellar neurons were isolated from fetuses of 16-17-day 
pregnant Wistar rats, as previously described (Silva et al., 2002). Fetuses were collected in 
HBSS medium, brain cortices, hippocampi and cerebella were mechanically fragmented, and 
the fragments transferred to a 0.5 g/L trypsin in Ca2+ and Mg2+ free HBSS medium and 
incubated for 15 min at 37ºC. After trypsinization, cells were washed twice in Ca2+ and Mg2+ 
free HBSS medium containing 10% fetal bovine serum, and resuspended in Neurobasal 
medium supplemented with 0.5 mM L-glutamine, 25 μM L-glutamic acid, 2% B-27 
supplement, and 0.12 mg/mL gentamicin. Finally, cells were seeded on poly-D-lysine coated 
tissue culture plates at a density of 2 x 105 cells/cm2 and maintained at 37ºC in a humidified 
atmosphere of 5% CO2. For hippocampal neurons, cells were first seeded in plating medium 
(MEM with Earle’s salts supplemented with 10 mM HEPES, 10 mM sodium pyruvate, 1 mM 
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glutamine, 12.5 μM glutamate, 10% FBS and 0.6% glucose) and after 2 h, the media was 
replaced with neuronal growth medium as abovementioned. In this work we used neurons at 
3 days in vitro (DIV). 
 
2.3. Treatment of neurons 
Neurons from cortex, hippocampus and cerebellum were incubated in Neurobasal 
medium without (control) or with 50 μM UCB in the presence of 100 μM HSA from 1 to 24 h, 
at 37ºC. Stock UCB solutions were extemporarily prepared in 0.1 M NaOH under the dark 
and the pH adjusted to 7.4 using 0.1 M HCl.  In parallel studies, cells were incubated with 
100 µM NAC, a precursor of glutathione synthesis, for 1 h prior to UCB addition.  
 
2.4. Quantification of nitrite levels 
Nitric oxide levels were estimated by measuring the concentrations of nitrites (NO2-), 
which are the resulting .NO metabolites. Briefly, supernatants free from cellular debris were 
mixed with Griess reagent [1 part 1% (w/v) sulfanilamide in 5% H3PO4, 1 part 0.1% (w/v) N-1-
naphthylethylenediamine (v/v)] in 96-well tissue culture plates for 10 min at room 
temperature in the dark. The absorbance at 540 nm was determined using a microplate 
reader (Bio-Rad Laboratories, Hercules, CA, USA). 
 
2.5. Western blot assay 
The intracellular forms of nNOS, caspase-3 and DJ-1 were determined by Western blot 
analysis as usual in our laboratory (Fernandes et al., 2006). Briefly, cells were washed in ice-
cold PBS and lysed in a buffer containing 20 mM Tris-HCl (pH 7.5); 150 mM NaCl; 1 mM 
Na2EDTA; 1 mM EGTA; 1% (v/v) Triton X-100; 2.5 mM sodium pyrophosphate; 1 mM β-
glycerophosphate; 1 mM Na3VO4; 1 μg/mL leupeptine and 1 mM PMSF. The lysate was 
sonicated for 20 s, centrifuged at 14000 g for 10 min at 4ºC and the supernatants were 
collected and stored at -80ºC. Protein concentrations were determined according to the 
Bradford method (Bradford, 1976) using Bio-Rad’s Protein Assay reagent (Bio-Rad, CA, 
USA).  Equal amounts of protein were subjected to sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis and transferred to a nitrocellulose membrane. After blocking with 5% milk 
solution, membranes were incubated with the primary antibody overnight at 4ºC [mouse anti-
nNOS (1:2500), rabbit anti-caspase-3 (1: 1000), rabbit anti-DJ1 (1:200) or anti-β-actin 
(1:5000)], and finally with horseradish peroxidase-labelled secondary antibody. Protein 
bands were detected by LumiGLO® and visualized by autoradiography with Hyperfilm ECL.  
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2.6. Determination of cGMP concentration: 
For quantification of cGMP content, the phosphodiesterase inhibitor IBMX was included 
in the incubation medium. Cell extracts collected from 9.6 cm2 wells were used for cGMP 
determination using a commercially available kit from Enzo Life Sciences and measurements 
were performed according to manufacturer’s instructions. 
 
2.7. Glutathione measurement 
After incubation period, neurons were washed with ice-cold PBS and immediately 
collected by scrapping off with 0.5 mL of 1% (w/v) sulfosalicyclic acid. Cell lysates were 
centrifuged at 13,000 g for 5 min at 4ºC, and the supernatants used for glutathione 
determinations. Total glutathione content (GSt, i.e. the amount of GSH plus two times the 
amount of GSSG) and oxidized glutathione (GSSG) were measured and calculated as 
previously described (Dringen and Hamprecht, 1996) and GSt and GSSG concentrations 
were expressed as nanomoles per milligram of protein. 
 
2.8. Assessment of ROS formation 
The nonfluorescent DHR 123 easily crosses cell membranes due to its lipophilicity and is 
converted by ROS into rhodamine 123, a fluorescent compound that accumulates in 
mitochondria and is considered as a sensitive indicator of ROS production in cell systems 
(Gomes et al., 2005). To evaluate the production of ROS in neuronal cultures, cells were 
seeded on glass coverslips placed in the 12-well culture plates. Cells were loaded, under 
light protection, with 6 μM DHR 123 for 30 min at 37 °C, prior to cellular treatment. At the end 
of the incubation period, cells were fixed with freshly prepared 4% paraformaldehyde in PBS, 
and the nuclei immunostained with Hoechst 33258 dye. Cellular fluorescence was observed 
using a fluorescence microscope (Axioskope®, Zeiss, Germany) and the intensity of the 
fluorescence emission was quantified in at least six microscopic fields (×400) per sample 
with an image analyzer software (ImageJ 1.29×, National Institutes of Health, USA) and 
expressed as a percentage per total number of cells.  Since UCB was referred as an 
autofluorescent molecule (Özkan et al., 1995), a set of experiments was performed in 
parallel, with no addition of DHR 123. The fact that no variations in the fluorescence intensity 
were noticed in these control experiments guarantees that the rise in the fluorescence 
intensity observed in the UCB-treated samples was due to ROS formation and not to UCB 
interference. 
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2.9. Evaluation of cell death 
Necrotic-like cell death was assessed by monitoring the cellular uptake of the fluorescent 
dye propidium iodide (PI). PI readily enters and stains non-viable cells, but cannot cross the 
membrane of viable cells. This dye binds to double-stranded DNA and emits red 
fluorescence (630 nm; absorbance 493 nm). Unpermeabilized adherent cells cultured on 
coverslips were incubated with a 75 μM PI solution for 15 min in the absence of light. 
Subsequently, cells were fixed with freshly prepared 4% (w/v) paraformaldehyde in PBS and 
the nuclei immunostained with Hoechst 33258 dye. Red-fluorescence and U.V. images of six 
random microscopic fields (original magnification: 400×) were acquired per sample by using 
a fluorescence microscope (Axioskope®, Zeiss, Germany) and the percentage of PI positive 
cells was counted and expressed as a percentage per total number of cells.   
 
2.10. Neurite Extension and Ramification 
For immunofluorescence detection of the cytoskeletal protein MAP-2, known to be 
located mainly in dendrites and widely used as a neuritic marker (Hammond, 2001), cells 
were fixed with freshly prepared 4% (w/v) paraformaldehyde in PBS and a standard indirect 
immunocytochemical technique was carried out using a mouse anti-MAP-2 antibody (1:100) 
as the primary antibody and a horse FITC-labeled anti-mouse antibody (1:227) as the 
secondary antibody. Fluorescence was visualized by using a fluorescence microscope 
(Axioskope®, Zeiss, Germany). Green-fluorescence images of ten random microscopic fields 
were acquired per sample. Evaluation of neurite extension and number of nodes from 
individual neurons were determined using HCA-Vision Neurite Analysis software (Australia). 
 
2.11. Densitometry and statistical analysis 
The relative intensities of protein and nucleic acid bands were analysed using the 
Quantity One (version 4.6) program (Bio-Rad, CA, USA). Results of, at least, three different 
experiments were expressed as mean ± SEM. Significant differences between two groups 
were determined by the two-tailed t-test performed on the basis of equal and unequal 
variance as appropriate. Comparison of more than two groups was done by ANOVA using 
Instat 3.05 (GraphPad Software, San Diego, CA, USA), followed by multiple comparisons 
Bonferroni post-hoc correction. Mean values were considered statistically significant when P 
values were lower than 0.05. 
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3. Results 
 
3.1. UCB-induced nNOS expression and production of nitrites and cGMP is enhanced 
in immature hippocampal neurons as compared to cerebellar or cortical neurons 
To investigate whether different brain regions present particular susceptibilities to UCB-
induced neuronal damage, we used 3 DIVs neurons isolated from cortex, hippocampus and 
cerebellum. Neuronal cells were incubated with 50 μM UCB plus 100 μM HSA, to produce a 
free UCB concentration of ~100 nM (Ostrow et al., 2003, Weisiger et al., 2001), that mimics 
moderate to severe neonatal jaundice, a condition already shown to induce oxidative stress 
and cell death in immature cortical neurons (Vaz et al., 2010). We started by investigating 
whether UCB up-regulates nNOS expression, as well as production of nitrites and cGMP, the 
resulting product of soluble guanylate cyclase stimulation by .NO (Knowles et al., 1989), in 
neurons exposed to UCB for 1 to 24 h. As shown in Figure IV.1A, UCB rapidly (at 1 h) 
induced nNOS expression in cortical and hippocampal neurons, but not in cerebellar 
neurons. The effect was already pronounced after 4 h of treatment (p<0.01 vs. respective 
controls) and decreased at 24 h. Furthermore, we observed a raise in the production of 
nitrites (Fig. IV.1B), as well as cGMP (Fig. IV.1C), after 1 h of treatment with UCB, in neurons 
from all brain regions (p<0.01 for nitrites and p<0.05 for cGMP vs. respective controls). To 
note that hippocampal neurons, namely at 4 h of incubation with UCB, showed to be the 
most sensitive regarding nNOS expression (1.4- vs. 1.2- and 1.0- fold in cortical and 
cerebellar neurons p<0.01), nitrite production (3.8- vs. 2.2-fold in cortical and cerebellum 
neurons, p<0.01) and cGMP content (1.7- vs. 1.3-fold, in cortical and cerebellar neurons, 
p<0.01 and p<0.05, respectively). 
 
3.2. UCB-induced oxidative stress is highest in immature hippocampal neurons, 
probably as a result of the lowest levels of total glutathione  
Having observed that RNS are produced by immature neurons exposed to UCB, we 
considered relevant to look for alterations in the oxidative status of neuronal cells from the 
three mentioned brain regions. Firstly, we determined whether UCB induced mitochondrial 
ROS production by evaluation of fluorescence intensity of rhodamine 123. 
As shown in Figure IV.2A-B, UCB induced oxidative stress more markedly after 4 h 
treatment in immature hippocampal and cerebellar neurons (p<0.01 vs. respective controls) 
by cortical cells (p<0.05 vs. respective control).  
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Figure IV.1 - Unconjugated 
bilirubin (UCB)-induced 
neuronal nitric oxide synthase 
(nNOS) expression and 
production of nitrites and cyclic 
GMP (cGMP) is enhanced in 
immature hippocampal neurons 
as compared to cerebellar or 
cortical neurons. Primary neuron 
cultures from rat cortex, 
hippocampus and cerebellum, at 3 
days in vitro, were incubated with 
either no addition (control) or with 
UCB (50 µM), in the presence of 
human serum albumin (100 μM), 
from 1 to 24 h at 37ºC. It was 
determined nNOS expression by 
western blot analysis (A), nitrites 
by Griess reagent (B) and cyclic 
GMP by a colorimetric kit (C). 
Results are mean (± SEM) from at 
least three independent 
experiments performed in 
duplicate. *p<0.05, **p<0.01 vs. 
respective control; $p<0.05, 
$$p<0.01 vs. cortical neurons; 
#p<0.05, ##p<0.01 vs. cerebellar 
neurons. 
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Figure IV.2 - Unconjugated bilirubin (UCB)-induced oxidative stress is highest in 
immature hippocampal neurons, as compared to the other brain regions. Primary 
neuron cultures from rat cortex, hippocampus and cerebellum, at 3 days in vitro, were treated 
as in Figure IV.1. Reactive oxygen species (ROS) content was evaluated by measuring 
fluorescence intensity of the cells (A) and expressed in arbitrary units (A.U.), resulting from 
fluorescence intensity per total number of cells (B). Scale bar represents 40 μm. Results are 
mean (± SEM) from at least three independent experiments performed in duplicate. *p<0.05, 
**p<0.01 vs. respective control; $$p<0.01 vs. cortical neurons; ##p<0.01 vs. cerebellar 
neurons. 
 
Secondly, we measured glutathione content of the UCB-treated neurons. We observed 
that UCB markedly disrupted glutathione homeostasis, as indicated in Fig. IV.3A by an 
increase in GSSG/GSt ratio, mostly in hippocampal neurons after 4 h of treatment (p<0.01) 
but also markedly either in cortical or cerebellar neurons (p<0.05). Therefore, we may 
assume that hippocampal neurons were again the most reactive to UCB in terms of ROS 
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production (2- vs. 1.4- and 1.7- fold in cortical and cerebellar neurons, respectively, p<0.01), 
and disruption of glutathione homeostasis (5.3- vs. 2.3- and 2.1-fold in cortical and cerebellar 
neurons, respectively, p<0.01), probably because they show, as indicated in Figure IV.3B, 
the lowest levels of total glutathione in the absence of UCB (p<0.01 vs. cortical neurons and 
p<0.05 vs. cerebellar neurons), whereas no significant changes were produced by UCB (data 
not shown).  
 
Figure IV.3 - Unconjugated bilirubin (UCB)-induced disruption of glutathione 
metabolism is particularly evident in immature hippocampal neurons, whose 
vulnerability appears to be determined by the lowest total glutathione levels relatively 
to the other brain regions. Primary neuron cultures from rat cortex, hippocampus and 
cerebellum, at 3 days in vitro, were treated as in Figure IV.1. Total (GSt) and oxidized 
(GSSG) glutathione were determined by an enzymatic assay and expressed as GSSG/GSx 
ratio (A) and as nmol/mg protein in the case of GSt (B). Results are mean (± SEM) from at 
least three independent experiments performed in duplicate. *p<0.05, **p<0.01 vs. respective 
control; $$p<0.01 vs. cortical neurons; #p<0.05, ##p<0.01 vs. cerebellar neurons. 
 
3.3. UCB-induced neuronal death is higher in immature cells from hippocampus than 
in those from cortex or cerebellum 
We kept on determining whether UCB-induced oxidative stress courses in parallel with 
cell death, by evaluating the necrotic-like cell death using PI uptake as an indicator of 
membrane integrity and cell damage. We have also determined the possible involvement of 
the apoptotic pathways by evaluating the relative levels of active form of caspase-3, an 
effector caspase of apoptotic cascade (Fink and Cookson, 2005). As demonstrated in Figure 
IV.4 A-B, UCB increased cellular uptake of PI in immature neurons, mainly after 4 h of 
exposure (p<0.05 vs. respective control in cortical and cerebellar neurons and p<0.01 in 
hippocampal ones). In Figure IV.4C, we verified an increase in the active form of caspase-3, 
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also with peak levels at 4 h of treatment (p<0.01 vs. respective controls). Once more, 
hippocampal neurons showed to be most sensitive to UCB, revealing higher necrosis (2.4- 
vs. 1.5- and 1.7-fold in cortical and cerebellar neurons, p<0.05) and apoptosis (1.3- vs. 1.2-
fold in cortical and cerebellar neurons). 
 
Figure IV.4 - Unconjugated bilirubin (UCB)-induced cell induced neuronal death is 
higher in cells from hippocampus than those from cortex or cerebellum. Primary 
neuron cultures from rat cortex, hippocampus and cerebellum, at 3 days in vitro, were treated 
as in Figure IV.1. Necrotic-like cell death was assessed by monitoring the cellular uptake of 
the fluorescent red dye propidium iodide (PI). PI+ cells are shown in pink, resulting from co-
localization with nuclear staining with Hoechst 33258 dye, in blue (A) and expressed as a 
percentage per total number of cells (B). Scale bar represents 40 μm. Caspase-3 expression 
was determined by western blot analysis (C). Results are mean (± SEM) from at least three 
independent experiments performed in duplicate. *p<0.05, **p<0.01 vs. respective control; 
$p<0.05, $$p<0.01 vs. cortical neurons; #p<0.05, ##p<0.01 vs. cerebellar neurons. 
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3.4. UCB-induced neuronal oxidative stress and cell death in immature neurons is 
prevented by NAC 
To determine whether oxidative stress is related to UCB-induced neuronal death, we 
evaluated ROS production, glutathione homeostasis and necrotic-like cell death in cells 
treated with 100 µM NAC for 1 h, followed by 4 h incubation with UCB or not. NAC is a 
cysteine donor, thus it promotes the synthesis of glutathione (Dringen, 2000, Zachwieja et 
al., 2005). The concentration of this molecule was chosen based on our previous data 
demonstrating that NAC prevents UCB-induced protein oxidation in 8 DIVs neurons (Brito et 
al., 2008b). As stated in Table IV.1, pre-incubation with NAC significantly decreased ROS 
production (p<0.05 vs. UCB-treated cortical neurons and p<0.01 vs. UCB-treated cerebellar 
and hippocampal neurons), GSSG/GSt ratio (p<0.05 vs. UCB-treated cortical and cerebellar 
neurons and p<0.01 vs. UCB-treated hippocampal neurons) and PI+ cells (p<0.05 vs. UCB-
treated cortical and hippocampal neurons and p<0.01 vs. UCB-treated cerebellar neurons). 
Together, these results indicate that oxidative stress is involved in neuronal death by UCB.    
 
3.5. UCB regulates DJ-1 protein expression in immature neurons, mainly in those from 
hippocampus, which is reverted by NAC 
There are several proteins that are differently expressed in response to toxic stimulus. 
DJ-1, a protein involved in Parkinson ’s disease pathogenesis (Bonifati et al., 2003), is 
particularly important as a redox-sensitive chaperone (Shendelman et al., 2004), protecting 
neurons from oxidative stress and cell death (Lev et al., 2008, Lev et al., 2009), thus, 
representing a putative protein for an adaptative response against UCB-induced oxidative 
stress and neurotoxicity. Therefore, we evaluated DJ-1 protein expression in immature 
neurons from the three regions, following incubation with UCB, in the absence or presence of 
NAC. As observed in Figure IV.5A,C, 4 h treatment with UCB led to an increased expression 
of DJ-1 in cortical and hippocampal neurons (respectively, p<0.05 and p<0.01 vs. respective 
control), suggesting that DJ-1 protein expression is up-regulated, as an attempt to diminish 
UCB-induced oxidative stress. However, after 24 h incubation, there is a significant decrease 
of DJ1 expression in neurons from the three regions (p<0.05 vs. respective control for 
cortical and cerebellar neurons and p<0.01 vs. respective control from hippocampal 
neurons), suggesting that this effort to prevent oxidative stress is transient as it fails after 
longer periods of neuronal exposure to UCB. Accordingly, with the abovementioned data, 
hippocampal neurons are the most affected ones (36% reduction vs. 15% and 9% in cortical 
and cerebellar neurons, respectively, p<0.01). In addition, this up or down-regulation of DJ-1 
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is suppressed by NAC (Fig. IV.5B, D). These data support the notion that UCB-induced 
oxidative stress mediates, at least in part, DJ-1 up-regulation.    
 
Table IV.1. Oxidative stress and cell death by UCB is higher in immature hippocampal 
neurons than in cells from cortex and cerebellum, and is partially prevented by NAC. 
 
Primary neuron cultures from rat cortex, hippocampus and cerebellum at, 3 days in vitro, 
were incubated with 50 µM unconjugated bilirubin (UCB), in the presence of 100 μM human 
serum albumin, for 24 h at 37ºC. In parallel experiments, cells were incubated with 100 mM 
N-acetyl cysteine (NAC), a precursor of glutathione synthesis for 1 h, prior to UCB addition. 
Reactive oxygen species (ROS) content was evaluated by measuring fluorescence intensity 
of the cells, total (GSt) and oxidized (GSSG) glutathione were determined by an enzymatic 
assay and necrotic-like cell death was assessed by monitoring the cellular uptake of the 
fluorescent red dye propidium iodide (PI). Results are expressed as fold change over 
respective control and are mean (± SEM) from at least three independent experiments 
performed in duplicate. *p<0.05, **p<0.01 vs. respective control; $p<0.05, $$p<0.01 vs. 
cortical neurons; ##p<0.01 vs. cerebellar neurons; &p<0.05,  &&p<0.01 vs. respective condition 
without NAC.  
 
 
Control UCB 50 μM NAC 100 μM
UCB 50 μM    
+ 
NAC 100 μM
Cortical 
neurons 1.00 ± 0.07 1.45 ± 0.10 0.99 ± 0.17 0.95 ± 0.14
ROS 
production Cerebellar neurons 1.00 ± 0.14 1.68 ± 0.18 0.58 ± 0.08 0.75 ± 0.02
Hippocampal 
neurons 1.00 ± 0.24 2.01 ± 0.27 0.58 ± 0.03 0.96 ± 0.03
Cortical 
neurons 1.00 ± 0.07 2.27 ± 0.15 1.21 ± 0.08 0.74 ± 0.02
GSSG/GSt Cerebellar neurons 1.00 ± 0.10 2.13 ± 0.14 1.00 ± 0.04 0.82 ± 0.11
Hippocampal 
neurons 1.00 ± 0.26 5.32 ± 0.77 0.63 ± 0.00 0.91 ± 0.25
Cortical 
neurons 1.00 ± 0.13 1.26 ± 0.24 0.80 ± 0.18 0.85 ± 0.05
PI+ cells Cerebellar neurons 1.00 ± 0.15 1.66 ± 0.26 0.56 ± 0.10 0.62 ± 0.12
Hippocampal 
neurons 1.00 ± 0.19 2.37 ± 0.14 0.74 ± 0.08 1.22 ± 0.38
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Figure IV.5 - Early up-regulation of DJ-1 protein expression by unconjugated bilirubin 
(UCB) is reverted for longer periods of incubation, and suppressed in the presence of 
N-acetyl cysteine (NAC), namely in immature neurons from hippocampus. Primary 
neuron cultures from rat cortex, hippocampus and cerebellum at, 3 days in vitro, were 
incubated with UCB (50 µM), in the presence of human serum albumin (100 μM), from 1 to 
24 h at 37ºC (A). In parallel experiments, cells were incubated with 100 μM NAC, a precursor 
of glutathione synthesis for 1 h, prior to UCB addition (B). DJ-1 expression was determined 
by western blot analysis. Representative results for 24 h incubation with UCB are indicated in 
the absence (C) or in the presence (D) of NAC. Results are mean (± SEM) from at least 
three independent experiments performed in duplicate. *p<0.05, **p<0.01 vs. respective 
control; $$p<0.01 vs. cortical neurons; ##p<0.01 vs. cerebellar neurons; &&p<0.01 vs. 
respective condition without NAC. 
 
3.6. UCB-induced reduction of neurite outgrowth and branching mainly in immature 
neurons from hippocampus, is closely followed by those from cerebellar and 
cortical regions, and is prevented by NAC 
.NO showed to be involved in cell death, as well as in impairment of neurite ramification 
and extension of immature cortical neurons after exposure to UCB, as we recently 
demonstrated (personal communication Ana Rita Vaz, 2010; personal communication 
Sandra L Silva, 2010, respectively). To investigate if oxidative stress affects neuritic 
arborization, we assessed the neuronal network dynamics in cells non-treated or treated with 
UCB in the presence or absence of NAC. We selected the longest time of incubation (24 h), 
based on our previous reports showing UCB-induced neurite impairment in immature cortical 
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neurons after 24 h treatment (Falcão et al., 2007) and because the decreased expression of 
DJ-1 was found at 24 h incubation. As shown in Figure IV.6, UCB led to a decrease in 
neurite extension and number of nodes in immature neurons from hippocampus and 
cerebellum (p<0.01 vs. respective control) followed by those from cortex (p<0.05 vs. 
respective control). In accordance with all the other results, neurite impairment by UCB was 
higher in hippocampal neurons, both in total neurite output (42% reduction vs. 19% and 32% 
in cortical and cerebellar neurons) and in number of branch points (38% reduction vs. 27% 
and 29% in cortical and cerebellar neurons). Interestingly, pre-incubation with NAC 
significantly prevented UCB-diminished neurite outgrowth (p<0.05), suggesting that 
glutathione content may account to the resistance against UCB-induced neurite network 
disruption. Therefore, different susceptibilities between brain regions may be partially due to 
distinct levels of antioxidants. 
 
4. Discussion 
In previous reports we demonstrated that UCB-induced neurotoxicity differs from nerve 
cell type and maturation state, being cortical neurons more susceptible than cortical 
astrocytes (Brito et al., 2008b, Falcão et al., 2006) and immature cells (3 DIVs) more 
vulnerable than more differentiated (8 DIVs) ones (Falcão et al., 2005, Falcão et al., 2006). 
Furthermore, oxidative stress and disruption of neuronal network dynamics were indicated as 
pathological hallmarks in UCB-induced neurotoxicity (Brito et al., 2008a, Falcão et al., 2007, 
Vaz et al., 2010, Fernandes et al., 2009). Based on these data, here we investigated for the 
first time whether brain UCB specific pattern toxicity is determined by differential regional 
susceptibility to UCB-induced oxidative stress and disruption of neurite arborization in 
immature neurons, due to the increased vulnerability of premature babies. We also looked 
for potential defence mechanisms as that of DJ-1 protein expression and glutathione content 
as modulators of UCB-induced neurotoxicity.   
In this study, we demonstrate that UCB leads to nitrosative and oxidative stress, as we 
observed nNOS increased protein expression, production of nitrites and cGMP, as well as an 
increase in the levels of ROS and of oxidized glutathione in immature neurons. Interestingly, 
in spite of these biomarkers of oxidative stress are observed in immature neurons isolated 
from all the three regions studied (cortex, cerebellum and hippocampus), they are mainly 
detected in cells from hippocampus. For this differential vulnerability to UCB within brain 
regions may account distinct responses at the cellular or biochemical processes, such as 
antioxidant defences. In fact, total glutathione levels were markedly lower in immature 
neurons from hippocampus, compared with those from cortex and cerebellum, as 
demonstrated in Figure IV.3B.  
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Figure IV.6 - Unconjugated bilirubin (UCB)-induced reduction of neurite outgrowth and 
branching in immature neurons from hippocampus is reduced at cerebellar and 
cortical levels, and is partly prevented by N-acetyl cysteine (NAC). Primary neuron 
cultures from rat cortex, hippocampus and cerebellum, at 3 days in vitro, were incubated with 
UCB (50 µM), in the presence of human serum albumin (100 μM), for 24 h at 37ºC. In 
parallel experiments, cells were incubated with 100 μM NAC, a precursor of glutathione 
synthesis for 1 h, prior to UCB addition. Neurite extension and number of nodes were 
evaluated by immunocytochemistry with MAP-2 labeling (A) as indicated in Methods. Scale 
bar 40 μM. Total neurite output (B) and number of branch points (C) were quantified in HCA-
Vision Neurite Analysis software. Results are mean (± SEM) from at least three independent 
experiments performed in duplicate. *p<0.05, **p<0.01 vs. respective control; $$p<0.01 vs. 
cortical neurons; &p<0.05, &&p<0.01 vs. respective condition without NAC. 
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Supporting this concept, it was reported that antioxidant enzymes, such as xantine 
oxidase and catalase, have maximum activity in cortex, followed by cerebellum and 
hippocampus in developing mouse brain exposed to lead (Prasanthi et al., 2010). 
Furthermore, primary astroglial cultures isolated from cortex, striatum, or hippocampus 
revealed distinct profiles of vulnerability when subjected to injury. While astrocytes from 
striatum showed increased injury by oxygen and glucose deprivation, they were more 
resistant to an oxidative insult resultant from exposure to H2O2 since they have higher levels 
of antioxidant defences, such as glutathione levels and glutathione peroxidase and 
superoxide dismutase activities (Xu et al., 2001). Interestingly, glutathione peroxidase activity 
was considered determinant in the recovery of the immature mouse brain subjected to 
traumatic brain injury (Tsuru-Aoyagi et al., 2009). Taking these into account, together with 
the preventive effects of NAC on UCB-induced neurotoxicity, we hypothesize that 
hippocampal vulnerability to UCB is, at least in part, due to the lower content of the 
antioxidant molecule glutathione. 
For the differential susceptibilities to UCB neurotoxicity in the different brain areas may 
also account the UCB specific affinities, after crossing the blood brain barrier. Hippocampus 
is one of the brain regions stained by UCB in severely jaundiced neonates who died with 
kernicterus (Ahdab-Barmada and Moossy, 1984, Hansen, 2000). The selective bilirubin 
deposition in cases of kernicterus seems to take into account the areas more vulnerable to 
hypoxic ischemic injury, such as the pyramidal cell layer of the hippocampus (Perlman et al. 
1997), which raises the question of whether hypoxic-ischemic injury is important to the 
development of the lesions by kernicterus. In addition, ischemic injury is also usually 
associated with an increased production of the VEGF, which was recently detected in 
hippocampal neurons from a kernicteric patient (personal communication Alexandra Brito, 
2010). It is known that hippocampus is particularly affected by hypoxic-ischemic insult in 
animal models of both mature and immature brain (Guzzetta et al., 2000, Jiang et al., 2004). 
To this feature may account the distribution of immature NMDA receptors, which 
corresponds to regions that preferentially express nNOS (Black et al., 1995, Greenamyre et 
al., 1987, Mitani et al., 1998). Interestingly, hippocampal neurons were the main responders 
to UCB in terms of nNOS protein expression and activation (increased concentrations of 
nitrates and cGMP). Inhibition of mitochondrial cytochrome c oxidase observed in immature 
neurons exposed to UCB (Vaz et al., 2010) is surely one of the causes. Accordingly, UCB 
was shown to promote cytochrome c release in isolated mitochondria from the brain and liver 
of adult male Wistar rats (Rodrigues et al., 2002, Rodrigues et al., 2000). Recently, our group 
demonstrated that .NO signalling mediates, at least in part, UCB-induced neuronal injury, 
both in mature (Brito et al., 2010) and in immature neurons (personal communication Ana 
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Rita Vaz, 2010), and also that inhibition of nNOS prevented  glutathione impairment (Brito et 
al., 2010). Additionally, neuronal damage mediated by nNOS was noticed in hypoxia-
ischemia (Ferriero et al., 1996, Ferriero et al., 1995) and its inhibition confered tissue 
protection and reduction of caspase-3 activation (Peeters-Scholte et al., 2002, Zhu et al., 
2004). All these findings are reinforced by data demonstrating that .NO and NOS mediate 
apoptosis during inflammation in neuronal cells (Hemmer et al., 2001, Heneka et al., 1998, 
Thomas et al., 2008), indicating that .NO is a player in the developing brain cytotoxicity.
Besides antioxidant defences, regional differences in the Ca2+-induced mitochondrial 
permeability transition (Friberg et al., 1999) and DNA damage (Cardozo-Pelaez et al., 2000) 
were reported between hippocampus, cortex, and striatum, which are also signs of increased 
pro-oxidant activity. Accordingly, our results demonstrated that intracellular production of 
ROS from those specific brain regions is a result of UCB interaction. Protein oxidation, lipid 
peroxidation, alterations in glutathione stores, decreased NADPH concentration and 
superoxide anion radical production are also additional features produced by UCB in cortical 
neurons (Brito et al., 2008b, Brito et al., 2010, Vaz et al., 2010).  
Here, we evidenced that UCB-induced oxidative and nitrosative stress occur in parallel 
with necrotic and apoptotic cell death, as demonstrated by increased levels of PI uptake and 
caspase-3 activation, thus participating in the mechanisms of UCB-induced neurotoxicity. 
Accordingly, experimental obstructive jaundice was shown to be correlated with oxidative 
stress in rats' brain (Chroni et al., 2006). This surely accounts for the preventive effect of 
NAC on UCB-induced oxidative stress and necrotic cell death. This is not without precedent 
since NAC treatment was shown to be neuroprotective in lead-induced lipid peroxidation and 
in antioxidant enzyme activities deficiencies of rats’ brain (Nehru and Kanwar, 2004), as well 
as during hypoxia in cultures of rats' hippocampal neurons (Jayalakshmi et al., 2005). 
Furthermore, results from our group demonstrated that NAC treatment protects from UCB-
induced protein oxidation (Brito et al., 2008b).   
We extended our studies to the evaluation of the expression of DJ-1, a protein involved 
in Parkinson’s disease pathogenesis (Bonifati et al., 2003), with particular relevance in 
neuroprotection against oxidative stress and cell death (Lev et al., 2009, Lev et al., 2008). 
Our data indicate that DJ-1 protein expression is transiently up-regulated suggesting an 
intervening role to diminish acute UCB-induced oxidative in hippocampal neurons. Recently 
DJ-1 was indicated as a protective factor against UCB-induced oxidative stress in human 
neuroblastoma SH-SY5Y cell line (Deganuto et al., 2010). DJ-1 was also shown to negatively 
regulate N-methyl-d-aspartate receptor (NMDAR) function and suppression of this protein led 
to NMDAR-induced cell death (Chang et al., 2010). This is of particular interest, since UCB-
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induced neurotoxicity is mediated by glutamate receptors in cultured rat brain neurons 
(Grojean et al., 2000, Grojean et al., 2001, Brito et al., 2010). Accumulation of extracellular 
glutamate, secreted by UCB-exposed neurons (Brito et al., 2010, Falcão et al., 2006), and 
glial cells, namely by microglia and immature astrocytes (Fernandes et al., 2004, Falcão et 
al., 2005, Gordo et al., 2006) is a dominant cell response. Nevertheless, persistent 
hyperbilirubinemia seems to down-regulated DJ-1, notoriously in hippocampus, what can 
contribute for the deleterious effects of the condition. Most important, this effect was reverted 
by NAC.  
It was reported by our group that UCB impairs of neurite extension and ramification, in 
immature cortical neurons, from which cells do not recover along the differentiation (Falcão 
et al., 2007). UCB also showed to interfere with the development of hippocampal neurons, 
reducing dendritic and axonal elongation and branching, axonal growth cones and number of 
dendritic spines and synapses (Fernandes et al., 2009). This UCB-elicited impairment in 
neuritic outgrowth was demonstrated to be mediated by .NO and overstimulation of NMDA 
receptors and, thus, prevented by the use of inhibitors, even during nerve cell maturation 
(personal communication Sandra L Silva, 2010). Interestingly, here we demonstrate that 
hippocampus is the most affected in neurite impairment by UCB, what raises the possibility 
that neonatal jaundice could have an impact on the infant’s learning and memory. 
Observations by Weir and Millar revealed that adverse effects for learning are observed in 
severe cases of hyperbilirubinemia history (Weir and Millar, 1997).  
In conclusion, the data obtained show that UCB, in conditions mimicking a moderate 
hyperbilirubinemia in the early neonatal period, induces oxidative stress in different brain 
regions, particularly in the hippocampus. Furthermore, these results provide specific features 
that may explain this differential susceptibility along different brain areas to UCB exposure, 
namely local differences in glutathione content and in DJ-1 expression, important molecules 
involved in the regulation of oxidative damage. Moreover, here we suggest that UCB 
neuronal exposure will differently affect neurite outgrowth and ramification in distinct cell 
populations, pointing hippocampal neurons as preferential target to short and long-term 
UCB-induced neuronal dysfunction. 
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1. Concluding remarks and perspectives 
The present thesis was designed to bring new insights into the cellular mechanisms 
underlying neonatal hyperbilirubinemia neurotoxicity, and particular attention was given to 
the role of oxidative stress in immature neurons exposed to unconjugated bilirubin (UCB). It 
is widely accepted that hyperbilirubinemia in preterm infants is more prevalent, more severe 
and represents an increased risk for the development of neurologic dysfunction in later life 
(Stevenson et al., 2001, Watchko, 2006). Therefore, it is important to better understand the 
essential mechanisms that contributes to the increased vulnerability of prematures to UCB 
encephalopathy.  
Cultured neuronal cells are powerful experimental models that we have adopted to 
evaluate the deleterious effects of UCB. We have decided to use rat primary cultures of 
neurons at 3 days in vitro (DIV), to mimic a condition of prematurity. This model was chosen 
based on previous results demonstrating that immature cells are more susceptible to UCB-
induced neurotoxic effects than more differentiated ones (Falcão et al., 2005, Falcão et al., 
2006). In addition, this work focused on primary cultures of neurons, since they showed to be 
more prone to oxidative injury and mitochondrial dysfunction and consequent cell death than 
astrocytes, for which differences in glutathione content appear to have an important role 
(Almeida et al., 2002, Almeida et al., 1998, Bolaños et al., 1996, Brito et al., 2008b). 
Using this model, in the first experimental part of this thesis (chapter II), it is 
demonstrated that UCB neuronal exposure rapidly inhibits cytochrome c oxidase (complex 
IV) activity and ascorbate-driven oxygen consumption in 3 DIV rat cortical neurons. This 
impairment of mitochondrial respiration was accompanied by a bioenergetic crisis, as judged 
by the collapse of the inner-mitochondrial membrane potential, increased glycolytic activity, 
and adenosine triphosphate (ATP) release. In addition, it was observed a disruption of 
oxidized status of the cells, with increased superoxide anion radical production, disruption of 
glutathione metabolism and impairment of reduced nicotinamide adenine dinucleotide 
phosphate (NADPH) production. These events coursed in parallel with apoptotic cell death, 
as determined by increased activities of mitochondrial-dependent caspases-9 and -3, as well 
as increased annexin V+ neurons and condensed or fragmented nuclei. The mitochondrial 
dysfunction observed by UCB may involve nitric oxide (.NO), which is capable of rapidly and 
reversibly inhibit the mitochondrial respiratory chain (Bolaños et al., 1994, Brown and 
Cooper, 1994, Cleeter et al., 1994). In fact, recent studies reported that neuronal oxidative 
disruption by UCB is counteracted by inhibition of neuronal NO synthase (nNOS) (Brito et al., 
2008a, Mancuso et al., 2008). In the present work, the mitochondrial impairment by UCB 
accompanied by the up-regulation of glycolysis suggests an attempt of immature neuronal 
cells to support the bioenergetic crisis, as previously demonstrated for astrocytes exposed to 
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toxic stimulus (Bolaños et al., 2004). Nevertheless, excess of neuronal released ATP 
determines .NO production and may be associated with neuronal apoptosis (Figueroa et al., 
2006, López et al., 2006). Finally, since NADPH levels are necessary to restore reduced 
glutathione (Dringen, 2000), UCB-induced up-regulation of glycolysis may lead to inhibition of 
the pentose-phosphate pathway (PPP), causing decrease of NADPH levels and, 
consequently,  glutathione oxidation, a notion recently reported for neuronal cultures 
(Herrero-Mendez et al., 2009). In this study, neuroprotective effects of glycoursodeoxycholic 
acid (GUDCA) were tested, since this bile acid was recently demonstrated to inhibit neuronal 
cell death and oxidative stress (Brito et al., 2008a), as well as astrocytic inflammatory 
response and consequent apoptotic and necrotic cell death (Fernandes et al., 2007b). In 
summary, treatment of neurons with GUDCA prior to exposure to UCB prevented inhibition of 
cytrochrome c oxidase activity, preserved cellular redox status and maintained cellular 
viability. Taken together, these data suggest that cytochrome c oxidase inhibition is involved 
in the neurotoxicity associated with UCB-induced neurological dysfunction and strongly 
indicates the possible therapeutic potential of GUDCA in the treatment of neonatal jaundice.  
In the second part of the work presented (chapter III), it is discussed the role of 
neuroinflammation, a risk factor that is often associated with neonatal hyperbilirubinemia and 
that is responsible for the alteration of blood brain barrier permeability through the release of 
great amounts of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α+, 
interleukin-1β (IL-1β) and interleukin-6 (IL-6) (Goldenberg and Andrews, 1996). In fact, 
infection increases the risk for UCB encephalopathy (Dawodu et al., 1984) and presence of 
inflammatory features, namely fever episodes and brain edema, were already described 
during or following moderate to severe hyperbilirubinemia (Kaplan and Hammerman, 2005). 
Interestingly, immature neuronal and astroglial cells showed higher levels of released 
glutamate and TNF-α induced by exposure to UCB than more differentiated ones (Falcão et 
al., 2006). Moreover, LPS showed to exacerbate the release of TNF-α and IL-1β by 
immature astrocytes (Falcão et al., 2005), which provides a basis for the increased risk of 
hyperbilirubinemia in the presence of sepsis. The results presented here reveal neuronal 
dysfunction in 3 DIV rat cortical neurons by exposure to UCB, resulting from activation of 
both the intrinsic and extrinsic pathways of apoptosis and loss of cellular functionality. Most 
important, the results provide supportive evidence for the commonly indicated higher risk of 
UCB brain damage in a condition of inflammation, since the association of pro-inflammatory 
cytokines, TNF-α+IL-1β, to the condition of hyperbilirubinemia significantly increased the 
cytotoxic potential of UCB through the same cascade of mediators. In this study, .NO 
signalling and JNK1/2 activation are pointed to be key players in neurotoxicity induced by 
hyperbilirubinemia and associated inflammation. In fact, several studies highlighted the 
Final considerations 
__________________________________________________________________________ 
 
 
141 
 
association between inflammation and the generation of reactive oxygen species and/or 
reactive nitrogen species (ROS/RNS) (Bian and Murad, 2001, Brito et al., 2007, Sener et al., 
2005) and one of them, .NO, is important in the pathogenesis of inflammation (Korhonen et 
al., 2005). .NO and induction of NOS are involved in apoptosis induced by inflammatory 
mediators in neuronal cells (Hemmer et al., 2001, Heneka et al., 1998, Thomas et al., 2008). 
Interestingly, in recent studies with mature neurons (rat primary cultures used at 8 DIV), UCB 
exposure increased the expression of nNOS and production of .NO, cyclic guanosine 3',5'-
monophosphate (cGMP) and ROS, along with protein oxidation and depletion of glutathione 
(Brito et al., 2008b, Brito et al., 2010). Furthermore, stress-activated protein kinases, such as 
c-Jun N-terminal kinases 1/2 (JNK1/2), become activated in response to toxic stimulus, such 
as the RNS (Luo et al., 1998, Marques et al., 2003), and the pro-inflammatory cytokines 
TNF-α and IL-1, pointing these kinases as strong effectors of neuronal apoptosis (Mielke and 
Herdegen, 2000, Tibbles and Woodgett, 1999). More recently, JNK 1/2 showed to directly 
mediate the UCB-stimulation of TNF-α by astrocytes (Fernandes et al., 2007a). This feature 
may be relevant if we consider that astrocytic activation has also been reported in several 
neurodegenerative disorders and that this transition may be accompanied by dysfunction of 
astrocytes leading to incorrect glia-to-neuron cross-talk (Rossi and Volterra, 2009). In 
conclusion, these results provide evidence for the commonly indicated higher risk of UCB 
brain damage in an inflammatory-associated condition.  
In the third part of this work (chapter IV), it is discussed the different regional 
vulnerability to UCB-induced neurotoxicity. For this purpose, rat primary neurons were 
isolated from cortex, hippocampus and cerebellum and cultured for 3 DIV. Hippocampal and 
cerebellar neurons were chosen based on preferential deposition pattern in the brain in 
kernicteric conditions (Ahdab-Barmada and Moossy, 1984, Hansen, 2000). Here it is 
demonstrated that neurons from hippocampus are more susceptible to UCB-induced 
oxidative and nitrosative stress than those from cerebellum and cortex. For this differential 
vulnerability to UCB within brain regions may account distinct antioxidant defences, since the 
lowest levels of total glutathione were found in immature neurons from hippocampus. In 
agreement with this concept, antioxidant enzymes, such as xantine oxidase, catalase and 
glutathione peroxidase, showed minimum activity in hippocampus in different models, such 
as developing mouse brain and astrocytic cultures (Prasanthi et al., 2010, Tsuru-Aoyagi et 
al., 2009, Xu et al., 2001). Considering these facts, together with the results achieved with 
the precursor of glutathione, N-acetylcysteine (NAC), where there was a protection from UCB 
neurotoxicity, it is conceivable that hippocampal preferential vulnerability to UCB is, at least 
in part, due to the lower glutathione content. Another important finding is the increased 
vulnerability of hippocampal neurons to UCB-induced neurite arborization impairment. 
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Interestingly, in a very recent study with the same cellular model, inhibition of nNOS 
abrogated the deleterious effects produced by UCB in network dynamics (personal 
communication Sandra L Silva, 2010), result that were maintained along cell maturation, 
indicating that short and long-term UCB toxic effects are prevented through inhibition of .NO 
release. Since hippocampus is crucial for the linkage of short-term memory to the learning 
process and the storage of spatial information (de Hoz et al., 2003, O'Neill et al., 2010, 
Scoville and Milner, 1957), disassembly of neuritic development in neonatal 
hyperbilirubinemia may account for a reduced learning memory ability and memory loss.  
Cytoskeleton disassembly, loss of dendrites and axons and impairment of 
neurotransmission are responsible for synaptic connectivity disruption, which are contributors 
to the development of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s 
diseases (Benitez-King et al., 2010, Evans et al., 2008). Since oxidative stress is a hallmark 
of these pathologies (Halliwell, 2006, Lin et al., 2005), a better understanding of the neuronal 
models comprising both oxidative stress and neuronal network dynamics is extremely 
important in the comprehension of neurodegenerative diseases pathogenesis. In this study it 
was also evaluated the expression of DJ-1, a protein involved in Parkinson’s disease 
pathogenesis (Bonifati et al., 2003). However, in our experimental model, the effort to 
prevent oxidative stress by increasing DJ-1 levels fails after long periods of UCB neuronal 
exposure in neurons from all the three regions. Since down-regulation of DJ-1 is suppressed 
in the presence of NAC, we consider that UCB-induced oxidative stress participates in DJ-1 
regulation. In conclusion, the data obtained in the present study show that the condition of 
neonatal hyperbilirubinemia induces oxidative stress in different brain regions, particularly in 
the hippocampus. Furthermore, these results provide specific features that may explain the 
differential susceptibility throughout different brain areas to UCB exposure, such as local 
differences in glutathione content and in DJ-1 expression, important molecules involved in 
the regulation of oxidative damage.  
The major findings of this thesis are summarized in Figure V.1. Although we were able to 
answer the questions that constitute the starting point of this work, others were raised and 
remain to be clarified.  
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Figure V.1 – Integrative schematic representation of the major findings achieved in the 
present work, using immature neurons (3 DIV) isolated from brain cortex of fetuses 
from 16 days (E16) pregnant Wistar rats as experimental model. In the first part of this 
work (A), 3 DIV cortical neurons (Cx) exposed to unconjugated bilirubin (UCB), in conditions 
mimicking neonatal hyperbilirubinemia in the prematures, suffered oxidative stress, 
mitochondrial dysfunction associated with bioenergetic crisis and  cell death, effects that 
were prevented in the presence of glycoursodeoxycholic acid (GUDCA). In the second part 
(B), it is concluded that UCB-induced nitrosative stress, c-Jun N-terminal kinases 1 and 2 
(JNK1/2) and cell death are intensified by pro-inflammatory cytokines as tumor necrosis 
factor-α (TNF-α) and interleukin-1β (IL-1β), used to mimic infection, in 3 DIV cortical neurons. 
In addition, both L-NAME (nitric oxide synthase inhibitor) and SP600125 (JNK1/2 inhibitor) 
reversed the effects produced by UCB either alone, or in association to pro-inflammatory 
cytokines. In the third part (C), neurons were isolated not only from cortex but also from 
cerebellum (Cb) and hippocampus (Hc). Hc neurons were the most susceptible to UCB-
induced oxidative and nitrosative stress, as well as to UCB-induced neuritic impairment and 
cell death. N-acetylcysteine (NAC), a precursor of glutathione synthesis, was able to 
counteract the UCB-induced neurotoxicity.  
 
Since hippocampal neurons were shown to be more vulnerable to UCB-induced 
neurotoxicity than those from cortex and cerebellum, and that antioxidant defences will 
appear to account for this differential vulnerability, it would be interesting to study whether 
treatment of neuronal cultures with molecules that showed here to have antioxidant capacity, 
such as GUDCA and NAC, are able to prevent from long term oxidative stress and energy 
dysfunction in immature cultured neurons exposed to UCB, either alone or in association with 
pro-inflammatory cytokines. This will contribute to elucidate the molecular events underlying 
the relation between neonatal hyperbilirubinemia, alone or with associated inflammation, and 
the development of neurological disorders in latter life. It would also be important to 
determine if glutathione is the only molecule presented in lower levels in neurons from 
hippocampus or if other antioxidant systems, like superoxide dismutase and catalase are 
also compromised in these cells.   
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Hc Cb
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Cell death
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Other interesting issue that deserves to be addressed is whether activated astrocytes 
and microglia exert a preventive or toxic effect on immature neuronal cells. Neuronal-glial 
interactions constitute a major feature in the maintenance of neuronal homeostasis regarding 
vascular, ionic, redox and metabolic function in the brain. In fact, astrocytes provide neurons 
with energy and substrates for neurotransmission, as well as glutathione precursors (Allen 
and Barres, 2005, Dringen et al., 2000). In addition, microglia is one of the brain’s major 
sources of ROS and RNS and elevated concentrations of .NO (Bishop and Anderson, 2005), 
and may be implicated in neurodegenerative diseases and neural injury as previously 
discussed. Interestingly it has been demonstrated that UCB is able to activate microglia by 
the acquisition of a phagocytic and inflammatory phenotype, which includes the release of 
pro-inflammatory cytokines and release of glutamate (Gordo et al., 2006, Silva et al., 2010). 
Interestingly, studies performed in our laboratory (personal communication Sandra L Silva, 
2010) suggest that microglia exposure to UCB increases .NO production, effect that seems to 
be further augmented when microglia is incubated with UCB-treated neuron conditioned 
medium. In addition, stimulation of hippocampal slice cultures by UCB was recently reported 
to increase nitrites release into the culture medium, as well as intracellular production of 
glutamate, which is completed abrogated in microglia-depleted slice cultures. Since .NO 
signalling by UCB is one important finding of the studies discussed in this thesis, these 
observations suggest that microglial reactivity may be important for UCB-induced 
neurotoxicity. Therefore, it would be interesting to evaluate whether microglia plays a role in 
mitochondrial dysfunction and consequent cell death observed in chapter II, by using other 
experimental models, such as neuron-microglia co-cultures or in models with depleted or 
non-depleted microglia slices. 
These advances may substantiate target-driven approaches to the prevention and 
treatment of UCB-induced neurological damage, and provide fruitful opportunities for future 
investigations. 
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